<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" open-status="O" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Metab (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Metab (Lond)</journal-id><journal-title-group><journal-title>Nutrition &amp; Metabolism</journal-title></journal-title-group><issn pub-type="epub">1743-7075</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5504778</article-id><article-id pub-id-type="publisher-id">200</article-id><article-id pub-id-type="doi">10.1186/s12986-017-0200-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="58733" pm="."><plain>Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Dludla</surname><given-names>Phiwayinkosi V.</given-names></name><address><phone>+27 219380877</phone><email>pdludla@mrc.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Joubert</surname><given-names>Elizabeth</given-names></name><address><email>JoubertL@arc.agric.za</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Muller</surname><given-names>Christo J.F.</given-names></name><address><email>christo.muller@mrc.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Louw</surname><given-names>Johan</given-names></name><address><email>johan.louw@mrc.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Rabia</given-names></name><address><email>rabia.johnson@mrc.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9155 0024</institution-id><institution-id institution-id-type="GRID">grid.415021.3</institution-id><institution/><institution>Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, </institution></institution-wrap>P.O. Box 19070, Tygerberg, 7505 South Africa </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2214 904X</institution-id><institution-id institution-id-type="GRID">grid.11956.3a</institution-id><institution>Division of Medical Physiology, </institution><institution>Faculty of Health Sciences, Stellenbosch University, </institution></institution-wrap>Tygerberg, South Africa </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0388 8690</institution-id><institution-id institution-id-type="GRID">grid.428715.d</institution-id><institution>Plant Bioactives Group, Post-Harvest and Wine Technology Division, </institution><institution>Agricultural Research Council (ARC) Infruitec- Nietvoorbij, </institution></institution-wrap>Stellenbosch, South Africa </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2214 904X</institution-id><institution-id institution-id-type="GRID">grid.11956.3a</institution-id><institution>Department of Food Science, </institution><institution>Stellenbosch University, </institution></institution-wrap>Stellenbosch, South Africa </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.442325.6</institution-id><institution>Department of Biochemistry and Microbiology, </institution><institution>University of Zululand, </institution></institution-wrap>KwaDlangezwa, South Africa </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>14</volume><elocation-id>45</elocation-id><history><date date-type="received"><day>26</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1"><SecTag type="ABS"><text><SENT sid="58734" pm="."><plain>Diabetic patients are at an increased risk of developing heart failure when compared to their non-diabetic counter parts. </plain></SENT>
<SENT sid="58735" pm="."><plain>Accumulative evidence suggests chronic hyperglycemia to be central in the development of myocardial infarction in these patients. </plain></SENT>
<SENT sid="58736" pm="."><plain>At present, there are limited therapies aimed at specifically protecting the diabetic heart at risk from hyperglycemia-induced injury. </plain></SENT>
<SENT sid="58737" pm="."><plain>Oxidative stress, through over production of free radical species, has been hypothesized to alter mitochondrial function and abnormally augment the activity of the NADPH oxidase enzyme system resulting in accelerated myocardial injury within a diabetic state. </plain></SENT>
<SENT sid="58738" pm="."><plain>This has led to a dramatic increase in the exploration of plant-derived materials known to possess antioxidative properties. </plain></SENT>
<SENT sid="58739" pm="."><plain>Several edible plants contain various natural constituents, including polyphenols that may counteract oxidative-induced tissue damage through their modulatory effects of intracellular signaling pathways. </plain></SENT>
<SENT sid="58740" pm="."><plain>Rooibos, an indigenous South African plant, well-known for its use as herbal tea, is increasingly studied for its metabolic benefits. </plain></SENT>
<SENT sid="58741" pm="."><plain>Prospective studies linking diet rich in polyphenols from rooibos to reduced diabetes associated cardiovascular complications have not been extensively assessed. </plain></SENT>
<SENT sid="58742" pm="."><plain>Aspalathin, a flavonoid, and phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside, a phenolic precursor, are some of the major compounds found in rooibos that can ameliorate hyperglycemia-induced cardiomyocyte damage in vitro. </plain></SENT>
<SENT sid="58743" pm="."><plain>While the latter has demonstrated potential to protect against cell apoptosis, the proposed mechanism of action of aspalathin is linked to its capacity to enhance the expression of nuclear factor (erythroid-derived 2)-like 2 (<italic>Nrf2</italic>) expression, an intracellular antioxidant response element. </plain></SENT>
<SENT sid="58744" pm="."><plain>Thus, here we review literature on the potential cardioprotective properties of flavonoids and a phenylpropenoic acid found in rooibos against diabetes-induced oxidative injury. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group xml:lang="en"><title>Keywords</title><kwd>Diabetes mellitus</kwd><kwd>Hyperglycemia</kwd><kwd>Oxidative stress</kwd><kwd>Cardiomyopathy</kwd><kwd>Rooibos</kwd><kwd>Polyphenols</kwd></kwd-group></SecTag><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001321</institution-id><institution>National Research Foundation</institution></institution-wrap></funding-source><award-id>87836</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Rabia</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001322</institution-id><institution>South African Medical Research Council</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec id="Sec1"><title><text><SENT sid="58745" pm="."><plain>Background </plain></SENT>
</text></title><p id="Par18"><text><SENT sid="58746" pm="."><plain>The prevalence of diabetes mellitus (DM) is increasing at an alarming rate worldwide. </plain></SENT>
<SENT sid="58747" pm="."><plain>According to recent data by the International Diabetes Federation, the number of individuals living with DM is 415 million, and this figure is estimated to reach 642 million by the year 2040 [<xref ref-type="bibr" rid="CR1">1</xref>]. </plain></SENT>
<SENT sid="58748" pm="."><plain>Type 2 DM, which is associated with insulin resistance and obesity, represents approximately 90% of diabetic cases worldwide [<xref ref-type="bibr" rid="CR2">2</xref>]. </plain></SENT>
<SENT sid="58749" pm="."><plain>Type 1 DM is characterized by deficient insulin secretion and chronic hyperglycemia. </plain></SENT>
<SENT sid="58750" pm="."><plain>Chronic hyperglycemia remains the leading causal factor for the development of cardiovascular disease (CVD) and heart failure (HF) in a diabetic state [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. </plain></SENT>
<SENT sid="58751" pm="."><plain>Chronic hyperglycemia alters the myocardial substrate preference in cardiomyocytes and augments production of free radical species, giving rise to oxidative stress [<xref ref-type="bibr" rid="CR5">5</xref>]. </plain></SENT>
<SENT sid="58752" pm="."><plain>Oxidative stress may directly induce cardiac structural remodeling, a prominent sign of diabetic cardiomyopathy (DCM) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. </plain></SENT>
<SENT sid="58753" pm="."><plain>DCM is a distinct clinical entity that was first described about four decades ago [<xref ref-type="bibr" rid="CR7">7</xref>]. </plain></SENT>
<SENT sid="58754" pm="."><plain>The diagnosis of DCM remains nebulous and the precise mechanism explaining DCM has been partially explained. </plain></SENT>
<SENT sid="58755" pm="."><plain>Although they remain mainly non-ischemic, distinctively affecting the heart muscle, cardiomyopathies play a pre-dominant role in inducing HF and are one of the major causes of death in Africa [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. </plain></SENT>
<SENT sid="58756" pm="."><plain>Currently, there is no specific treatment for DCM; however, therapeutic drugs certainly play a significant role in the treatment of diabetes and its cardiovascular complications. </plain></SENT>
</text></p><p id="Par19"><text><SENT sid="58757" pm="."><plain>Insulin and metformin are the commonly used therapies for the treatment of DM and have been shown to present limited cardiac protective properties [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. </plain></SENT>
<SENT sid="58758" pm="."><plain>It is known that CVD-related deaths in individuals with DM are still a major concern [<xref ref-type="bibr" rid="CR13">13</xref>]. </plain></SENT>
<SENT sid="58759" pm="."><plain>Furthermore, lifestyle intervention of restricted energy intake and physical activity in persons with impaired glucose tolerance has been shown to improve CVD function. </plain></SENT>
<SENT sid="58760" pm="."><plain>Nonetheless, most individuals do not adhere to such lifestyle interventions. </plain></SENT>
<SENT sid="58761" pm="."><plain>On the other hand, antioxidants are among the leading therapies being investigated for their efficacy against various metabolic complications [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. </plain></SENT>
<SENT sid="58762" pm="."><plain>In the last decade, there has been much interest in the potential health benefits of plant polyphenols, such as resveratrol, mangiferin and aspalathin as dietary antioxidants [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. </plain></SENT>
<SENT sid="58763" pm="."><plain>The rooibos flavonoid and dihydrochalcone, aspalathin, has been investigated and reported to contribute to the antidiabetic properties of rooibos extract as reviewed by Muller and colleagues [<xref ref-type="bibr" rid="CR18">18</xref>]. </plain></SENT>
<SENT sid="58764" pm="."><plain>This flavonoid and others have been shown to exert their therapeutic effects by mainly regulating the expression of key genes involved in energy metabolism and oxidative stress. </plain></SENT>
<SENT sid="58765" pm="."><plain>Prime examples include 5′-adenosine monophosphate-activated protein kinase (AMPK), which is crucial for maintenance of myocardial substrate metabolism and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a transcription factor that is upregulated in response to oxidative stress [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. </plain></SENT>
<SENT sid="58766" pm="."><plain>This review will discuss the cardioprotective potential of rooibos flavonoids and the phenylpropenoic acid, phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside (PPAG), against hyperglycemia-induced injury and heart disease. </plain></SENT>
<SENT sid="58767" pm="."><plain>Physiological context is provided by a short overview of the role of oxidative stress in a diabetic heart. </plain></SENT>
</text></p><sec id="Sec2"><title><text><SENT sid="58768" pm="."><plain>Mechanisms of oxidative stress leading to cardiac tissue damage </plain></SENT>
</text></title><p id="Par20"><text><SENT sid="58769" pm="."><plain>Chronic hyperglycemia is strongly associated with enhanced oxidative stress-induced myocardial injury [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. </plain></SENT>
<SENT sid="58770" pm="."><plain>This has been confirmed by various laboratory studies showing strong correlation between oxidative stress and matrix remodeling in cardiomyocytes isolated from diabetic heart tissue [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. </plain></SENT>
<SENT sid="58771" pm="."><plain>Oxidative stress is aggravated by enhanced levels of Reactive Oxygen Species (ROS) within cardiomyocytes [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. </plain></SENT>
<SENT sid="58772" pm="."><plain>Abnormal ROS production elicits an increased pro-inflammatory response resulting in myocardial apoptosis [<xref ref-type="bibr" rid="CR25">25</xref>]. </plain></SENT>
<SENT sid="58773" pm="."><plain>Some of the well-known reactive oxygen substances, associated with myocardial damage include superoxide anion (O<sub>2</sub> <sup>•−</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). </plain></SENT>
<SENT sid="58774" pm="."><plain>Generation of ROS is generally a cascade of reactions that starts with the formation of O<sub>2</sub> <sup>•−</sup> [<xref ref-type="bibr" rid="CR26">26</xref>]. </plain></SENT>
<SENT sid="58775" pm="."><plain>Superoxide anion rapidly dismutates to H<sub>2</sub>O<sub>2</sub>, either spontaneously or catalytically by superoxide dismutase (SOD), while H<sub>2</sub>O<sub>2</sub> is decomposed by catalase (CAT) to water and oxygen. </plain></SENT>
<SENT sid="58776" pm="."><plain>However, the mitochondrial electron transport chain and the actions of the nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase; Nox) enzymes remain the foremost sources of stress in cardiomyocytes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). </plain></SENT>
<SENT sid="58777" pm="."><plain>Mitochondrial structural modification is affiliated with reduced endogenous antioxidant status in cardiomyocytes from diabetic heart tissue [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. </plain></SENT>
<SENT sid="58778" pm="."><plain>Correspondingly, augmented activity of NADPH oxidase is demonstrated in the myocardium of diabetic animals at the same rate as oxidative damage [<xref ref-type="bibr" rid="CR28">28</xref>].<SecTag type="FIG"><fig id="Fig1"><label>Fig. 1</label><caption><p>Chronic hyperglycemia is strongly associated with enhanced oxidative stress-induced myocardial injury. </plain></SENT>
<SENT sid="58779" pm="."><plain>The mitochondrial electron transport chain and the actions of the nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) enzymes remain the foremost sources of stress in cardiomyocytes</p></caption><graphic xlink:href="12986_2017_200_Fig1_HTML" id="MO1"/></fig></SecTag> </plain></SENT>
</text></p><p id="Par21"><text><SENT sid="58780" pm="."><plain>The mitochondrion is an essential organelle for intracellular energy production. </plain></SENT>
<SENT sid="58781" pm="."><plain>Increasing the cellular demand of the mitochondrion to produce energy is associated with accelerated ROS production. </plain></SENT>
<SENT sid="58782" pm="."><plain>Given that a diabetic heart has a diminished mitochondrial antioxidant capacity [<xref ref-type="bibr" rid="CR29">29</xref>], it is therefore not surprising that minor alterations in mitochondrial structure or function induced by increased ROS are associated with major changes in the heart muscle [<xref ref-type="bibr" rid="CR30">30</xref>]. </plain></SENT>
<SENT sid="58783" pm="."><plain>Increased ROS and mitochondrial depolarization, subsequent to diastolic dysfunction, have been reported in patients with metabolic disturbances [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. </plain></SENT>
<SENT sid="58784" pm="."><plain>However, data explaining the precise role of mitochondrial dysfunction in a diabetic heart are still lacking. </plain></SENT>
</text></p><p id="Par22"><text><SENT sid="58785" pm="."><plain>Concurrent with energy generation is the constant generation of ROS within the mitochondria [<xref ref-type="bibr" rid="CR33">33</xref>]. </plain></SENT>
<SENT sid="58786" pm="."><plain>Accumulation of these radicals results in the induction of mitochondrial permeability transition (MPT) and the opening of high conductance permeability transition pores [<xref ref-type="bibr" rid="CR34">34</xref>]. </plain></SENT>
<SENT sid="58787" pm="."><plain>MPT formation has been reported to lead to an altered redox state of the mitochondria [<xref ref-type="bibr" rid="CR30">30</xref>]. </plain></SENT>
<SENT sid="58788" pm="."><plain>With disease states, the MPT opening is unique for being nonselective and allowing for the accumulation of excessive calcium (Ca<sup>2+</sup>) and other toxic compounds [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. </plain></SENT>
<SENT sid="58789" pm="."><plain>The fate of the cell after an insult depends on the extent of MPT pore formation [<xref ref-type="bibr" rid="CR36">36</xref>–<xref ref-type="bibr" rid="CR38">38</xref>]. </plain></SENT>
<SENT sid="58790" pm="."><plain>If MPT pore formation occurs only to a limited extent, the cell may recover through cell recovery mechanisms such as activation of mitophagy/ubiquitination, whereas if MPT pore formation is exacerbated, it accelerates apoptosis [<xref ref-type="bibr" rid="CR38">38</xref>]. </plain></SENT>
<SENT sid="58791" pm="."><plain>If it occurs to an even larger degree, the cell is likely to undergo necrotic cell death [<xref ref-type="bibr" rid="CR38">38</xref>]. </plain></SENT>
<SENT sid="58792" pm="."><plain>Thus, prevention of mitochondrial membrane depolarization may play a role in reducing myocardial injury associated with chronic hyperglycemia. </plain></SENT>
</text></p><p id="Par23"><text><SENT sid="58793" pm="."><plain>On the other hand, Nox is another system that plays a notable role in the generation of ROS in many cell types, including cardiomyocytes. </plain></SENT>
<SENT sid="58794" pm="."><plain>Nox generates intracellular ROS by transferring electrons from NADPH across the cell membrane and coupling these to molecular oxygen to produce O<sub>2</sub> <sup>•−</sup>. </plain></SENT>
<SENT sid="58795" pm="."><plain>Nox exists in different isoforms, i.e. Nox1 to Nox4, with Nox2 and Nox4 predominant in the heart muscle [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. </plain></SENT>
<SENT sid="58796" pm="."><plain>Nox1 has been identified to be the major source of ROS production in vascular tissues, resulting in low levels of nitric oxide [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. </plain></SENT>
<SENT sid="58797" pm="."><plain>Decreased levels of nitric oxide are connected to impaired endothelium-dependent vasodilation of coronary arteries [<xref ref-type="bibr" rid="CR43">43</xref>]. </plain></SENT>
<SENT sid="58798" pm="."><plain>Human aortic endothelial cells exposed to high glucose concentrations display amplified expression of Nox1 concomitant to enhanced oxidative damage [<xref ref-type="bibr" rid="CR44">44</xref>]. </plain></SENT>
<SENT sid="58799" pm="."><plain>The same study showed that diabetic mice lacking Nox1 had profound anti-atherosclerotic outcome related to reduced ROS generation. </plain></SENT>
<SENT sid="58800" pm="."><plain>Although Nox2 and Nox4 are predominant in the heart muscles, these two ROS producing enzymes are also expressed in other cell types and are implicated in agonist-stimulated redox-sensitive signal transduction [<xref ref-type="bibr" rid="CR39">39</xref>]. </plain></SENT>
<SENT sid="58801" pm="."><plain>Nox2 has been shown to play a central role in insulin resistance-mediated oxidative damage in vascular tissue [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. </plain></SENT>
<SENT sid="58802" pm="."><plain>Nox2 knockout transgenic mice with endothelial-specific insulin resistance present reduced ROS production and vascular dysfunction [<xref ref-type="bibr" rid="CR45">45</xref>]. </plain></SENT>
<SENT sid="58803" pm="."><plain>On the other hand, the Nox4 isoform is specifically expressed in mitochondria of cardiomyocytes; and mice lacking the Nox4 gene show reduced free radical damage [<xref ref-type="bibr" rid="CR28">28</xref>]. </plain></SENT>
<SENT sid="58804" pm="."><plain>Its overexpression in the mouse heart deteriorates cardiac dysfunction by initiating apoptosis through cytochrome c release [<xref ref-type="bibr" rid="CR28">28</xref>]. </plain></SENT>
<SENT sid="58805" pm="."><plain>Cytochrome c is a vital component of the mitochondrial electron transport chain, acting as an electron shuttle during redox generation of ATP [<xref ref-type="bibr" rid="CR47">47</xref>]. </plain></SENT>
<SENT sid="58806" pm="."><plain>Its release and mitochondrial depolarization are considered key physiological events of apoptosis [<xref ref-type="bibr" rid="CR48">48</xref>]. </plain></SENT>
<SENT sid="58807" pm="."><plain>In cardiomyocytes exposed to high glucose concentrations, cytochrome c release is enough to cause apoptosis, independent of mitochondrial depolarization status [<xref ref-type="bibr" rid="CR49">49</xref>]. </plain></SENT>
<SENT sid="58808" pm="."><plain>Complex systems within the apoptotic pathway exacerbate myocardial injury through cytochrome c release [<xref ref-type="bibr" rid="CR50">50</xref>]. </plain></SENT>
<SENT sid="58809" pm="."><plain>Therefore, interventions that could inhibit pro-apoptotic proteins and mitochondrial cytochrome c release could salvage myocardial injury. </plain></SENT>
</text></p></sec><sec id="Sec3"><title><text><SENT sid="58810" pm="."><plain>Endogenous cardioprotective mechanisms </plain></SENT>
</text></title><sec id="Sec4"><title><text><SENT sid="58811" pm="."><plain>Activation of AMPK </plain></SENT>
</text></title><p id="Par24"><text><SENT sid="58812" pm="."><plain>AMPK is a heterotrimeric protein composed of a catalytic alpha, non-catalytic beta and gamma subunit. </plain></SENT>
<SENT sid="58813" pm="."><plain>The main function of this kinase is to preserve ATP or to promote alternative pathways of ATP generation. </plain></SENT>
<SENT sid="58814" pm="."><plain>It functions as a sensor during low energy states such as ischemia to change substrate utilization and thereby increase or decrease ATP synthesis. </plain></SENT>
<SENT sid="58815" pm="."><plain>Its activation is controlled by an increase in the AMP:ATP ratio [<xref ref-type="bibr" rid="CR51">51</xref>]. </plain></SENT>
<SENT sid="58816" pm="."><plain>Stimulation of AMPK leads to phosphorylation of many target proteins important for ATP synthesis and utilization while concurrently inhibiting ATP-consuming pathways such as fatty acid synthesis. </plain></SENT>
<SENT sid="58817" pm="."><plain>In the diabetic heart, AMPK activation is linked to phosphorylation of both acetyl-CoA carboxylase and malonyl-CoA decarboxylase; however, its association with the latter in the heart remains to be fully elucidated [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]. </plain></SENT>
<SENT sid="58818" pm="."><plain>Acetyl-CoA carboxylase and malonyl-CoA decarboxylase are both important for the interconversion of acetyl-CoA to malonyl-CoA (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). </plain></SENT>
<SENT sid="58819" pm="."><plain>Phosphorylation of acetyl-CoA carboxylase by AMPK reduces the generation of malonyl-CoA; thus promoting the entry of FFAs for beta-oxidation into mitochondria through carnitine palmitoyltransferase I [<xref ref-type="bibr" rid="CR55">55</xref>]. </plain></SENT>
<SENT sid="58820" pm="."><plain>Resultant increased levels of ATP and citrate through beta-oxidation are responsible for the allosteric inhibition of glycolysis through phosphofructokinase-1 [<xref ref-type="bibr" rid="CR56">56</xref>]. </plain></SENT>
<SENT sid="58821" pm="."><plain>This causes accelerated ROS production and associated membrane peroxidation [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. </plain></SENT>
<SENT sid="58822" pm="."><plain>Hence, adequate control of uptake and oxidation of FFAs remain crucial for optimal functioning of the myocardium, especially in a diabetic state.<SecTag type="FIG"><fig id="Fig2"><label>Fig. 2</label><caption><p>AMPK is associated with the phosphorylation of ACC and MCD to regulate myocardial energy metabolism. </plain></SENT>
<SENT sid="58823" pm="."><plain>Chronic hyperglycemia activates AMPK, resulting in the phosphorylation of ACC, releasing the inhibitory effect of malonly-CoA on CPT1 and subsequently leading to enhanced entry of FFAs via CPT1 into the mitochondria for beta-oxidation. </plain></SENT>
<SENT sid="58824" pm="."><plain>Abnormally increased beta-oxidation is further accountable for mitochondrial membrane damage through peroxyl radicals. Keys: ACC- acetyl-CoA carboxylase; AMPK- 5’ adenosine monophosphate (AMP)-activated protein kinase; CPT1- carnitine palmitoyltransferase 1; FFA- free fatty acid; MCD- malonyl-CoA decarboxylase</p></caption><graphic xlink:href="12986_2017_200_Fig2_HTML" id="MO2"/></fig></SecTag> </plain></SENT>
</text></p></sec><sec id="Sec5"><title><text><SENT sid="58825" pm="."><plain>Activation of Nrf2 </plain></SENT>
</text></title><p id="Par25"><text><SENT sid="58826" pm="."><plain>Free radicals within mitochondria are generally removed by mitochondrial SOD, thereby generating H<sub>2</sub>O<sub>2</sub>. </plain></SENT>
<SENT sid="58827" pm="."><plain>This process allows H<sub>2</sub>O<sub>2</sub> to be further reduced to water by glutathione (GSH) or CAT. </plain></SENT>
<SENT sid="58828" pm="."><plain>GSH remains an important intracellular antioxidant to prevent free radical damage. </plain></SENT>
<SENT sid="58829" pm="."><plain>GSH can easily be oxidized to its disulfide form during oxidation reactions; thus, NADP transhydrogenase enzymes remain important to maintain the reduced form of this co-factor [<xref ref-type="bibr" rid="CR57">57</xref>]. </plain></SENT>
<SENT sid="58830" pm="."><plain>NADP transhydrogenase functions by transferring electrons from a reduced form of nicotinamide adenine dinucleotide (NADH) to NADP<sup>+</sup> in order to regenerate GSH [<xref ref-type="bibr" rid="CR58">58</xref>]. </plain></SENT>
<SENT sid="58831" pm="."><plain>Reduced expression of GSH is consistently reported in experimental models investigating a diabetic heart [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. </plain></SENT>
<SENT sid="58832" pm="."><plain>This was confirmed when investigated in either human subjects at risk of CVD or mice that are chronically subjected to hyperglycemia and hyperlipidemia [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. </plain></SENT>
</text></p><p id="Par26"><text><SENT sid="58833" pm="."><plain>Expression of antioxidant response genes, including GSH is regulated by the redox-sensitive transcription factor, Nrf2 [<xref ref-type="bibr" rid="CR61">61</xref>]. </plain></SENT>
<SENT sid="58834" pm="."><plain>Nrf2 is a transcriptional regulator that is activated in response to intracellular stress (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). </plain></SENT>
<SENT sid="58835" pm="."><plain>Genes activated by Nrf2 can be classified into different groups, including phase II detoxifying and cytoprotective enzymes. </plain></SENT>
<SENT sid="58836" pm="."><plain>Nrf2 resides in the cytoplasm, where it is subjected to continuous degradation by the ubiquitin-proteasome [<xref ref-type="bibr" rid="CR62">62</xref>]. </plain></SENT>
<SENT sid="58837" pm="."><plain>Under stressful conditions such as ischemia or oxidative stress, Nrf2 is activated by disassociating from its negative regulator Kelch-like ECH-associated protein 1 (Keap1) and translocates to the nucleus. </plain></SENT>
<SENT sid="58838" pm="."><plain>Once in the nucleus, it forms a heterodimer with Maf protein before binding to the antioxidant response element (ARE) to initiate and activate antioxidant defence genes [<xref ref-type="bibr" rid="CR63">63</xref>]. </plain></SENT>
<SENT sid="58839" pm="."><plain>An overview of the pathway associated with the activation of Nrf2 and its protective effect against ROS in a cardiac cell is illustrated by Fig. <xref rid="Fig3" ref-type="fig">3</xref>. </plain></SENT>
<SENT sid="58840" pm="."><plain>Activation of Nrf2 in epithelial cells has been shown to induce GSH synthesis and thus protects against oxidative stress [<xref ref-type="bibr" rid="CR64">64</xref>]. </plain></SENT>
<SENT sid="58841" pm="."><plain>In addition to its negative regulation of Nrf2, Keap1 also acts as a sensor for a wide array of stressors that could activate Nrf2. </plain></SENT>
<SENT sid="58842" pm="."><plain>Significant down-regulation of cardiac Nrf2 expression is concomitant to increased ROS and reactive nitrogen species damage in hearts of diabetic animals [<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>]. </plain></SENT>
<SENT sid="58843" pm="."><plain>Thus, agents that can significantly up-regulate Nrf2 expression have a potential to protect cardiomyocytes against high glucose-induced apoptosis.<SecTag type="FIG"><fig id="Fig3"><label>Fig. 3</label><caption><p>The role of Nrf2 in response to increased ROS within a diabetic heart. </plain></SENT>
<SENT sid="58844" pm="."><plain>Nox and mitochondrial-ETC cause augmented production of O<sub>2</sub> <sup>∙−</sup>, which damages the cell through ROS. </plain></SENT>
<SENT sid="58845" pm="."><plain>The cell reacts by activating the Nrf2-mediated antioxidant response system. </plain></SENT>
<SENT sid="58846" pm="."><plain>Activated Nrf2 causes it to dissociate from Keap1 and migrate into the nucleus where it binds ARE and cause increased expression of cytoprotective genes and phase II detoxifying enzymes to eliminate ROS. Keys: ARE-antioxidant response element; CAT- catalase; Gpx- glutathione peroxidase; GSH- glutathione; Keap1- Kelch-like ECH-associated protein 1; Nox- NADPH oxidase; O<sub>2</sub> <sup>∙−</sup> superoxide ion; Nrf2- nuclear factor (erythroid-derived 2)-like 2; ROS-reactive oxygen species</p></caption><graphic xlink:href="12986_2017_200_Fig3_HTML" id="MO3"/></fig></SecTag> </plain></SENT>
</text></p></sec><sec id="Sec6"><title><text><SENT sid="58847" pm="."><plain>Cardioprotective potential of current antidiabetic agents </plain></SENT>
</text></title><p id="Par27"><text><SENT sid="58848" pm="."><plain>Primary interventions that may salvage a diabetic heart at risk from myocardial infarction mainly target maintaining low blood sugar levels [<xref ref-type="bibr" rid="CR13">13</xref>]. </plain></SENT>
<SENT sid="58849" pm="."><plain>While such interventions are achievable and beneficial to the heart, adherence to lifestyle changes remains a big challenge. </plain></SENT>
<SENT sid="58850" pm="."><plain>Therefore, antidiabetic agents that could suppress postprandial and chronic hyperglycemia may be effective in decreasing the risk of HF. </plain></SENT>
<SENT sid="58851" pm="."><plain>Despite evidence on the efficacy of antidiabetic and antidyslipidemic drugs such as dipeptidyl peptidase-4 inhibitors and statins [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>], metformin remains the leading first line antidiabetic drug for type 2 diabetic individuals with known cardiac complications [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. </plain></SENT>
<SENT sid="58852" pm="."><plain>In addition to its accomplished antidiabetic properties [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>], metformin is associated with improved clinical outcomes in diabetic patients with HF [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. </plain></SENT>
<SENT sid="58853" pm="."><plain>Although clinical data are lacking, metformin enhances the efficacy of a number of synthetic drugs and novel medicinal compounds currently screened for metabolic benefits in vitro [<xref ref-type="bibr" rid="CR73">73</xref>–<xref ref-type="bibr" rid="CR75">75</xref>]. </plain></SENT>
<SENT sid="58854" pm="."><plain>Metformin monotherapy or its use as an add-on effect to glibenclamide improves the intracellular antioxidant status of the myocardium in streptozotocin-induced diabetic Sprague-Dawley rats [<xref ref-type="bibr" rid="CR76">76</xref>]. </plain></SENT>
<SENT sid="58855" pm="."><plain>In addition to improving the antioxidant capacity of heart cells, metformin may benefit the heart by enhancing autophagy and inhibiting MPT opening [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. </plain></SENT>
<SENT sid="58856" pm="."><plain>However, an increasing toll of cardiovascular related deaths in diabetic patients on treatment warrants further investigation into alternative treatment regimes. </plain></SENT>
</text></p></sec><sec id="Sec7"><title><text><SENT sid="58857" pm="."><plain>Cardioprotective potential of rooibos </plain></SENT>
</text></title><p id="Par28"><text><SENT sid="58858" pm="."><plain>In recent years, the use of plant-derived products as a cardioprotective therapy is receiving increasing attention [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. </plain></SENT>
<SENT sid="58859" pm="."><plain>Rooibos (<italic>Aspalathus linearis</italic>) is an indigenous South African plant well-known for its potential health benefits. </plain></SENT>
<SENT sid="58860" pm="."><plain>Rooibos tea is available in two forms: a “fermented” or oxidized form; and an “unfermented” or unoxidized form (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). </plain></SENT>
<SENT sid="58861" pm="."><plain>The unfermented product is also referred to as green rooibos. </plain></SENT>
<SENT sid="58862" pm="."><plain>The “fermentation” process gives fermented rooibos its distinctive reddish-brown colour, while unfermented rooibos tea maintains its green colour (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). </plain></SENT>
<SENT sid="58863" pm="."><plain>The fermentation process is important to develop the characteristic taste and aroma of rooibos tea, traditionally consumed [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58864" pm="."><plain>Its effect on the health outcomes of rooibos is obscured if the products do not originate from the same bush due to large inherent variation in the phenolic content of the rooibos plant [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58865" pm="."><plain>However, it is well established fermentation decreased the flavonoid content of rooibos [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58866" pm="."><plain>Infusions and extracts prepared from unfermented rooibos have higher antioxidant capacity than those from fermented rooibos, largely due to higher levels of flavonoids, in particular aspalathin in the unoxidized plant material [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58867" pm="."><plain>Consumption of a “ready-to-drink” unfermented rooibos beverage as opposed to one produced from fermented rooibos effected a 28% higher total radical-trapping antioxidant potential in the plasma of human subjects [<xref ref-type="bibr" rid="CR82">82</xref>]. </plain></SENT>
<SENT sid="58868" pm="."><plain>Nonetheless, both forms of rooibos are increasingly studied in experimental diabetes and related complications, given that fermented rooibos is more readily available and forms the bulk of rooibos production [<xref ref-type="bibr" rid="CR81">81</xref>].<SecTag type="FIG"><fig id="Fig4"><label>Fig. 4</label><caption><p>Photos of a rooibos plantation (<bold>a</bold>) and the two forms of processed plant material (<bold>b</bold>), fermented and unfermented rooibos with spray-dried powders of their hot water extracts. </plain></SENT>
<SENT sid="58869" pm="."><plain>The fermentation process gives fermented rooibos its distinctive reddish-brown colour, while unfermented rooibos tea maintains its green colour</p></caption><graphic xlink:href="12986_2017_200_Fig4_HTML" id="MO4"/></fig></SecTag> </plain></SENT>
</text></p><p id="Par29"><text><SENT sid="58870" pm="."><plain>In a recent study, Oh and colleagues have demonstrated that the total flavonoid content of a water extract of rooibos, determined using a colorimetric assay based on aluminium complexation, is higher than that of lemongrass tea, mulberry leaf tea, bamboo leaf tea, lotus leaf tea, and persimmon leaf tea [<xref ref-type="bibr" rid="CR83">83</xref>]. </plain></SENT>
<SENT sid="58871" pm="."><plain>However, they further showed that the total flavonoid content of this extract is slightly lower than that of green and black tea. </plain></SENT>
<SENT sid="58872" pm="."><plain>Von Gadow and colleagues have also previously shown that both fermented and unfermented rooibos, when tested together with green, oolong and black tea, present strong antioxidant properties in vitro [<xref ref-type="bibr" rid="CR84">84</xref>]. </plain></SENT>
<SENT sid="58873" pm="."><plain>They further showed that this antioxidant effect, as evaluated using the 2,2-diphenyl-1-picrylhydrazyl radical assay, was reduced in the order: green tea &gt; unfermented rooibos &gt; fermented rooibos &gt; semifermented rooibos &gt; black tea &gt; oolong tea. </plain></SENT>
<SENT sid="58874" pm="."><plain>Accompanying its well-documented antioxidant capacity [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR84">84</xref>–<xref ref-type="bibr" rid="CR89">89</xref>], rooibos has been shown to inhibit adipogenesis in vitro [<xref ref-type="bibr" rid="CR90">90</xref>], reverse palmitate-induced insulin resistance in 3T3-L1 adipocytes [<xref ref-type="bibr" rid="CR91">91</xref>] and prevent inflammation in vivo [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR94">94</xref>]. </plain></SENT>
<SENT sid="58875" pm="."><plain>An aspalathin-enriched green rooibos extract, containing 18.4% aspalathin has demonstrated an even higher hypoglycemic potential through its inhibitory effect of alpha-glucosidase and suppressing fasting plasma glucose levels in animal models [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. </plain></SENT>
<SENT sid="58876" pm="."><plain>Another green rooibos extract, containing 6.6% aspalathin promoted glucose transporter 4 translocation to the plasma membrane and suppressed advanced glycation end products (AGEs)-induced oxidative damage in cultured skeletal L6 muscle cells, pancreatic beta-cells and obese diabetic KK-Ay mice [<xref ref-type="bibr" rid="CR96">96</xref>]. </plain></SENT>
<SENT sid="58877" pm="."><plain>Rooibos inhibits experimentally-induced oxidative stress [<xref ref-type="bibr" rid="CR21">21</xref>]; and improved cardiovascular function by reducing lipid peroxidation, blood pressure and angiotensin-converting (ACE) enzyme in various experimental models [<xref ref-type="bibr" rid="CR97">97</xref>–<xref ref-type="bibr" rid="CR100">100</xref>]. </plain></SENT>
<SENT sid="58878" pm="."><plain>Moreover, it protected against ischemia-reperfusion injury by modulating the phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT) pathway [<xref ref-type="bibr" rid="CR101">101</xref>]. </plain></SENT>
<SENT sid="58879" pm="."><plain>Controlling free fatty acid oxidation by modulating phosphorylation of AMPK remains central in the preventive effect of rooibos against diabetes associated cardiac complications [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. </plain></SENT>
<SENT sid="58880" pm="."><plain>The cardioprotective potential of rooibos is summarized in Table <xref rid="Tab1" ref-type="table">1</xref>.<SecTag type="TABLE"><table-wrap id="Tab1"><label>Table 1</label><caption><p>The cardioprotective effect of rooibos, its flavonoids and a phenylpropenoic acid</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Rooibos/compounds</th><th>Model</th><th>Experimental outcome</th><th>References</th></tr></thead><tbody><tr><td rowspan="6">Rooibos</td><td>Aqueous extract of fermented rooibos on cardiomyocytes isolated from diabetic rats</td><td>Prevented experimentally induced oxidative stress and ischemia</td><td>[<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td>Fermented rooibos tea for 6 weeks in human subjects at risk of cardiovascular disease (CVD)</td><td>Reduced CVD risk by improving lipid profile and redox status</td><td>[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td>Aqueous extract of fermented rooibos in endothelial cells from human umbilical veins (HUVECs)</td><td>Prevented vascular-induced inflammation by enhancing nitric oxide production</td><td>[<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td>Aqueous extract of fermented rooibos on non-diabetic rats</td><td>Acted as a bronchodilator, antispasmodic and blood pressure lowering effects</td><td>[<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td>Fermented rooibos tea in healthy human subjects</td><td>Prevented myocardial infarction by inhibiting angiotensin-converting enzyme (ACE)</td><td>[<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr><tr><td>Aqueous extracts of fermented and unfermented rooibos in non-diabetic rats</td><td>Reversed ischemia-reperfusion injury</td><td>[<xref ref-type="bibr" rid="CR101">101</xref>]</td></tr><tr><td rowspan="2">Aspalathin and nothofagin</td><td>Aspalathin and nothofagin on high glucose-induced vascular in HUVECs and mice</td><td>Prevented inflammation and thrombosis by suppressing TNF-α, IL-6 and NF-κB</td><td>[<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td>Aspalathin in H9c2 cardiomyocytes exposed to high glucose and cardiomyocytes isolated from insulin resistant rats</td><td>Prevented cell apoptosis by reducing phosphorylation of AMPK; decreasing inflammation and lipid accumulation; and attenuated oxidative damage via increasing <italic>Nrf2</italic> expression</td><td>[<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR124">124</xref>–<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td>Orientin and isoorientin</td><td>Orientin on isolated hearts of nondiabetic rats, rabbits and guinea pigs as well as H9c2 cells</td><td>Prevented ischemia-reperfusion injury and platelet aggregation by inhibiting mPTP formation and apoptosis</td><td>[<xref ref-type="bibr" rid="CR137">137</xref>–<xref ref-type="bibr" rid="CR139">139</xref>]</td></tr><tr><td>Orientin and isoorientin</td><td>Orientin on rats</td><td>Prevented myocardial infarction</td><td>[<xref ref-type="bibr" rid="CR134">134</xref>]</td></tr><tr><td/><td>Isoorientin in low density lipoprotein isolated from human plasma</td><td>Prevented formation of atherosclerotic lesions by inhibiting low density lipoprotein (LDL) oxidation</td><td>[<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td/><td>Orientin in non-diabetic rats</td><td>Attenuated ventricular remodeling associated with myocardial infarction</td><td>[<xref ref-type="bibr" rid="CR136">136</xref>]</td></tr><tr><td/><td>Orientin and isoorientin in lipopolysaccharide-induced reperfusion injury</td><td>Protected vascular barrier integrity by inhibiting hyperpermeability</td><td>[<xref ref-type="bibr" rid="CR223">223</xref>]</td></tr><tr><td rowspan="4">Vitexin and isovitexin</td><td>Vitexin on primary cardiomyocytes and isolated rat hearts and on rats</td><td>Prevented ischemia-reperfusion injury by reducing calcium overload and modulating ERK1/2 signaling and MAPK pathway</td><td>[<xref ref-type="bibr" rid="CR146">146</xref>, <xref ref-type="bibr" rid="CR149">149</xref>, <xref ref-type="bibr" rid="CR224">224</xref>]</td></tr><tr><td>Vitexin on primary rat cardiomyocytes</td><td>Prevented cardiac hypertrophy by inhibiting calcineurin and CaMKII signaling pathways</td><td>[<xref ref-type="bibr" rid="CR151">151</xref>]</td></tr><tr><td>Vitexin on dogs</td><td>Reduced aortic pressure, arterial and pulmonary capillary pressure and heart rate</td><td>[<xref ref-type="bibr" rid="CR150">150</xref>, <xref ref-type="bibr" rid="CR225">225</xref>]</td></tr><tr><td>Vitexin on rats</td><td>Attenuated acute doxorubicin cardiotoxicity by reducing oxidative stress and apoptosis</td><td>[<xref ref-type="bibr" rid="CR226">226</xref>]</td></tr><tr><td rowspan="4">Luteolin and chrysoeriol</td><td>Luteolin on isolated rat cardiomyocytes, rabbit hearts and anesthetized pigs</td><td>Prevented ischemia-reperfusion injury and enhanced relative coronary flow</td><td>[<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR159">159</xref>, <xref ref-type="bibr" rid="CR162">162</xref>]</td></tr><tr><td>Luteolin on rat endothelium-denuded aortic rings</td><td>Induced vasorelaxion by regulating calcium and potassium channels and reducing oxidative stress</td><td>[<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td>Luteolin on vascular smooth muscle cells and rats</td><td>Prevented hypertensive vascular remodeling</td><td>[<xref ref-type="bibr" rid="CR160">160</xref>]</td></tr><tr><td>Luteolin on diabetic and normal rats</td><td>Alleviated vascular complications associated with insulin resistance through the Pparγ pathway</td><td>[<xref ref-type="bibr" rid="CR161">161</xref>]</td></tr><tr><td rowspan="2">Luteolin and chrysoeriol</td><td>Luteolin-7-glucoside on isolated primary rat cardiomyocytes</td><td>Prevented ischemia-reperfusion injury and increased of coronary flow</td><td>[<xref ref-type="bibr" rid="CR228">228</xref>]</td></tr><tr><td>Chrysoeriol in rats under anesthesia and H9c2 cells</td><td>Reduced arterial blood pressure and protected against doxorubicin-induced cardiotoxicity</td><td>[<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR172">172</xref>]</td></tr><tr><td>Quercetin and rutin</td><td>Quercetin on rats</td><td>Protected against diabetic cardiomyopathy, autoimmune myocarditis, LDL-oxidation, and doxorubicin-induced lipid peroxidation</td><td>[<xref ref-type="bibr" rid="CR185">185</xref>–<xref ref-type="bibr" rid="CR192">192</xref>]</td></tr><tr><td/><td>Quercetin in either endothelial cells or rats</td><td>Presented antihypertensive potential and reduced cardiac hypertrophy by increasing antioxidant capacity</td><td>[<xref ref-type="bibr" rid="CR229">229</xref>–<xref ref-type="bibr" rid="CR233">233</xref>]</td></tr><tr><td>Hyperoside and rutin</td><td>Hyperoside in vitro and in vivo</td><td>Protected against hyperglycemia induced inflammation</td><td>[<xref ref-type="bibr" rid="CR208">208</xref>]</td></tr><tr><td/><td>Hyperoside in ECV304 cells</td><td>Prevented advanced glycation end products and promoted via the c-Jun N-terminal kinases (JNK) pathway</td><td>[<xref ref-type="bibr" rid="CR205">205</xref>]</td></tr><tr><td/><td>Hyperoxide in vitro and in vivo</td><td>Hydrogen peroxide induced cell damage and ischemia reperfusion injury</td><td>[<xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR211">211</xref>, <xref ref-type="bibr" rid="CR212">212</xref>]</td></tr><tr><td/><td>Rutin on rats</td><td>Protected against advanced glycation end products, oxidative stress and myocardial infarction</td><td>[<xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR234">234</xref>, <xref ref-type="bibr" rid="CR235">235</xref>]</td></tr><tr><td>Phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside (PPAG)</td><td>PPAG on high-glucose exposed H9c2 cells</td><td>Protected against substrate impairment, mitochondrial depolarization and cell apoptosis</td><td>[<xref ref-type="bibr" rid="CR221">221</xref>]</td></tr></tbody></table></table-wrap></SecTag> </plain></SENT>
</text></p><p id="Par30"><text><SENT sid="58881" pm="."><plain>A profound relationship between a diet rich in polyphenols and health has given hope to long-term effective interventions that could prolong the onset of diabetes and its co-morbidities [<xref ref-type="bibr" rid="CR102">102</xref>]. </plain></SENT>
<SENT sid="58882" pm="."><plain>Flavonoids constitute a major sub-class of polyphenols, which can be further divided into different sub-groups such as dihydrochalcones, flavonols and flavones, the predominant rooibos flavonoid sub-groups. </plain></SENT>
<SENT sid="58883" pm="."><plain>Variations in the hydroxylation pattern, glycosylation and chromane ring (Ring C) underpin their structural differences (Table <xref rid="Tab2" ref-type="table">2</xref>). </plain></SENT>
<SENT sid="58884" pm="."><plain>Structural features of flavonoids relevant for their antioxidant properties [<xref ref-type="bibr" rid="CR103">103</xref>] also explain binding affinity to plasma proteins [<xref ref-type="bibr" rid="CR104">104</xref>] and enzymes such as alpha-glucosidase [<xref ref-type="bibr" rid="CR105">105</xref>]. </plain></SENT>
<SENT sid="58885" pm="."><plain>Whilst in vitro data suggest flavonoid aglycones to be more effective than their glycosides, lack of in vivo data precludes broad generalizations concerning the effect of glycosylation on the benefits of flavonoids for human health [<xref ref-type="bibr" rid="CR106">106</xref>].<SecTag type="TABLE"><table-wrap id="Tab2"><label>Table 2</label><caption><p>Molecular structures of flavonoids and a phenylpropenoid present in rooibos</p></caption><graphic xlink:href="12986_2017_200_Tab2_HTML" id="MO5"/></table-wrap></SecTag> </plain></SENT>
</text></p><p id="Par31"><text><SENT sid="58886" pm="."><plain>In the following sections the focus will fall on flavonoids found in rooibos that have an ameliorative effect against various metabolic diseases. </plain></SENT>
<SENT sid="58887" pm="."><plain>Of interest is the predominance of <italic>C</italic>-glucosyl flavonoids in rooibos, and in particular the dihydrochalcones (aspalathin and nothofagin) and their flavone derivatives (orientin, isoorientin, vitexin and isovitexin). </plain></SENT>
<SENT sid="58888" pm="."><plain>The major flavonols are <italic>O</italic>-glycosyl derivatives of quercetin, i.e. quercetin-3-<italic>O</italic>-robinobioside, hyperoside, isoquercitrin, and rutin. </plain></SENT>
<SENT sid="58889" pm="."><plain>The aglycones, luteolin, chrysoeriol and quercetin, are present in low to trace levels in rooibos [<xref ref-type="bibr" rid="CR107">107</xref>]. </plain></SENT>
<SENT sid="58890" pm="."><plain>Discussion of their bioactivities is included to underscore the health potential of rooibos. </plain></SENT>
</text></p><p id="Par32"><text><SENT sid="58891" pm="."><plain>PPAG is per definition not a phenolic compound due to the absence of a hydroxyl group on the phenyl ring. </plain></SENT>
<SENT sid="58892" pm="."><plain>This compound is a biosynthetic precursor of flavonoids [<xref ref-type="bibr" rid="CR108">108</xref>] and rooibos is one of the few plants demonstrated to date to be a substantial source. </plain></SENT>
</text></p></sec><sec id="Sec8"><title><text><SENT sid="58893" pm="."><plain>Rooibos dihydrochalcones </plain></SENT>
</text></title><p id="Par33"><text><SENT sid="58894" pm="."><plain>The dihydrochalcone, aspalathin is unique to rooibos, while its 3-deoxy analogue, nothofagin, is relatively rare with its presence also confirmed in <italic>Notofagus fusca</italic> and <italic>Schoepfia chinensis</italic> [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58895" pm="."><plain>Unfermented rooibos tea beverage contains 10-fold or more aspalathin and nothofagin when compared to the fermented product [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. </plain></SENT>
<SENT sid="58896" pm="."><plain>This is not surprising as the fermentation process is known to reduce their content in rooibos [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]. </plain></SENT>
<SENT sid="58897" pm="."><plain>Despite <italic>C</italic>-glycosides having very low bioavailability due to the inability of intestinal enzymes to hydrolyze the C-C bond linking the sugar moiety to the aglycone and thus influencing their absorption process [<xref ref-type="bibr" rid="CR111">111</xref>], aspalathin has been reported in the plasma of subjects who consumed 500 mL of green rooibos infusion, containing 287 mg aspalathin [<xref ref-type="bibr" rid="CR112">112</xref>]. </plain></SENT>
<SENT sid="58898" pm="."><plain>However, generally as reported for other dihydrochalcones [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>], the human gut microbiota can possibly enhance the absorption of aspalathin and nothofagin in the small intestine by splitting off the aglycone from the glucose moiety [<xref ref-type="bibr" rid="CR115">115</xref>]. </plain></SENT>
<SENT sid="58899" pm="."><plain>In vivo, the low levels of aspalathin are difficult to detect in serum, however metabolites (glucuronides and sulfates) of aspalathin and nothofagin have been detected in urine of human subjects 5 h after consumption of 500 mL of either fermented or unfermented rooibos [<xref ref-type="bibr" rid="CR109">109</xref>]. </plain></SENT>
<SENT sid="58900" pm="."><plain>Recent data have demonstrated that aspalathin is absorbed and metabolized in mice to mostly sulphate conjugates detected in urine, while the mode of absorption is hypothesized to occur through the monolayer paracellularly [<xref ref-type="bibr" rid="CR116">116</xref>]. </plain></SENT>
</text></p><p id="Par34"><text><SENT sid="58901" pm="."><plain>The biological of activity of aspalathin and nothofagin has been primary associated with their known strong antioxidant properties [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. </plain></SENT>
<SENT sid="58902" pm="."><plain>Both compounds protected against high glucose-induced vascular inflammation and platelet aggregation when tested in endothelial cells and mice; however, nothofagin did not have any anticoagulant effect in mice [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. </plain></SENT>
<SENT sid="58903" pm="."><plain>Increasing research is presented focusing on aspalathin and its enhanced efficacy to prevent metabolic-associated complications in vitro and in vivo models [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR120">120</xref>–<xref ref-type="bibr" rid="CR122">122</xref>]. </plain></SENT>
<SENT sid="58904" pm="."><plain>Our laboratory has presented recent evidence that aspalathin reversed palmitate-induced insulin resistance in cultured adipocytes [<xref ref-type="bibr" rid="CR123">123</xref>], while it prevented high glucose-inducedapoptosis by improving substrate metabolism in H9c2 cells exposed to high glucose or cardiomyocytes from insulin resistant rats [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. </plain></SENT>
<SENT sid="58905" pm="."><plain>In addition to regulating AMPK and enhancing <italic>Nrf2</italic> expression, aspalathin can modulate the expression of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein 1/2, transcriptional factors involved in lipid metabolism, in addition to inhibiting inflammation via interleukin-6/Janus kinase 2 pathways, leading to reduced myocardial apoptosis [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR126">126</xref>]. </plain></SENT>
</text></p></sec><sec id="Sec9"><title><text><SENT sid="58906" pm="."><plain>Rooibos flavones </plain></SENT>
</text></title><p id="Par35"><text><SENT sid="58907" pm="."><plain>The major flavones present in rooibos include orientin and isoorientin, the flavone derivatives of aspalathin, and vitexin and isovitexin, the flavone derivatives of nothofagin. </plain></SENT>
<SENT sid="58908" pm="."><plain>Minor flavones include the aglycones, luteolin, and chrysoeriol (Table <xref rid="Tab2" ref-type="table">2</xref>). </plain></SENT>
<SENT sid="58909" pm="."><plain>Lower levels of flavones are present in fermented rooibos [<xref ref-type="bibr" rid="CR81">81</xref>]. </plain></SENT>
<SENT sid="58910" pm="."><plain>Food processing may also change their content. </plain></SENT>
<SENT sid="58911" pm="."><plain>The orientin and isoorientin content of a ready-to-drink rooibos beverage showed a slight change as a result of pasteurization and storage, postulated to be due to the conversion of aspalathin to these compounds [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. </plain></SENT>
<SENT sid="58912" pm="."><plain>Except for luteolin, there is very limited data on the characteristic metabolism and transportation of these flavone glucosides. </plain></SENT>
<SENT sid="58913" pm="."><plain>The absorption of orientin, isoorientin and vitexin has been reported on Caco-2 cell monolayers [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>], with transporter mediated efflux in addition to passive diffusion shown to be the predominant mode of transportation. </plain></SENT>
<SENT sid="58914" pm="."><plain>In a pharmacokinetics study using Sprague–Dawley rats, intravenous administration of a 20 mg/kg dose of orientin was found to be highly recovered in plasma and eliminated within 90 min after intravenous administration [<xref ref-type="bibr" rid="CR130">130</xref>]. </plain></SENT>
<SENT sid="58915" pm="."><plain>On the other hand, permeability and absorption rate of luteolin has been shown to be significantly greater in the colon and ileum compared to the duodenum and jejunum in rats [<xref ref-type="bibr" rid="CR131">131</xref>]. </plain></SENT>
<SENT sid="58916" pm="."><plain>Furthermore, some of these compounds, including isoorientin may be deglycosylated to their aglycones by gut microbiota as reviewed by Muller et al. [<xref ref-type="bibr" rid="CR18">18</xref>]. </plain></SENT>
</text></p><p id="Par36"><text><SENT sid="58917" pm="."><plain>The strong antioxidant properties of flavones have been associated with their free radical scavenging properties [<xref ref-type="bibr" rid="CR132">132</xref>]. </plain></SENT>
<SENT sid="58918" pm="."><plain>Although very few studies are available on the antidiabetic properties of orientin and isoorientin, extracts with abundant levels of vitexin, orientin and isoorientin have been shown to inhibit adipogenesis in 3T3-L1 adipocytes [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. </plain></SENT>
<SENT sid="58919" pm="."><plain>Relevant to the cardiovascular system, these compounds have been reported to inhibit high glucose-induced vascular inflammation [<xref ref-type="bibr" rid="CR134">134</xref>], atherosclerosis [<xref ref-type="bibr" rid="CR135">135</xref>], cardiac remodeling [<xref ref-type="bibr" rid="CR136">136</xref>] and ischemia-reperfusion injury [<xref ref-type="bibr" rid="CR137">137</xref>–<xref ref-type="bibr" rid="CR139">139</xref>]. </plain></SENT>
<SENT sid="58920" pm="."><plain>Additional protective effects of these compounds are summarized in Table <xref rid="Tab1" ref-type="table">1</xref> and are mainly mediated by nuclear factor kappa B, a transcriptional factor involved in diabetic-induced HF [<xref ref-type="bibr" rid="CR140">140</xref>]. </plain></SENT>
<SENT sid="58921" pm="."><plain>Moreover, isoorientin has been shown to reduce other diabetic associated complications such as lipid toxicity and insulin resistance [<xref ref-type="bibr" rid="CR141">141</xref>]. </plain></SENT>
<SENT sid="58922" pm="."><plain>Together with direct radical scavenging activity, the protective mechanism of isoorientin has been linked to the induction of Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling [<xref ref-type="bibr" rid="CR142">142</xref>]. </plain></SENT>
<SENT sid="58923" pm="."><plain>On the other hand, oral administration of vitexin and isovitexin at 1 mg/kg has been shown to reduce postprandial blood glucose levels in sucrose loaded normoglycemic mice [<xref ref-type="bibr" rid="CR143">143</xref>]. </plain></SENT>
<SENT sid="58924" pm="."><plain>In addition to inhibiting α-glucosidase [<xref ref-type="bibr" rid="CR144">144</xref>], vitexin and isovitexin rich extracts have been demonstrated to attenuate diabetes linked complications such as adipogenesis and AGEs in vitro [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR145">145</xref>]. </plain></SENT>
<SENT sid="58925" pm="."><plain>Vitexin reverses ischemia-reperfusion injury in perfused rat hearts and brain by attenuating inflammatory response and apoptosis [<xref ref-type="bibr" rid="CR146">146</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]; it increased coronary artery blood flow and cardiac output in anesthetized animals [<xref ref-type="bibr" rid="CR150">150</xref>]; and it improved cardiac hypertrophy by reducing the expression of calcium downstream effectors, calcineurin-NFATc3 and phosphorylated calmodulin kinase II (CaMKII), both in vitro and in vivo [<xref ref-type="bibr" rid="CR151">151</xref>]. </plain></SENT>
<SENT sid="58926" pm="."><plain>Other associated cardioprotective mechanisms of vitexin may include inhibiting cardiomyocyte apoptosis by reducing calcium overload and extracellular signal regulated kinase (ERK1/2) [<xref ref-type="bibr" rid="CR152">152</xref>]. </plain></SENT>
</text></p><p id="Par37"><text><SENT sid="58927" pm="."><plain>Furthermore, although available in trace levels in rooibos, release of luteolin from orientin and isoorientin in the gut may enhance the levels to physiological relevance. </plain></SENT>
<SENT sid="58928" pm="."><plain>Accumulative evidence suggests strong ameliorative effect of luteolin against diabetes and CVD associated complications [<xref ref-type="bibr" rid="CR153">153</xref>–<xref ref-type="bibr" rid="CR155">155</xref>]. </plain></SENT>
<SENT sid="58929" pm="."><plain>The antidiabetic properties of luteolin include improving hepatic insulin sensitivity by suppressing gluconeogenesis in diet-induced obese mice [<xref ref-type="bibr" rid="CR153">153</xref>]; it prevented neuronal injury and cognitive performance by attenuating oxidative stress in rats [<xref ref-type="bibr" rid="CR154">154</xref>]; and attenuated morphological destruction of the kidney in rats [<xref ref-type="bibr" rid="CR155">155</xref>]. </plain></SENT>
<SENT sid="58930" pm="."><plain>The anti-inflammatory properties of luteolin include inhibiting elevated levels of interleukin-1β and nuclear factor kappa B [<xref ref-type="bibr" rid="CR156">156</xref>–<xref ref-type="bibr" rid="CR158">158</xref>]. </plain></SENT>
<SENT sid="58931" pm="."><plain>Relevant to the heart, luteolin reduced systolic and diastolic blood pressure of various animal models [<xref ref-type="bibr" rid="CR159">159</xref>, <xref ref-type="bibr" rid="CR160">160</xref>]; it improved contractile function [<xref ref-type="bibr" rid="CR161">161</xref>]; and blocked apoptosis following ischemia-reperfusion in adult rat cardiomyocytes via downregulating microRNA-208b-3p [<xref ref-type="bibr" rid="CR162">162</xref>]; it attenuated HF in a rat model of DCM [<xref ref-type="bibr" rid="CR163">163</xref>]; and protected against acute and chronic periods of isoproterenol-induced myocardial infarction by suppressing mitochondrial lipid peroxidation [<xref ref-type="bibr" rid="CR164">164</xref>]. </plain></SENT>
<SENT sid="58932" pm="."><plain>One of the important mechanisms linked to the cardioprotective effect of luteolin during ischemia-reperfusion injury include regulation of ERK1/2 and c-Jun N-terminal kinase (JNK), which are pathways implicated in generation of inflammation [<xref ref-type="bibr" rid="CR165">165</xref>]. </plain></SENT>
<SENT sid="58933" pm="."><plain>The number of functional hydroxyl groups on the structure of luteolin directly correlates to its scavenging effect of hydroxyl radicals [<xref ref-type="bibr" rid="CR166">166</xref>]. </plain></SENT>
</text></p><p id="Par38"><text><SENT sid="58934" pm="."><plain>Another flavone of interest that is present in very low quantities in rooibos is chrysoeriol [<xref ref-type="bibr" rid="CR167">167</xref>]. </plain></SENT>
<SENT sid="58935" pm="."><plain>Chrysoeriol has been previously shown to be more effective in the protection against lipid peroxidation than its glycoside (chrysoeriol-6-<italic>O</italic>-acetyl-4′-β-D-glucoside) when tested in vitro [<xref ref-type="bibr" rid="CR168">168</xref>]. </plain></SENT>
<SENT sid="58936" pm="."><plain>In addition to preventing H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in osteoblasts [<xref ref-type="bibr" rid="CR169">169</xref>], chrysoeriol protected Raw264.7 macrophages from lipopolysaccharide-induced inflammation by blocking activator protein 1, which is crucial in the transcriptional activation of inducible nitric oxide synthase [<xref ref-type="bibr" rid="CR170">170</xref>]. </plain></SENT>
<SENT sid="58937" pm="."><plain>A hydroalcoholic extract of <italic>Tecoma stans</italic>, containing 96% chrysoeriol presented an enhanced activity to inhibit pancreatic lipase [<xref ref-type="bibr" rid="CR171">171</xref>]. </plain></SENT>
<SENT sid="58938" pm="."><plain>Relevant to the heart, chrysoeriol can lower arterial blood pressure in rats under anesthesia [<xref ref-type="bibr" rid="CR97">97</xref>]; and it can protect against doxorubicin-induced cardiotoxicity by inhibiting apoptosis in H9c2 cells [<xref ref-type="bibr" rid="CR172">172</xref>]. </plain></SENT>
<SENT sid="58939" pm="."><plain>However, no published study is available on the effect of chrysoeriol on a diabetic heart at present. </plain></SENT>
</text></p></sec><sec id="Sec10"><title><text><SENT sid="58940" pm="."><plain>Rooibos flavonols </plain></SENT>
</text></title><p id="Par39"><text><SENT sid="58941" pm="."><plain>Quercetin and its glycosides, quercetin-3-<italic>O</italic>-robinobioside, hyperoside, isoquercitrin, and rutin are classified by a distinct 3-hydroxyflavone backbone and are the major flavonols present in rooibos (Table <xref rid="Tab2" ref-type="table">2</xref>). </plain></SENT>
<SENT sid="58942" pm="."><plain>Generally, based on a specific population assessed, the average intake of flavonols may range between 20 to 35 mg/day [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR174">174</xref>]. </plain></SENT>
<SENT sid="58943" pm="."><plain>Although additional studies are required to validate their bioavailability, flavonol aglycones have been shown to be highly absorbed in the gut [<xref ref-type="bibr" rid="CR175">175</xref>]. </plain></SENT>
<SENT sid="58944" pm="."><plain>The type of sugar moiety and stability of aglycone largely affect the absorption of each compound as shown for quercetin glycosides from onions being better absorbed than pure aglycones [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR176">176</xref>]. </plain></SENT>
<SENT sid="58945" pm="."><plain>Another study has demonstrated that isoquercitrin and hyperoside are highly absorbable in rats [<xref ref-type="bibr" rid="CR177">177</xref>]. </plain></SENT>
<SENT sid="58946" pm="."><plain>Regular consumption of flavonols has been found to be protective against ischemic heart disease in some individuals [<xref ref-type="bibr" rid="CR178">178</xref>]. </plain></SENT>
<SENT sid="58947" pm="."><plain>Quercetin attenuated paracetamol-induced liver damage and impairment of kidney function such as intracytoplasmic vacuolization and brush border loss in rats [<xref ref-type="bibr" rid="CR179">179</xref>]. </plain></SENT>
<SENT sid="58948" pm="."><plain>Quercetin has a high affinity to inhibit AGEs such as methylglyoxal and glyoxal in a bovine serum albumin system [<xref ref-type="bibr" rid="CR180">180</xref>]. </plain></SENT>
</text></p><p id="Par40"><text><SENT sid="58949" pm="."><plain>Quercetin and rutin further exhibit a broad range of pharmacological activities within the myocardium (Table <xref rid="Tab1" ref-type="table">1</xref>). </plain></SENT>
<SENT sid="58950" pm="."><plain>These compounds presented atherosclerosis lowering properties by reducing hepatic fatty acid synthesis in mice [<xref ref-type="bibr" rid="CR181">181</xref>]. </plain></SENT>
<SENT sid="58951" pm="."><plain>They enhanced glucose uptake in muscle cells subjected to oxidative stress [<xref ref-type="bibr" rid="CR182">182</xref>] and prevented against dyslipidemia associated complications such as inflammation and lipid toxicity by enhancing antioxidant capacity in rats [<xref ref-type="bibr" rid="CR183">183</xref>]. </plain></SENT>
<SENT sid="58952" pm="."><plain>Interestingly, in the heart, quercetin and rutin have been shown to directly alleviate DCM by improving myocardial ultrastructure in diabetic animals through aldose reductase, oxidative stress inhibitory activity and modulation of cardiac calcium homeostasis [<xref ref-type="bibr" rid="CR184">184</xref>–<xref ref-type="bibr" rid="CR187">187</xref>]. </plain></SENT>
<SENT sid="58953" pm="."><plain>The use of quercetin at a dose of 10 mg/kg body weight for 28 days protected against autoimmune myocarditis by suppressing oxidative stress in rats [<xref ref-type="bibr" rid="CR188">188</xref>]. </plain></SENT>
<SENT sid="58954" pm="."><plain>Quercetin is thought to exert cardiac protection through quenching lipid peroxidation, as it is a known scavenger of peroxyl radicals [<xref ref-type="bibr" rid="CR189">189</xref>–<xref ref-type="bibr" rid="CR192">192</xref>]. </plain></SENT>
<SENT sid="58955" pm="."><plain>In a double-blind randomized clinical trial on women (<italic>n</italic> = 72), quercetin supplementation (500 mg capsule daily) for 10 weeks significantly reduced systolic blood pressure but had no effect on other cardiovascular parameters and inflammatory biomarkers [<xref ref-type="bibr" rid="CR193">193</xref>]. </plain></SENT>
<SENT sid="58956" pm="."><plain>Likewise, rutin protected against myocardial damage in a diabetic state by decreasing postprandial hyperglycemia and slowing down formation of AGEs in various experimental models [<xref ref-type="bibr" rid="CR194">194</xref>–<xref ref-type="bibr" rid="CR197">197</xref>]. </plain></SENT>
<SENT sid="58957" pm="."><plain>In combination with aspalathin, rutin reduced blood glucose concentrations of streptozotocin-induced diabetic rats over a 6 h monitoring period [<xref ref-type="bibr" rid="CR95">95</xref>]. </plain></SENT>
<SENT sid="58958" pm="."><plain>It further improved glucose homeostasis in streptozotocin-induced diabetic rats suppressing gluconeogenesis [<xref ref-type="bibr" rid="CR197">197</xref>]. </plain></SENT>
<SENT sid="58959" pm="."><plain>Regulation of glucose metabolism and increasing intracellular antioxidant capacity have been proposed to be the main cardioprotective effects of both quercetin and rutin [<xref ref-type="bibr" rid="CR198">198</xref>, <xref ref-type="bibr" rid="CR199">199</xref>]. </plain></SENT>
</text></p><p id="Par42"><text><SENT sid="58960" pm="."><plain>Like quercetin and chrysoeriol, hyperoside is often present in very low quantities in a cup of fermented rooibos tea [<xref ref-type="bibr" rid="CR167">167</xref>]. </plain></SENT>
<SENT sid="58961" pm="."><plain>Plants and extracts rich in hyperoside have been established to display antidiabetic properties [<xref ref-type="bibr" rid="CR200">200</xref>–<xref ref-type="bibr" rid="CR202">202</xref>]. </plain></SENT>
<SENT sid="58962" pm="."><plain>Hyperoside prevented against diabetic nephropathy by inhibiting apoptosis and albuminuria in glomerular podocytes isolated from diabetic rats and mice [<xref ref-type="bibr" rid="CR203">203</xref>, <xref ref-type="bibr" rid="CR204">204</xref>]. </plain></SENT>
<SENT sid="58963" pm="."><plain>Other biological activities of hyperoside include reducing accelerated production of AGEs in ECV304 cells via the JNK pathway [<xref ref-type="bibr" rid="CR205">205</xref>]; suppression of inflammation through reducing nuclear factor-κB activation in mouse peritoneal macrophages [<xref ref-type="bibr" rid="CR206">206</xref>]; and inhibition of α-glucosidase and apoptosis in liver cells [<xref ref-type="bibr" rid="CR207">207</xref>]. </plain></SENT>
<SENT sid="58964" pm="."><plain>In the heart, hyperoside protected hyperglycemia-induced inflammation in vitro and in vivo [<xref ref-type="bibr" rid="CR208">208</xref>]; hydrogen peroxide-induced oxidative damage [<xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]; and it protected against ischemic-reperfusion injury in isolated rat hearts [<xref ref-type="bibr" rid="CR211">211</xref>]. </plain></SENT>
<SENT sid="58965" pm="."><plain>The protective mechanism of hyperoside against diabetes and heart associated complications has been mainly through suppressing cell apoptosis, improving mitochondrial function and regulating Nrf2 and extracellular signal-regulated protein kinase signaling [<xref ref-type="bibr" rid="CR212">212</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]. </plain></SENT>
</text></p></sec><sec id="Sec11"><title><text><SENT sid="58966" pm="."><plain>PPAG </plain></SENT>
</text></title><p id="Par43"><text><SENT sid="58967" pm="."><plain>PPAG is a phenylpropenoic glucoside (Table <xref rid="Tab2" ref-type="table">2</xref>) that acts as a precursor in the flavonoid biosynthesis pathway and has been shown by various studies to be present in rooibos [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. </plain></SENT>
<SENT sid="58968" pm="."><plain>The occurrence of PPAG in rooibos was described for the first time about two decades ago [<xref ref-type="bibr" rid="CR108">108</xref>] and its bioavailability profile is yet to be established. </plain></SENT>
<SENT sid="58969" pm="."><plain>Phenylpyruvic acids apparently play a key role in the biosynthesis of a number of secondary metabolites, including PPAG [<xref ref-type="bibr" rid="CR214">214</xref>]. </plain></SENT>
<SENT sid="58970" pm="."><plain>The biological activity of a compound with similar structure to PPAG such as 3-phenylpyruvate has long been reported to display antidiabetic properties [<xref ref-type="bibr" rid="CR215">215</xref>, <xref ref-type="bibr" rid="CR216">216</xref>]. </plain></SENT>
<SENT sid="58971" pm="."><plain>Exposure of cardiomyocytes isolated from diabetic rats to a low concentration of fermented rooibos that contains a relatively high level of PPAG (0.71 g/100 g extract) prevents oxidative stress and apoptosis [<xref ref-type="bibr" rid="CR21">21</xref>]. </plain></SENT>
<SENT sid="58972" pm="."><plain>Recent findings indicated that this compound attenuates insulin resistance and protects beta cells from obese and streptozotocin-induced mice against endoplasmic reticulum stress-induced apoptosis [<xref ref-type="bibr" rid="CR217">217</xref>–<xref ref-type="bibr" rid="CR219">219</xref>]. </plain></SENT>
<SENT sid="58973" pm="."><plain>Data available on the cardioprotective properties of PPAG are limited to a study in H9c2 cardiomyocytes, showing that PPAG abolishes high glucose-induced altered myocardial substrate metabolism and apoptosis by increasing the Bcl2/Bax ratio and reducing caspase 3/7 activity [<xref ref-type="bibr" rid="CR21">21</xref>]. </plain></SENT>
<SENT sid="58974" pm="."><plain>This study further showed that PPAG displayed reduced capacity to protect H9c2 cells against oxidative stress. </plain></SENT>
<SENT sid="58975" pm="."><plain>This result was anticipated since PPAG is not expected to be an active antioxidant as it lacks the phenolic structural features that are required for free radical scavenging ability [<xref ref-type="bibr" rid="CR220">220</xref>]. </plain></SENT>
<SENT sid="58976" pm="."><plain>Interestingly, PPAG used in combination with a known antidiabetic agent such as metformin demonstrated better protection of cardiomyocytes exposed to high glucose-induced oxidative stress than when used as a monotherapy [<xref ref-type="bibr" rid="CR221">221</xref>]. </plain></SENT>
<SENT sid="58977" pm="."><plain>Correspondingly, Patel et al. [<xref ref-type="bibr" rid="CR222">222</xref>] recently showed that PPAG has no inhibitory effect on cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, which are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones and sulfonylureas. </plain></SENT>
<SENT sid="58978" pm="."><plain>Supporting the potential use of nutraceutical agents such as PPAG, especially in combination with a current antidiabetic agent to attenuate oxidative stress-induced damage and protect diabetic individuals at risk of myocardial infarction needs further investigation. </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="CONCL"><sec id="Sec12"><title><text><SENT sid="58979" pm="."><plain>Conclusions </plain></SENT>
</text></title><p id="Par44"><text><SENT sid="58980" pm="."><plain>Blood glucose lowering therapies such as metformin and insulin have played a major role in prolonging lives of diabetic patients. </plain></SENT>
<SENT sid="58981" pm="."><plain>However, tight control of blood glucose remains a challenge in such patients. </plain></SENT>
<SENT sid="58982" pm="."><plain>By contrast, ameliorative therapies for oxidative stress, including polyphenols as an adjunct to current blood lowering drugs, show promise in protecting diabetic hearts in experimental models. </plain></SENT>
<SENT sid="58983" pm="."><plain>In recent years, rooibos has gained popularity due to its potential use as a dietary supplement that is rich in polyphenols. </plain></SENT>
<SENT sid="58984" pm="."><plain>The presence of constituents such as aspalathin, nothofagin and PPAG that are unique to rooibos or rarely occur in other plants make it attractive for scientific investigation. </plain></SENT>
<SENT sid="58985" pm="."><plain>The compounds present in rooibos continue to present robust biological properties that are associated with ameliorative effects on inflammation and apoptosis, leading to improved cardiac function in different animal models. </plain></SENT>
<SENT sid="58986" pm="."><plain>In addition, current evidence has suggested that the combinational use of some of these compounds with known antidiabetic agents such as metformin may enhance their biological efficacy. </plain></SENT>
<SENT sid="58987" pm="."><plain>However, this review clearly highlights the evidence gap pertaining to the molecular mechanisms associated with the cardioprotective effect of rooibos and its polyphenols. </plain></SENT>
<SENT sid="58988" pm="."><plain>Once these molecular mechanisms are established, in addition to verification of such findings in clinical studies, it could make a significant step in accelerating development of an evidenced-based rooibos nutraceutical. </plain></SENT>
<SENT sid="58989" pm="."><plain>It is therefore imperative that we further investigate the mechanism(s) by which rooibos flavonoids and PPAG modulate diabetes-induced cardiovascular related complications thereby identifying new therapeutic candidates. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ABBR"><glossary><title>Abbreviations</title><def-list><def-item><term>ACE</term><def><p>Angiotensin-converting enzyme</p></def></def-item><def-item><term>AGEs</term><def><p id="Par2">Advanced glycation end products</p></def></def-item><def-item><term>AMPK</term><def><p id="Par3">5′-adenosine monophosphate-activated protein kinase</p></def></def-item><def-item><term>ARE</term><def><p>Antioxidant response element</p></def></def-item><def-item><term>CaMKII</term><def><p>Calmodulin kinase II</p></def></def-item><def-item><term>CAT</term><def><p id="Par4">Catalase</p></def></def-item><def-item><term>CVD</term><def><p id="Par5">Cardiovascular disease</p></def></def-item><def-item><term>DCM</term><def><p id="Par6">Diabetic cardiomyopathy</p></def></def-item><def-item><term>DM</term><def><p id="Par7">Diabetes mellitus</p></def></def-item><def-item><term>ERK1/2</term><def><p>Extracellular signal-regulated protein kinases 1 and 2</p></def></def-item><def-item><term>FFAs</term><def><p id="Par8">Free fatty acids</p></def></def-item><def-item><term>GSH</term><def><p id="Par9">Glutathione</p></def></def-item><def-item><term>H<sub>2</sub>O<sub>2</sub></term><def><p id="Par10">Hydrogen peroxide</p></def></def-item><def-item><term>HF</term><def><p id="Par11">Heart failure</p></def></def-item><def-item><term>HUVECs</term><def><p>Human umbilical vein endothelial cells</p></def></def-item><def-item><term>IL-6</term><def><p>Interleukin-6</p></def></def-item><def-item><term>JNK- c</term><def><p>Jun N-terminal kinases</p></def></def-item><def-item><term>Keap1</term><def><p>Kelch-like ECH-associated protein 1</p></def></def-item><def-item><term>LDL</term><def><p>Low density lipoprotein</p></def></def-item><def-item><term>MAPK</term><def><p>Mitogen-activated protein kinases</p></def></def-item><def-item><term>MPT</term><def><p id="Par12">Mitochondrial permeability transition</p></def></def-item><def-item><term>NF-kB</term><def><p>Nuclear factor kappa B</p></def></def-item><def-item><term>Nox</term><def><p id="Par13">NADPH oxidase</p></def></def-item><def-item><term>Nrf2</term><def><p id="Par14">Nuclear factor (erythroid-derived 2)-like 2</p></def></def-item><def-item><term>PPAG</term><def><p id="Par15">Phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside</p></def></def-item><def-item><term>ROS</term><def><p id="Par16">Reactive oxygen species</p></def></def-item><def-item><term>SOD</term><def><p id="Par17">Superoxide dismutase</p></def></def-item></def-list></glossary></SecTag><SecTag type="ACK_FUND"><ack><title>Acknowledgements</title><p><text4fund><text><SENT sid="58990" pm="."><plain>Not applicable. </plain></SENT>
</text></text4fund></p><sec id="FPar1"><title>Availability of data and materials</title><p id="Par45"><text4fund><text><SENT sid="58991" pm="."><plain>Not applicable. </plain></SENT>
</text></text4fund></p></sec><sec id="FPar2"><title>Funding</title><p id="Par46"><text4fund><text><SENT sid="58992" pm="."><plain>This research was funded in part by the National Research Foundation (NRF) Thuthuka Programme Grant 87,836 and the South Africa Medical Research Council’s Biomedical Research and Innovation Platform. </plain></SENT>
<SENT sid="58993" pm="."><plain>The grantholders acknowledge that opinions, findings and conclusions or recommendations expressed in any publication generated by the NRF supported research are those of the authors, and that the NRF accepts no liability whatsoever in this regard. </plain></SENT>
<SENT sid="58994" pm="."><plain>Funding from Stellenbosch University and Ernst Ethel Erikson trust is also acknowledged. </plain></SENT>
<SENT sid="58995" pm="."><plain>The PhD from which this study emanated was funded by the South African Medical Research Council under SAMRC Internship Scholarship Programme. </plain></SENT>
<SENT sid="58996" pm="."><plain>The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. </plain></SENT>
</text></text4fund></p></sec></ack></SecTag><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>PVD, EJ, CJF, JL and RJ performed literature search and wrote the manuscript. All authors reviewed, edited and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par47">Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par48">Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par49">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher’s Note</title><p id="Par41">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><SecTag type="REF"><ref-list id="Bib1"><title>References</title><ref id="CR1"><text><SENT sid="58997" pm="."><plain><label>1.</label><mixed-citation publication-type="other">International Diabetes Federation (IDF). </plain></SENT>
<SENT sid="58998" pm="."><plain>IDF Diabetes atlas 7th edition. <ext-link ext-link-type="uri" xlink:href="http://idf.org">idf.org</ext-link> [Internet]. </plain></SENT>
<SENT sid="58999" pm="."><plain>Accessed at: <ext-link ext-link-type="uri" xlink:href="http://www.diabetesatlas.org">http://www.diabetesatlas.org</ext-link>/. </plain></SENT>
<SENT sid="59000" pm="."><plain>Accessed 12 December 2016.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR2"><text><SENT sid="59001" pm="."><plain><label>2.</label><mixed-citation publication-type="other">World Health Organization (WHO). </plain></SENT>
<SENT sid="59002" pm="."><plain>Global status report on noncommunicable diseases 2014. </plain></SENT>
<SENT sid="59003" pm="."><plain>World Health 176. </plain></SENT>
<SENT sid="59004" pm="."><plain>2014; doi:ISBN 9789241564854.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR3"><text><SENT sid="59005" pm="."><plain><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>BJ</given-names></name><name><surname>Mazze</surname><given-names>R</given-names></name></person-group><article-title>Clinical consequences of the diabetes control and complications trial</article-title><source>N J Med</source><year>1994</year><volume>91</volume><issue>4</issue><fpage>221</fpage><lpage>224</lpage><?supplied-pmid 8202266?><pub-id pub-id-type="pmid">8202266</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR4"><text><SENT sid="59006" pm="."><plain><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudina</surname><given-names>S</given-names></name><name><surname>Abel</surname><given-names>ED</given-names></name></person-group><article-title>Diabetic cardiomyopathy, causes and effects</article-title><source>Rev Endocr Metab Disord</source><year>2010</year><volume>11</volume><issue>1</issue><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1007/s11154-010-9131-7</pub-id><?supplied-pmid 20180026?><pub-id pub-id-type="pmid">20180026</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR5"><text><SENT sid="59007" pm="."><plain><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukidome</surname><given-names>D</given-names></name><name><surname>Nishikawa</surname><given-names>T</given-names></name><name><surname>Sonoda</surname><given-names>K</given-names></name><name><surname>Imoto</surname><given-names>K</given-names></name><name><surname>Fujisawa</surname><given-names>K</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><name><surname>Motoshima</surname><given-names>H</given-names></name><name><surname>Taguchi</surname><given-names>T</given-names></name><name><surname>Matsumura</surname><given-names>T</given-names></name><name><surname>Araki</surname><given-names>E</given-names></name></person-group><article-title>Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><issue>1</issue><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.2337/diabetes.55.01.06.db05-0943</pub-id><?supplied-pmid 16380484?><pub-id pub-id-type="pmid">16380484</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR6"><text><SENT sid="59008" pm="."><plain><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casaclang-Verzosa</surname><given-names>G</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name><name><surname>Tsang</surname><given-names>TS</given-names></name></person-group><article-title>Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>51</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2007.09.026</pub-id><?supplied-pmid 18174029?><pub-id pub-id-type="pmid">18174029</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR7"><text><SENT sid="59009" pm="."><plain><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubler</surname><given-names>S</given-names></name><name><surname>Dlugash</surname><given-names>J</given-names></name><name><surname>Yuceoglu</surname><given-names>YZ</given-names></name><name><surname>Kumral</surname><given-names>T</given-names></name><name><surname>Branwood</surname><given-names>AW</given-names></name><name><surname>Grishman</surname><given-names>A</given-names></name></person-group><article-title>New type of cardiomyopathy associated with diabetic glomerulosclerosis</article-title><source>Am J Cardiol</source><year>1972</year><volume>30</volume><issue>6</issue><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/0002-9149(72)90595-4</pub-id><?supplied-pmid 4263660?><pub-id pub-id-type="pmid">4263660</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR8"><text><SENT sid="59010" pm="."><plain><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kengne</surname><given-names>AP</given-names></name><name><surname>Dzudie</surname><given-names>A</given-names></name><name><surname>Sobngwi</surname><given-names>E</given-names></name></person-group><article-title>Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes</article-title><source>Vasc Health Risk Manag</source><year>2008</year><volume>4</volume><issue>1</issue><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.2147/vhrm.2008.04.01.123</pub-id><?supplied-pmid 18629376?><pub-id pub-id-type="pmid">18629376</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR9"><text><SENT sid="59011" pm="."><plain><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbanya</surname><given-names>JCN</given-names></name><name><surname>Motala</surname><given-names>AA</given-names></name><name><surname>Sobngwi</surname><given-names>E</given-names></name><name><surname>Assah</surname><given-names>FK</given-names></name><name><surname>Enoru</surname><given-names>ST</given-names></name></person-group><article-title>Diabetes in sub-Saharan Africa</article-title><source>Lancet</source><year>2010</year><volume>375</volume><issue>9733</issue><fpage>2254</fpage><lpage>2266</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)60550-8</pub-id><?supplied-pmid 20609971?><pub-id pub-id-type="pmid">20609971</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR10"><text><SENT sid="59012" pm="."><plain><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonassen</surname><given-names>AK</given-names></name><name><surname>Sack</surname><given-names>MN</given-names></name><name><surname>Mjøs</surname><given-names>OD</given-names></name><name><surname>Yellon</surname><given-names>DM</given-names></name></person-group><article-title>Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling</article-title><source>Circ Res</source><year>2001</year><volume>89</volume><issue>12</issue><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1161/hh2401.101385</pub-id><?supplied-pmid 11739285?><pub-id pub-id-type="pmid">11739285</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR11"><text><SENT sid="59013" pm="."><plain><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eurich</surname><given-names>DT</given-names></name><name><surname>Majumdar</surname><given-names>SR</given-names></name><name><surname>McAlister</surname><given-names>FA</given-names></name><name><surname>Tsuyuki</surname><given-names>RT</given-names></name><name><surname>Johnson</surname><given-names>JA</given-names></name></person-group><article-title>Improved clinical outcomes associated with metformin in patients with diabetes and heart failure</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><issue>10</issue><fpage>2345</fpage><lpage>2351</lpage><pub-id pub-id-type="doi">10.2337/diacare.28.10.2345</pub-id><?supplied-pmid 16186261?><pub-id pub-id-type="pmid">16186261</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR12"><text><SENT sid="59014" pm="."><plain><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>M</given-names></name><name><surname>Van der Horst</surname><given-names>ICC</given-names></name><name><surname>van Melle</surname><given-names>JP</given-names></name><name><surname>Qian</surname><given-names>C</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name><name><surname>Silljé</surname><given-names>HHW</given-names></name><name><surname>De Boer</surname><given-names>RA</given-names></name></person-group><article-title>Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2011</year><volume>301</volume><issue>2</issue><fpage>H459</fpage><lpage>H468</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00054.2011</pub-id><?supplied-pmid 21572014?><pub-id pub-id-type="pmid">21572014</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR13"><text><SENT sid="59015" pm="."><plain><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudina</surname><given-names>S</given-names></name><name><surname>Abel</surname><given-names>ED</given-names></name></person-group><article-title>Diabetic cardiomyopathy revisited</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>25</issue><fpage>3213</fpage><lpage>3223</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.679597</pub-id><?supplied-pmid 17592090?><pub-id pub-id-type="pmid">17592090</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR14"><text><SENT sid="59016" pm="."><plain><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maritim</surname><given-names>AC</given-names></name><name><surname>Sanders</surname><given-names>RA</given-names></name><name><surname>Watkins</surname><given-names>JB</given-names></name></person-group><article-title>Diabetes, oxidative stress, and antioxidants: A review</article-title><source>J Biochem Mol Toxicol</source><year>2003</year><volume>17</volume><issue>1</issue><fpage>24</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/jbt.10058</pub-id><?supplied-pmid 12616644?><pub-id pub-id-type="pmid">12616644</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR15"><text><SENT sid="59017" pm="."><plain><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name></person-group><article-title>Intake and circulating concentrations of antioxidants in metabolic syndrome</article-title><source>Curr Atheroscler Rep</source><year>2006</year><volume>8</volume><issue>6</issue><fpage>448</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1007/s11883-006-0018-8</pub-id><?supplied-pmid 17045069?><pub-id pub-id-type="pmid">17045069</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR16"><text><SENT sid="59018" pm="."><plain><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szkudelski</surname><given-names>T</given-names></name><name><surname>Szkudelska</surname><given-names>K</given-names></name></person-group><article-title>Anti-diabetic effects of resveratrol</article-title><source>Ann N Y Acad Sci</source><year>2011</year><volume>1215</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05844.x</pub-id><?supplied-pmid 21261639?><pub-id pub-id-type="pmid">21261639</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR17"><text><SENT sid="59019" pm="."><plain><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellamuthu</surname><given-names>PS</given-names></name><name><surname>Muniappan</surname><given-names>BP</given-names></name><name><surname>Perumal</surname><given-names>SM</given-names></name><name><surname>Kandasamy</surname><given-names>M</given-names></name></person-group><article-title>Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats</article-title><source>J Heal Sci</source><year>2009</year><volume>55</volume><issue>2</issue><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1248/jhs.55.206</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR18"><text><SENT sid="59020" pm="."><plain><label>18.</label><mixed-citation publication-type="other">Muller CJ, Malherbe CJ, Chellan N, Yagasaki K, Miura Y, Joubert E. </plain></SENT>
<SENT sid="59021" pm="."><plain>Potential of rooibos, its major <italic>C-</italic>glucosyl flavonoids and <italic>Z</italic>-2-(β-D-glucopyranoloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome. </plain></SENT>
<SENT sid="59022" pm="."><plain>Crit Rev Food Sci Nutr. </plain></SENT>
<SENT sid="59023" pm="."><plain>2016; doi:10.1080/10408398.2016.1157568.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR19"><text><SENT sid="59024" pm="."><plain><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Ichikawa</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Si</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Goldblatt</surname><given-names>CS</given-names></name><name><surname>Meyer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>T</given-names></name></person-group><article-title>Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Diabetes</source><year>2011</year><volume>60</volume><issue>2</issue><fpage>625</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.2337/db10-1164</pub-id><?supplied-pmid 21270272?><pub-id pub-id-type="pmid">21270272</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR20"><text><SENT sid="59025" pm="."><plain><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarquini</surname><given-names>R</given-names></name><name><surname>Lazzeri</surname><given-names>C</given-names></name><name><surname>Pala</surname><given-names>L</given-names></name><name><surname>Rotella</surname><given-names>CM</given-names></name><name><surname>Gensini</surname><given-names>GF</given-names></name></person-group><article-title>The diabetic cardiomyopathy</article-title><source>Acta Diabetol</source><year>2011</year><volume>48</volume><issue>3</issue><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1007/s00592-010-0180-x</pub-id><?supplied-pmid 20198391?><pub-id pub-id-type="pmid">20198391</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR21"><text><SENT sid="59026" pm="."><plain><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dludla</surname><given-names>PV</given-names></name><name><surname>Muller</surname><given-names>CJF</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Salie</surname><given-names>R</given-names></name><name><surname>Opoku</surname><given-names>AR</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name></person-group><article-title>The cardioprotective effect of an aqueous extract of fermented rooibos (<italic>Aspalathus linearis</italic>) on cultured cardiomyocytes derived from diabetic rats</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><issue>5</issue><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.10.029</pub-id><?supplied-pmid 24268738?><pub-id pub-id-type="pmid">24268738</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR22"><text><SENT sid="59027" pm="."><plain><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uemura</surname><given-names>S</given-names></name><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Glassford</surname><given-names>AJ</given-names></name><name><surname>Asagami</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name><name><surname>Tsao</surname><given-names>PS</given-names></name></person-group><article-title>Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress</article-title><source>Circ Res</source><year>2001</year><volume>88</volume><issue>12</issue><fpage>1291</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1161/hh1201.092042</pub-id><?supplied-pmid 11420306?><pub-id pub-id-type="pmid">11420306</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR23"><text><SENT sid="59028" pm="."><plain><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajamani</surname><given-names>U</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name></person-group><article-title>Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis</article-title><source>Am J Physiol Cell Physiol</source><year>2010</year><volume>299</volume><issue>1</issue><fpage>C139</fpage><lpage>C147</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00020.2010</pub-id><?supplied-pmid 20410435?><pub-id pub-id-type="pmid">20410435</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR24"><text><SENT sid="59029" pm="."><plain><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacco</surname><given-names>F</given-names></name><name><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Oxidative stress and diabetic complications</article-title><source>Circ Res</source><year>2010</year><volume>107</volume><issue>9</issue><fpage>1058</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.223545</pub-id><?supplied-pmid 21030723?><pub-id pub-id-type="pmid">21030723</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR25"><text><SENT sid="59030" pm="."><plain><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>YJ</given-names></name></person-group><article-title>Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome c-mediated caspase-3 activation pathway</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><issue>6</issue><fpage>1938</fpage><lpage>1948</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.6.1938</pub-id><?supplied-pmid 12031984?><pub-id pub-id-type="pmid">12031984</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR26"><text><SENT sid="59031" pm="."><plain><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Jha</surname><given-names>AB</given-names></name><name><surname>Dubey</surname><given-names>RS</given-names></name><name><surname>Pessarakli</surname><given-names>M</given-names></name></person-group><article-title>Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions</article-title><source>J Bot</source><year>2012</year><volume>2012</volume><fpage>217037</fpage></element-citation> </plain></SENT>
</text></ref><ref id="CR27"><text><SENT sid="59032" pm="."><plain><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansley</surname><given-names>DM</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Oxidative stress and myocardial injury in the diabetic heart</article-title><source>J Pathol</source><year>2013</year><volume>229</volume><issue>2</issue><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1002/path.4113</pub-id><?supplied-pmid 23011912?><pub-id pub-id-type="pmid">23011912</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR28"><text><SENT sid="59033" pm="."><plain><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>J</given-names></name><name><surname>Ago</surname><given-names>T</given-names></name><name><surname>Matsushima</surname><given-names>S</given-names></name><name><surname>Zhai</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>MD</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><article-title>NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>35</issue><fpage>15565</fpage><lpage>15570</lpage><pub-id pub-id-type="doi">10.1073/pnas.1002178107</pub-id><?supplied-pmid 20713697?><pub-id pub-id-type="pmid">20713697</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR29"><text><SENT sid="59034" pm="."><plain><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>K</given-names></name><name><surname>Bernardo</surname><given-names>BC</given-names></name><name><surname>McMullen</surname><given-names>JR</given-names></name><name><surname>Ritchie</surname><given-names>RH</given-names></name></person-group><article-title>Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways</article-title><source>Pharmacol Ther</source><year>2014</year><volume>142</volume><issue>3</issue><fpage>375</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2014.01.003</pub-id><?supplied-pmid 24462787?><pub-id pub-id-type="pmid">24462787</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR30"><text><SENT sid="59035" pm="."><plain><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín-García</surname><given-names>J</given-names></name><name><surname>Akhmedov</surname><given-names>AT</given-names></name><name><surname>Moe</surname><given-names>GW</given-names></name></person-group><article-title>Mitochondria in heart failure: The emerging role of mitochondrial dynamics</article-title><source>Heart Fail Rev</source><year>2013</year><volume>18</volume><issue>4</issue><fpage>439</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1007/s10741-012-9330-2</pub-id><?supplied-pmid 22707247?><pub-id pub-id-type="pmid">22707247</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR31"><text><SENT sid="59036" pm="."><plain><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sack</surname><given-names>MN</given-names></name></person-group><article-title>Type 2 diabetes, mitochondrial biology and the heart</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>46</volume><issue>6</issue><fpage>842</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.02.001</pub-id><?supplied-pmid 19217910?><pub-id pub-id-type="pmid">19217910</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR32"><text><SENT sid="59037" pm="."><plain><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montaigne</surname><given-names>D</given-names></name><name><surname>Marechal</surname><given-names>X</given-names></name><name><surname>Lefebvre</surname><given-names>P</given-names></name><name><surname>Modine</surname><given-names>T</given-names></name><name><surname>Fayad</surname><given-names>G</given-names></name><name><surname>Dehondt</surname><given-names>H</given-names></name><name><surname>Hurt</surname><given-names>C</given-names></name><name><surname>Coisne</surname><given-names>A</given-names></name><name><surname>Koussa</surname><given-names>M</given-names></name><name><surname>Remy-Jouet</surname><given-names>I</given-names></name><name><surname>Zerimech</surname><given-names>F</given-names></name><name><surname>Boulanger</surname><given-names>E</given-names></name><name><surname>Lacroix</surname><given-names>D</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name><name><surname>Neviere</surname><given-names>R</given-names></name></person-group><article-title>Mitochondrial dysfunction as an arrhythmogenic substrate: A translational proof-of-concept study in patients with metabolic syndrome developing post-operative atrial fibrillation</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>16</issue><fpage>1466</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2013.03.061</pub-id><?supplied-pmid 23644086?><pub-id pub-id-type="pmid">23644086</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR33"><text><SENT sid="59038" pm="."><plain><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamzami</surname><given-names>N</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Castedo</surname><given-names>M</given-names></name><name><surname>Decaudin</surname><given-names>D</given-names></name><name><surname>Macho</surname><given-names>A</given-names></name><name><surname>Hirsch</surname><given-names>T</given-names></name><name><surname>Susin</surname><given-names>SA</given-names></name><name><surname>Petit</surname><given-names>PX</given-names></name><name><surname>Mignotte</surname><given-names>B</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death</article-title><source>J Exp Med</source><year>1995</year><volume>182</volume><issue>2</issue><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1084/jem.182.2.367</pub-id><?supplied-pmid 7629499?><pub-id pub-id-type="pmid">7629499</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR34"><text><SENT sid="59039" pm="."><plain><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baines</surname><given-names>CP</given-names></name></person-group><article-title>The molecular composition of the mitochondrial permeability transition pore</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>46</volume><issue>6</issue><fpage>850</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.02.007</pub-id><?supplied-pmid 19233198?><pub-id pub-id-type="pmid">19233198</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR35"><text><SENT sid="59040" pm="."><plain><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crompton</surname><given-names>M</given-names></name></person-group><article-title>The mitochondrial permeability transition pore and its role in cell death</article-title><source>Biochem J</source><year>1999</year><volume>341</volume><issue>Pt 2</issue><fpage>233</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1042/bj3410233</pub-id><?supplied-pmid 10393078?><pub-id pub-id-type="pmid">10393078</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR36"><text><SENT sid="59041" pm="."><plain><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemasters</surname><given-names>JJ</given-names></name><name><surname>Nieminen</surname><given-names>AL</given-names></name><name><surname>Qian</surname><given-names>T</given-names></name><name><surname>Trost</surname><given-names>LC</given-names></name><name><surname>Elmore</surname><given-names>SP</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Crowe</surname><given-names>RA</given-names></name><name><surname>Cascio</surname><given-names>WE</given-names></name><name><surname>Bradham</surname><given-names>CA</given-names></name><name><surname>Brenner</surname><given-names>DA</given-names></name><name><surname>Herman</surname><given-names>B</given-names></name></person-group><article-title>The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy</article-title><source>Biochim Biophys Acta-Bioenerg.</source><year>1998</year><volume>1366</volume><issue>1–2</issue><fpage>177</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/S0005-2728(98)00112-1</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR37"><text><SENT sid="59042" pm="."><plain><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>JQ</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name></person-group><article-title>Physiological and pathological roles of the mitochondrial permeability transition pore in the heart</article-title><source>Cell Metab</source><year>2015</year><volume>21</volume><issue>2</issue><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.001</pub-id><?supplied-pmid 25651175?><pub-id pub-id-type="pmid">25651175</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR38"><text><SENT sid="59043" pm="."><plain><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Bravo-San Pedro</surname><given-names>JM</given-names></name><name><surname>Vitale</surname><given-names>I</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name><name><surname>Abrams</surname><given-names>JM</given-names></name><name><surname>Adam</surname><given-names>D</given-names></name><name><surname>Alnemri</surname><given-names>ES</given-names></name><name><surname>Altucci</surname><given-names>L</given-names></name><name><surname>Andrews</surname><given-names>D</given-names></name><name><surname>Annicchiarico-Petruzzelli</surname><given-names>M</given-names></name><name><surname>Baehrecke</surname><given-names>EH</given-names></name><name><surname>Bazan</surname><given-names>NG</given-names></name><name><surname>Bertrand</surname><given-names>MJ</given-names></name><name><surname>Bianchi</surname><given-names>K</given-names></name><name><surname>Blagosklonny</surname><given-names>MV</given-names></name><name><surname>Blomgren</surname><given-names>K</given-names></name><name><surname>Borner</surname><given-names>C</given-names></name><name><surname>Bredesen</surname><given-names>DE</given-names></name><name><surname>Brenner</surname><given-names>C</given-names></name><name><surname>Campanella</surname><given-names>M</given-names></name><name><surname>Candi</surname><given-names>E</given-names></name><name><surname>Cecconi</surname><given-names>F</given-names></name><name><surname>Chan</surname><given-names>FK</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Cheng</surname><given-names>EH</given-names></name><name><surname>Chipuk</surname><given-names>JE</given-names></name><name><surname>Cidlowski</surname><given-names>JA</given-names></name><name><surname>Ciechanover</surname><given-names>A</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>De Laurenzi</surname><given-names>V</given-names></name><name><surname>De Maria</surname><given-names>R</given-names></name><name><surname>Debatin</surname><given-names>KM</given-names></name><name><surname>Di Daniele</surname><given-names>N</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name><name><surname>Dynlacht</surname><given-names>BD</given-names></name><name><surname>El-Deiry</surname><given-names>WS</given-names></name><name><surname>Fimia</surname><given-names>GM</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Fulda</surname><given-names>S</given-names></name><name><surname>Garrido</surname><given-names>C</given-names></name><name><surname>Gougeon</surname><given-names>ML</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Gronemeyer</surname><given-names>H</given-names></name><name><surname>Hajnoczky</surname><given-names>G</given-names></name><name><surname>Hardwick</surname><given-names>JM</given-names></name><name><surname>Hengartner</surname><given-names>MO</given-names></name><name><surname>Ichijo</surname><given-names>H</given-names></name><name><surname>Joseph</surname><given-names>B</given-names></name><name><surname>Jost</surname><given-names>PJ</given-names></name><name><surname>Kaufmann</surname><given-names>T</given-names></name><name><surname>Kepp</surname><given-names>O</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Knight</surname><given-names>RA</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Lemasters</surname><given-names>JJ</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name><name><surname>Linkermann</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name><name><surname>Lockshin</surname><given-names>RA</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Lugli</surname><given-names>E</given-names></name><name><surname>Madeo</surname><given-names>F</given-names></name><name><surname>Malorni</surname><given-names>W</given-names></name><name><surname>Marine</surname><given-names>JC</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name><name><surname>Martinou</surname><given-names>JC</given-names></name><name><surname>Medema</surname><given-names>JP</given-names></name><name><surname>Meier</surname><given-names>P</given-names></name><name><surname>Melino</surname><given-names>S</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Moll</surname><given-names>U</given-names></name><name><surname>Muñoz-Pinedo</surname><given-names>C</given-names></name><name><surname>Nuñez</surname><given-names>G</given-names></name><name><surname>Oberst</surname><given-names>A</given-names></name><name><surname>Panaretakis</surname><given-names>T</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Peter</surname><given-names>ME</given-names></name><name><surname>Piacentini</surname><given-names>M</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name><name><surname>Prehn</surname><given-names>JH</given-names></name><name><surname>Puthalakath</surname><given-names>H</given-names></name><name><surname>Rabinovich</surname><given-names>GA</given-names></name><name><surname>Ravichandran</surname><given-names>KS</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>Rodrigues</surname><given-names>CM</given-names></name><name><surname>Rubinsztein</surname><given-names>DC</given-names></name><name><surname>Rudel</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Simon</surname><given-names>HU</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name><name><surname>Szabadkai</surname><given-names>G</given-names></name><name><surname>Tait</surname><given-names>SW</given-names></name><name><surname>Tang</surname><given-names>HL</given-names></name><name><surname>Tavernarakis</surname><given-names>N</given-names></name><name><surname>Tsujimoto</surname><given-names>Y</given-names></name><name><surname>Berghe</surname><given-names>TV</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name><name><surname>Villunger</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>EF</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name><name><surname>White</surname><given-names>E</given-names></name><name><surname>Wood</surname><given-names>WG</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zakeri</surname><given-names>Z</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name><name><surname>Melino</surname><given-names>G</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015</article-title><source>Cell Death Differ</source><year>2014</year><volume>22</volume><issue>1</issue><fpage>58</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.137</pub-id><?supplied-pmid 25236395?><pub-id pub-id-type="pmid">25236395</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR39"><text><SENT sid="59044" pm="."><plain><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><article-title>The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology</article-title><source>Physiol Rev</source><year>2007</year><volume>87</volume><issue>1</issue><fpage>245</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1152/physrev.00044.2005</pub-id><?supplied-pmid 17237347?><pub-id pub-id-type="pmid">17237347</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR40"><text><SENT sid="59045" pm="."><plain><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mapanga</surname><given-names>RF</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name></person-group><article-title>Damaging effects of hyperglycemia on cardiovascular function: Spotlight on glucose metabolic pathways</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2016</year><volume>310</volume><issue>2</issue><fpage>H153</fpage><lpage>H173</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00206.2015</pub-id><?supplied-pmid 26519027?><pub-id pub-id-type="pmid">26519027</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR41"><text><SENT sid="59046" pm="."><plain><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paravicini</surname><given-names>TM</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name></person-group><article-title>NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><issue>Suppl 2</issue><fpage>S170</fpage><lpage>S180</lpage><pub-id pub-id-type="doi">10.2337/dc08-s247</pub-id><?supplied-pmid 18227481?><pub-id pub-id-type="pmid">18227481</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR42"><text><SENT sid="59047" pm="."><plain><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>XJ</given-names></name><name><surname>Peng</surname><given-names>YB</given-names></name><name><surname>Hu</surname><given-names>YP</given-names></name><name><surname>Shi</surname><given-names>YZ</given-names></name><name><surname>Yao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>NADPH oxidase 1 and its derived reactive oxygen species mediated tissue injury and repair</article-title><source>Oxidative Med Cell Longev</source><year>2014</year><volume>2014</volume><fpage>282854</fpage><pub-id pub-id-type="doi">10.1155/2014/282854</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR43"><text><SENT sid="59048" pm="."><plain><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockklauser-Färber</surname><given-names>K</given-names></name><name><surname>Ballhausen</surname><given-names>T</given-names></name><name><surname>Laufer</surname><given-names>A</given-names></name><name><surname>Rösen</surname><given-names>P</given-names></name></person-group><article-title>Influence of diabetes on cardiac nitric oxide synthase expression and activity</article-title><source>Biochim Biophys Acta</source><year>2000</year><volume>1535</volume><issue>1</issue><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/S0925-4439(00)00078-8</pub-id><?supplied-pmid 11113627?><pub-id pub-id-type="pmid">11113627</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR44"><text><SENT sid="59049" pm="."><plain><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>SP</given-names></name><name><surname>Di Marco</surname><given-names>E</given-names></name><name><surname>Okabe</surname><given-names>J</given-names></name><name><surname>Szyndralewiez</surname><given-names>C</given-names></name><name><surname>Heitz</surname><given-names>F</given-names></name><name><surname>Montezano</surname><given-names>AC</given-names></name><name><surname>De Haan</surname><given-names>JB</given-names></name><name><surname>Koulis</surname><given-names>C</given-names></name><name><surname>El-Osta</surname><given-names>A</given-names></name><name><surname>Andrews</surname><given-names>KL</given-names></name><name><surname>Chin-Dusting</surname><given-names>JPF</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Wingler</surname><given-names>K</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Schmidt</surname><given-names>HHHW</given-names></name><name><surname>Jandeleit-Dahm</surname><given-names>KA</given-names></name></person-group><article-title>NADPH Oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis</article-title><source>Circulation</source><year>2013</year><volume>127</volume><issue>18</issue><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.132159</pub-id><?supplied-pmid 23564668?><pub-id pub-id-type="pmid">23564668</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR45"><text><SENT sid="59050" pm="."><plain><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukumar</surname><given-names>P</given-names></name><name><surname>Viswambharan</surname><given-names>H</given-names></name><name><surname>Imrie</surname><given-names>H</given-names></name><name><surname>Cubbon</surname><given-names>RM</given-names></name><name><surname>Yuldasheva</surname><given-names>N</given-names></name><name><surname>Gage</surname><given-names>M</given-names></name><name><surname>Galloway</surname><given-names>S</given-names></name><name><surname>Skromna</surname><given-names>A</given-names></name><name><surname>Kandavelu</surname><given-names>P</given-names></name><name><surname>Santos</surname><given-names>CX</given-names></name><name><surname>Gatenby</surname><given-names>VK</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Beech</surname><given-names>DJ</given-names></name><name><surname>Wheatcroft</surname><given-names>SB</given-names></name><name><surname>Channon</surname><given-names>KM</given-names></name><name><surname>Shah</surname><given-names>AM</given-names></name><name><surname>Kearney</surname><given-names>MT</given-names></name></person-group><article-title>Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction</article-title><source>Diabetes</source><year>2013</year><volume>62</volume><issue>6</issue><fpage>2130</fpage><lpage>2134</lpage><pub-id pub-id-type="doi">10.2337/db12-1294</pub-id><?supplied-pmid 23349484?><pub-id pub-id-type="pmid">23349484</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR46"><text><SENT sid="59051" pm="."><plain><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>LM</given-names></name><name><surname>Mai</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>JM</given-names></name></person-group><article-title>Crucial roles of Nox2-derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle-aged mice</article-title><source>Br J Pharmacol</source><year>2013</year><volume>170</volume><issue>5</issue><fpage>1064</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1111/bph.12336</pub-id><?supplied-pmid 23957783?><pub-id pub-id-type="pmid">23957783</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR47"><text><SENT sid="59052" pm="."><plain><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boekema</surname><given-names>EJ</given-names></name><name><surname>Braun</surname><given-names>HP</given-names></name></person-group><article-title>Supramolecular structure of the mitochondrial oxidative phosphorylation system</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1074/jbc.R600031200</pub-id><?supplied-pmid 17102127?><pub-id pub-id-type="pmid">17102127</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR48"><text><SENT sid="59053" pm="."><plain><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname><given-names>S</given-names></name></person-group><article-title>Apoptosis: A review of programmed cell death</article-title><source>Toxicol Pathol</source><year>2007</year><volume>35</volume><issue>4</issue><fpage>495</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><?supplied-pmid 17562483?><pub-id pub-id-type="pmid">17562483</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR49"><text><SENT sid="59054" pm="."><plain><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>XY</given-names></name><name><surname>Song</surname><given-names>YH</given-names></name><name><surname>Geng</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>QX</given-names></name><name><surname>Shan</surname><given-names>ZX</given-names></name><name><surname>Lin</surname><given-names>SG</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>376</volume><issue>3</issue><fpage>548</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.09.025</pub-id><?supplied-pmid 18801338?><pub-id pub-id-type="pmid">18801338</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR50"><text><SENT sid="59055" pm="."><plain><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name></person-group><article-title>Critical upstream signals of cytochrome c release induced by a novel Bcl-2 inhibitor</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>18</issue><fpage>19133</fpage><lpage>19140</lpage><pub-id pub-id-type="doi">10.1074/jbc.M400295200</pub-id><?supplied-pmid 14966123?><pub-id pub-id-type="pmid">14966123</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR51"><text><SENT sid="59056" pm="."><plain><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zungu</surname><given-names>M</given-names></name><name><surname>Schisler</surname><given-names>JC</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name><name><surname>McCudden</surname><given-names>C</given-names></name><name><surname>Patterson</surname><given-names>C</given-names></name><name><surname>Willis</surname><given-names>MS</given-names></name></person-group><article-title>Regulation of AMPK by the ubiquitin proteasome system</article-title><source>Am J Pathol</source><year>2011</year><volume>178</volume><issue>1</issue><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2010.11.030</pub-id><?supplied-pmid 21224036?><pub-id pub-id-type="pmid">21224036</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR52"><text><SENT sid="59057" pm="."><plain><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Gammon</surname><given-names>SR</given-names></name><name><surname>Knippers</surname><given-names>JD</given-names></name><name><surname>Paulsen</surname><given-names>SR</given-names></name><name><surname>Rubink</surname><given-names>DS</given-names></name><name><surname>Winder</surname><given-names>WW</given-names></name></person-group><article-title>Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle</article-title><source>J Appl Physiol</source><year>2002</year><volume>92</volume><issue>6</issue><fpage>2475</fpage><lpage>2482</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00071.2002</pub-id><?supplied-pmid 12015362?><pub-id pub-id-type="pmid">12015362</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR53"><text><SENT sid="59058" pm="."><plain><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambandam</surname><given-names>N</given-names></name><name><surname>Steinmetz</surname><given-names>M</given-names></name><name><surname>Chu</surname><given-names>A</given-names></name><name><surname>Altarejos</surname><given-names>JY</given-names></name><name><surname>Dyck</surname><given-names>JRB</given-names></name><name><surname>Lopaschuk</surname><given-names>GD</given-names></name></person-group><article-title>Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5’AMP-activated protein kinase (AMPK) studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique</article-title><source>Eur J Biochem</source><year>2004</year><volume>271</volume><issue>13</issue><fpage>2831</fpage><lpage>2840</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.2004.04218.x</pub-id><?supplied-pmid 15206948?><pub-id pub-id-type="pmid">15206948</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR54"><text><SENT sid="59059" pm="."><plain><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownsey</surname><given-names>RW</given-names></name><name><surname>Boone</surname><given-names>AN</given-names></name><name><surname>Elliott</surname><given-names>JE</given-names></name><name><surname>Kulpa</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>WM</given-names></name></person-group><article-title>Regulation of acetyl-CoA carboxylase</article-title><source>Biochem Soc Trans</source><year>2006</year><volume>34</volume><issue>Pt 2</issue><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1042/BST0340223</pub-id><?supplied-pmid 16545081?><pub-id pub-id-type="pmid">16545081</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR55"><text><SENT sid="59060" pm="."><plain><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makaula</surname><given-names>S</given-names></name><name><surname>Adam</surname><given-names>T</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name></person-group><article-title>Upstream stimulatory factor 1 transactivates the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase</article-title><source>Arch Biochem Biophys</source><year>2006</year><volume>446</volume><issue>1</issue><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2005.10.025</pub-id><?supplied-pmid 16376850?><pub-id pub-id-type="pmid">16376850</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR56"><text><SENT sid="59061" pm="."><plain><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randle</surname><given-names>PJ</given-names></name><name><surname>Garland</surname><given-names>PB</given-names></name><name><surname>Hales</surname><given-names>CN</given-names></name><name><surname>Newsholme</surname><given-names>EA</given-names></name></person-group><article-title>The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus</article-title><source>Lancet</source><year>1963</year><volume>281</volume><issue>7285</issue><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(63)91500-9</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR57"><text><SENT sid="59062" pm="."><plain><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revollo</surname><given-names>J</given-names></name><name><surname>Grimm</surname><given-names>A</given-names></name><name><surname>Imai</surname><given-names>S</given-names></name></person-group><article-title>The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals</article-title><source>Curr Opin</source><year>2007</year><volume>23</volume><issue>2</issue><fpage>164</fpage><lpage>170</lpage></element-citation> </plain></SENT>
</text></ref><ref id="CR58"><text><SENT sid="59063" pm="."><plain><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydström</surname><given-names>J</given-names></name></person-group><article-title>Mitochondrial NADPH, transhydrogenase and disease</article-title><source>Biochim Biophys Acta-Bioenerg</source><year>2006</year><volume>1757</volume><issue>5–6</issue><fpage>721</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2006.03.010</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR59"><text><SENT sid="59064" pm="."><plain><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marnewick</surname><given-names>JL</given-names></name><name><surname>Rautenbach</surname><given-names>F</given-names></name><name><surname>Venter</surname><given-names>I</given-names></name><name><surname>Neethling</surname><given-names>H</given-names></name><name><surname>Blackhurst</surname><given-names>DM</given-names></name><name><surname>Wolmarans</surname><given-names>P</given-names></name><name><surname>MacHaria</surname><given-names>M</given-names></name></person-group><article-title>Effects of rooibos (<italic>Aspalathus linearis</italic>) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease</article-title><source>J Ethnopharmacol</source><year>2011</year><volume>133</volume><issue>1</issue><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.08.061</pub-id><?supplied-pmid 20833235?><pub-id pub-id-type="pmid">20833235</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR60"><text><SENT sid="59065" pm="."><plain><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>MP</given-names></name><name><surname>Lim</surname><given-names>YC</given-names></name><name><surname>Hwang</surname><given-names>J</given-names></name><name><surname>Na</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Ha</surname><given-names>KS</given-names></name></person-group><article-title>C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation</article-title><source>Diabetes</source><year>2013</year><volume>62</volume><issue>1</issue><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.2337/db12-0293</pub-id><?supplied-pmid 22923476?><pub-id pub-id-type="pmid">22923476</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR61"><text><SENT sid="59066" pm="."><plain><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Kan</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name></person-group><article-title>Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>46</volume><issue>1</issue><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.10.007</pub-id><?supplied-pmid 19007787?><pub-id pub-id-type="pmid">19007787</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR62"><text><SENT sid="59067" pm="."><plain><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>A</given-names></name><name><surname>Kang</surname><given-names>MI</given-names></name><name><surname>Watai</surname><given-names>Y</given-names></name><name><surname>Tong</surname><given-names>KI</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><issue>1</issue><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1128/MCB.26.1.221-229.2006</pub-id><?supplied-pmid 16354693?><pub-id pub-id-type="pmid">16354693</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR63"><text><SENT sid="59068" pm="."><plain><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>HK</given-names></name><name><surname>Olayanju</surname><given-names>A</given-names></name><name><surname>Goldring</surname><given-names>CE</given-names></name><name><surname>Park</surname><given-names>BK</given-names></name></person-group><article-title>The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation</article-title><source>Biochem Pharmacol</source><year>2013</year><volume>85</volume><issue>6</issue><fpage>705</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2012.11.016</pub-id><?supplied-pmid 23219527?><pub-id pub-id-type="pmid">23219527</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR64"><text><SENT sid="59069" pm="."><plain><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kode</surname><given-names>A</given-names></name><name><surname>Rajendrasozhan</surname><given-names>S</given-names></name><name><surname>Caito</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SR</given-names></name><name><surname>Megson</surname><given-names>IL</given-names></name><name><surname>Rahman</surname><given-names>I</given-names></name></person-group><article-title>Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2008</year><volume>294</volume><issue>3</issue><fpage>L478</fpage><lpage>L488</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00361.2007</pub-id><?supplied-pmid 18162601?><pub-id pub-id-type="pmid">18162601</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR65"><text><SENT sid="59070" pm="."><plain><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheen</surname><given-names>AJ</given-names></name></person-group><article-title>Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes</article-title><source>Postgrad Med</source><year>2013</year><volume>125</volume><issue>3</issue><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.3810/pgm.2013.05.2659</pub-id><?supplied-pmid 23748503?><pub-id pub-id-type="pmid">23748503</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR66"><text><SENT sid="59071" pm="."><plain><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>F</given-names></name><name><surname>Huffman</surname><given-names>MD</given-names></name><name><surname>Macedo</surname><given-names>AF</given-names></name><name><surname>Moore</surname><given-names>TH</given-names></name><name><surname>Burke</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Ward</surname><given-names>K</given-names></name><name><surname>Ebrahim</surname><given-names>S</given-names></name></person-group><article-title>Statins for the primary prevention of cardiovascular disease</article-title><source>Cochrane Database Syst Rev</source><year>2013</year><volume>1</volume><fpage>CD004816</fpage></element-citation> </plain></SENT>
</text></ref><ref id="CR67"><text><SENT sid="59072" pm="."><plain><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>R</given-names></name><name><surname>Malik</surname><given-names>IS</given-names></name></person-group><article-title>Metformin: safety in cardiac patients</article-title><source>Postgrad Med J</source><year>2010</year><volume>86</volume><issue>2</issue><fpage>371</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1136/hrt.2009.173773</pub-id><?supplied-pmid 20547605?><pub-id pub-id-type="pmid">20547605</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR68"><text><SENT sid="59073" pm="."><plain><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messaoudi</surname><given-names>SE</given-names></name><name><surname>Rongen</surname><given-names>GA</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name></person-group><article-title>The cardioprotective effects of metformin</article-title><source>Curr Opin Lipidol</source><year>2011</year><volume>22</volume><issue>6</issue><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1097/MOL.0b013e32834ae1a7</pub-id><?supplied-pmid 21897229?><pub-id pub-id-type="pmid">21897229</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR69"><text><SENT sid="59074" pm="."><plain><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>CJ</given-names></name></person-group><article-title>Metformin: effects on micro and macrovascular complications in type 2 diabetes</article-title><source>Cardiovasc Drugs Ther</source><year>2008</year><volume>22</volume><issue>3</issue><fpage>215</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1007/s10557-008-6092-0</pub-id><?supplied-pmid 18288595?><pub-id pub-id-type="pmid">18288595</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR70"><text><SENT sid="59075" pm="."><plain><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanas</surname><given-names>N</given-names></name><name><surname>Maltezos</surname><given-names>E</given-names></name></person-group><article-title>Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?</article-title><source>Curr Pharm Des</source><year>2009</year><volume>15</volume><issue>27</issue><fpage>3179</fpage><lpage>3192</lpage><pub-id pub-id-type="doi">10.2174/138161209789057995</pub-id><?supplied-pmid 19754390?><pub-id pub-id-type="pmid">19754390</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR71"><text><SENT sid="59076" pm="."><plain><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lexis</surname><given-names>CP</given-names></name><name><surname>van der Horst</surname><given-names>IC</given-names></name><name><surname>Lipsic</surname><given-names>E</given-names></name><name><surname>Wieringa</surname><given-names>WG</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>van den Heuvel</surname><given-names>AF</given-names></name><name><surname>van der Werf</surname><given-names>HW</given-names></name><name><surname>Schurer</surname><given-names>RA</given-names></name><name><surname>Pundziute</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>ES</given-names></name><name><surname>Nieuwland</surname><given-names>W</given-names></name><name><surname>Willemsen</surname><given-names>HM</given-names></name><name><surname>Dorhout</surname><given-names>B</given-names></name><name><surname>Molmans</surname><given-names>BH</given-names></name><name><surname>van der Horst-Schrivers</surname><given-names>AN</given-names></name><name><surname>Wolffenbuttel</surname><given-names>BH</given-names></name><name><surname>ter Horst</surname><given-names>GJ</given-names></name><name><surname>van Rossum</surname><given-names>AC</given-names></name><name><surname>Tijssen</surname><given-names>JG</given-names></name><name><surname>Hillege</surname><given-names>HL</given-names></name><name><surname>de Smet</surname><given-names>BJ</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name></person-group><article-title>GIPS-III Investigators. </plain></SENT>
<SENT sid="59077" pm="."><plain>Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial</article-title><source>JAMA</source><year>2014</year><volume>311</volume><issue>15</issue><fpage>1526</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.3315</pub-id><?supplied-pmid 24687169?><pub-id pub-id-type="pmid">24687169</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR72"><text><SENT sid="59078" pm="."><plain><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosiak</surname><given-names>M</given-names></name><name><surname>Postula</surname><given-names>M</given-names></name><name><surname>Kaplon-Cieslicka</surname><given-names>A</given-names></name><name><surname>Trzepla</surname><given-names>E</given-names></name><name><surname>Czlonkowski</surname><given-names>A</given-names></name><name><surname>Filipiak</surname><given-names>KJ</given-names></name><name><surname>Opolski</surname><given-names>G</given-names></name></person-group><article-title>Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes</article-title><source>Adv Med Sci</source><year>2013</year><volume>58</volume><issue>2</issue><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.2478/ams-2013-0009</pub-id><?supplied-pmid 24327531?><pub-id pub-id-type="pmid">24327531</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR73"><text><SENT sid="59079" pm="."><plain><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Dludla</surname><given-names>P</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>February</surname><given-names>F</given-names></name><name><surname>Mazibuko</surname><given-names>S</given-names></name><name><surname>Ghoor</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name></person-group><article-title>Aspalathin, a dihydrochalcone <italic>C</italic>-glucoside, protects H9c2 cardiomyocytes against high glucose-induced shifts in substrate preference and apoptosis</article-title><source>Mol Nutr Food Res</source><year>2016</year><volume>60</volume><issue>4</issue><fpage>922</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500656</pub-id><?supplied-pmid 26773306?><pub-id pub-id-type="pmid">26773306</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR74"><text><SENT sid="59080" pm="."><plain><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name></person-group><article-title>Combination therapy for type 2 diabetes: dapagliflozin plus metformin</article-title><source>Expert Opin Pharmacother</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>117</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1517/14656566.2016.1121235</pub-id><?supplied-pmid 26567559?><pub-id pub-id-type="pmid">26567559</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR75"><text><SENT sid="59081" pm="."><plain><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falah</surname><given-names>RR</given-names></name><name><surname>Talib</surname><given-names>WH</given-names></name><name><surname>Shbailat</surname><given-names>SJ</given-names></name></person-group><article-title>Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis</article-title><source>Ther Adv Med Oncol</source><year>2017</year><volume>9</volume><issue>4</issue><fpage>235</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1177/1758834016687482</pub-id><?supplied-pmid 28491145?><pub-id pub-id-type="pmid">28491145</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR76"><text><SENT sid="59082" pm="."><plain><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erejuwa</surname><given-names>OO</given-names></name><name><surname>Sulaiman</surname><given-names>SA</given-names></name><name><surname>Wahab</surname><given-names>MSA</given-names></name><name><surname>Sirajudeen</surname><given-names>KNS</given-names></name><name><surname>Salleh</surname><given-names>MS</given-names></name><name><surname>Gurtu</surname><given-names>S</given-names></name></person-group><article-title>Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats</article-title><source>Int J Mol Sci</source><year>2010</year><volume>11</volume><issue>5</issue><fpage>2056</fpage><lpage>2066</lpage><pub-id pub-id-type="doi">10.3390/ijms11052056</pub-id><?supplied-pmid 20559501?><pub-id pub-id-type="pmid">20559501</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR77"><text><SENT sid="59083" pm="."><plain><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Zou</surname><given-names>MH</given-names></name></person-group><article-title>AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy</article-title><source>Autophagy</source><year>2011</year><volume>7</volume><issue>10</issue><fpage>1254</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.4161/auto.7.10.16740</pub-id><?supplied-pmid 21685727?><pub-id pub-id-type="pmid">21685727</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR78"><text><SENT sid="59084" pm="."><plain><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>MA</given-names></name><name><surname>Rutter-Locher</surname><given-names>Z</given-names></name><name><surname>Gonçalves</surname><given-names>LM</given-names></name><name><surname>Providência</surname><given-names>LA</given-names></name><name><surname>Davidson</surname><given-names>SM</given-names></name><name><surname>Yellon</surname><given-names>DM</given-names></name><name><surname>Mocanu</surname><given-names>MM</given-names></name></person-group><article-title>Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2011</year><volume>300</volume><issue>6</issue><fpage>H2123</fpage><lpage>H2134</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00707.2010</pub-id><?supplied-pmid 21421816?><pub-id pub-id-type="pmid">21421816</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR79"><text><SENT sid="59085" pm="."><plain><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ríos</surname><given-names>JL</given-names></name><name><surname>Francini</surname><given-names>F</given-names></name><name><surname>Schinella</surname><given-names>GR</given-names></name></person-group><article-title>Natural products for the treatment of type 2 diabetes mellitus</article-title><source>Planta Med</source><year>2015</year><volume>81</volume><issue>12–13</issue><fpage>975</fpage><lpage>994</lpage><?supplied-pmid 26132858?><pub-id pub-id-type="pmid">26132858</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR80"><text><SENT sid="59086" pm="."><plain><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>SK</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Ojha</surname><given-names>SK</given-names></name><name><surname>Sharma</surname><given-names>SB</given-names></name></person-group><article-title>Cardiovascular friendly natural products: a promising approach in the management of CVD</article-title><source>Nat Prod Res</source><year>2010</year><volume>24</volume><issue>9</issue><fpage>873</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1080/14786410903417378</pub-id><?supplied-pmid 20461632?><pub-id pub-id-type="pmid">20461632</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR81"><text><SENT sid="59087" pm="."><plain><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name></person-group><article-title>Rooibos (<italic>Aspalathus linearis</italic>) beyond the farm gate: From herbal tea to potential phytopharmaceutical</article-title><source>S Afr J Bot</source><year>2011</year><volume>77</volume><issue>4</issue><fpage>869</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2011.07.004</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR82"><text><SENT sid="59088" pm="."><plain><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villaño</surname><given-names>D</given-names></name><name><surname>Pecoraria</surname><given-names>M</given-names></name><name><surname>Testa</surname><given-names>MF</given-names></name><name><surname>Raguzzini</surname><given-names>A</given-names></name><name><surname>Stalmach</surname><given-names>A</given-names></name><name><surname>Crozier</surname><given-names>A</given-names></name><name><surname>Tubili</surname><given-names>C</given-names></name><name><surname>Serafini</surname><given-names>M</given-names></name></person-group><article-title>Unfermented and fermented rooibos teas (<italic>Aspalathus linearis</italic>) increase plasma total antioxidant capacity in healthy humans</article-title><source>Food Chem</source><year>2010</year><volume>123</volume><issue>3</issue><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.05.032</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR83"><text><SENT sid="59089" pm="."><plain><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Jo</surname><given-names>H</given-names></name><name><surname>Cho</surname><given-names>AR</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>J</given-names></name></person-group><article-title>Antioxidant and antimicrobial activities of various leafy herbal teas</article-title><source>Food Control</source><year>2013</year><volume>31</volume><issue>2</issue><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2012.10.021</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR84"><text><SENT sid="59090" pm="."><plain><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Gadow</surname><given-names>A</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Hansmann</surname><given-names>CF</given-names></name></person-group><article-title>Comparison of the antioxidant activity of rooibos tea (<italic>Aspalathus linearis</italic>) with green, oolong and black tea</article-title><source>Food Chem</source><year>1997</year><volume>60</volume><issue>1</issue><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(96)00312-3</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR85"><text><SENT sid="59091" pm="."><plain><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Winterton</surname><given-names>P</given-names></name><name><surname>Britz</surname><given-names>TJ</given-names></name><name><surname>Ferreira</surname><given-names>D</given-names></name></person-group><article-title>Superoxide anion and α, α-diphenyl-β-picrylhydrazyl radical scavenging capacity of rooibos (<italic>Aspalathus linearis</italic>) aqueous extracts, crude phenolic fractions, tannin and flavonoids</article-title><source>Food Res Int</source><year>2004</year><volume>37</volume><issue>2</issue><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2003.09.011</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR86"><text><SENT sid="59092" pm="."><plain><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waisundara</surname><given-names>VY</given-names></name><name><surname>Hoon</surname><given-names>LY</given-names></name></person-group><article-title>Free radical scavenging ability of <italic>Aspalathus linearis</italic> in two <italic>in vitro</italic> models of diabetes and cancer</article-title><source>J Tradit Complement Med</source><year>2015</year><volume>5</volume><issue>3</issue><fpage>174</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2014.11.009</pub-id><?supplied-pmid 26151031?><pub-id pub-id-type="pmid">26151031</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR87"><text><SENT sid="59093" pm="."><plain><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulicná</surname><given-names>O</given-names></name><name><surname>Vancová</surname><given-names>O</given-names></name><name><surname>Bozek</surname><given-names>P</given-names></name><name><surname>Cársky</surname><given-names>J</given-names></name><name><surname>Sebeková</surname><given-names>K</given-names></name><name><surname>Boor</surname><given-names>P</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Greksák</surname><given-names>M</given-names></name></person-group><article-title>Rooibos tea (<italic>Aspalathus linearis</italic>) partially prevents oxidative stress in streptozotocin-induced diabetic rats</article-title><source>Physiol Res</source><year>2006</year><volume>55</volume><issue>2</issue><fpage>157</fpage><lpage>164</lpage><?supplied-pmid 15910170?><pub-id pub-id-type="pmid">15910170</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR88"><text><SENT sid="59094" pm="."><plain><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>IS</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>HP</given-names></name></person-group><article-title>Anti-oxidative effects of Rooibos tea (<italic>Aspalathus linearis</italic>) on immobilization-induced oxidative stress in rat brain</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>1</issue><fpage>e87061</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0087061</pub-id><?supplied-pmid 24466326?><pub-id pub-id-type="pmid">24466326</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR89"><text><SENT sid="59095" pm="."><plain><label>89.</label><mixed-citation publication-type="other">Ajuwon OR, Marnewick JL, Davids LM. </plain></SENT>
<SENT sid="59096" pm="."><plain>Rooibos (<italic>Aspalathus linearis</italic>) and its major flavonoids – potential against oxidative stress-induced conditions. </plain></SENT>
<SENT sid="59097" pm="."><plain>InTech 2015;<ext-link ext-link-type="uri" xlink:href="http://doi.org/10.5772/61614">http://doi.org/10.5772/61614</ext-link>.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR90"><text><SENT sid="59098" pm="."><plain><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>M</given-names></name><name><surname>Mazibuko</surname><given-names>SE</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Pheiffer</surname><given-names>C</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>CJF</given-names></name></person-group><article-title>Effects of fermented rooibos (<italic>Aspalathus linearis</italic>) on adipocyte differentiation</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><issue>2</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.08.011</pub-id><?supplied-pmid 24060217?><pub-id pub-id-type="pmid">24060217</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR91"><text><SENT sid="59099" pm="."><plain><label>91.</label><mixed-citation publication-type="other">Mazibuko SE. </plain></SENT>
<SENT sid="59100" pm="."><plain>In vitro and in vivo effect of <italic>Aspalathus linearis</italic> and its major polyphenols on carbohydrate and lipid metabolism in insulin resistant models. </plain></SENT>
<SENT sid="59101" pm="."><plain>Doctoral dissertation, University of Zululand, 2014. </plain></SENT>
<SENT sid="59102" pm="."><plain>Accessed 12 December 2016.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR92"><text><SENT sid="59103" pm="."><plain><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>H</given-names></name><name><surname>Ohtsuka</surname><given-names>Y</given-names></name><name><surname>Haruna</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>S</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Yamashiro</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name></person-group><article-title>Studies of anti-inflammatory effects of rooibos tea in rats</article-title><source>Pediatr Int</source><year>2009</year><volume>51</volume><issue>5</issue><fpage>700</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200X.2009.02835.x</pub-id><?supplied-pmid 19419525?><pub-id pub-id-type="pmid">19419525</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR93"><text><SENT sid="59104" pm="."><plain><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltrán-Debón</surname><given-names>R</given-names></name><name><surname>Rull</surname><given-names>A</given-names></name><name><surname>Rodríguez-Sanabria</surname><given-names>F</given-names></name><name><surname>Iswaldi</surname><given-names>I</given-names></name><name><surname>Herranz-López</surname><given-names>M</given-names></name><name><surname>Aragonès</surname><given-names>G</given-names></name><name><surname>Camps</surname><given-names>J</given-names></name><name><surname>Alonso-Villaverde</surname><given-names>C</given-names></name><name><surname>Menéndez</surname><given-names>JA</given-names></name><name><surname>Micol</surname><given-names>V</given-names></name><name><surname>Segura-Carretero</surname><given-names>A</given-names></name><name><surname>Joven</surname><given-names>J</given-names></name></person-group><article-title>Continuous administration of polyphenols from aqueous rooibos (<italic>Aspalathus linearis</italic>) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><issue>5</issue><fpage>414</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.11.008</pub-id><?supplied-pmid 21211952?><pub-id pub-id-type="pmid">21211952</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR94"><text><SENT sid="59105" pm="."><plain><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Swart</surname><given-names>AC</given-names></name></person-group><article-title>Rooibos (<italic>Aspalathus linearis</italic>) facilitates an anti-inflammatory state, modulating IL-6 and IL-10 while not inhibiting the acute glucocorticoid response to a mild novel stressor <italic>in vivo</italic></article-title><source>J Funct Foods</source><year>2016</year><volume>27</volume><fpage>42</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.08.055</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR95"><text><SENT sid="59106" pm="."><plain><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>CJF</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Sanderson</surname><given-names>M</given-names></name><name><surname>Malherbe</surname><given-names>CJ</given-names></name><name><surname>Fey</surname><given-names>SJ</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name></person-group><article-title>Acute assessment of an aspalathin-enriched green rooibos (<italic>Aspalathus linearis</italic>) extract with hypoglycemic potential</article-title><source>Phytomedicine</source><year>2012</year><volume>20</volume><issue>1</issue><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2012.09.010</pub-id><?supplied-pmid 23083813?><pub-id pub-id-type="pmid">23083813</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR96"><text><SENT sid="59107" pm="."><plain><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamakura</surname><given-names>R</given-names></name><name><surname>Son</surname><given-names>MJ</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Yagasaki</surname><given-names>K</given-names></name></person-group><article-title>Antidiabetic effect of green rooibos (<italic>Aspalathus linearis</italic>) extract in cultured cells and type 2 diabetic model KK-A(y) mice</article-title><source>Cytotechnology</source><year>2015</year><volume>67</volume><issue>4</issue><fpage>699</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1007/s10616-014-9816-y</pub-id><?supplied-pmid 25410530?><pub-id pub-id-type="pmid">25410530</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR97"><text><SENT sid="59108" pm="."><plain><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AU</given-names></name><name><surname>Gilani</surname><given-names>AH</given-names></name></person-group><article-title>Selective bronchodilatory effect of rooibos tea (<italic>Aspalathus linearis</italic>) and its flavonoid, chrysoeriol</article-title><source>Eur J Nutr</source><year>2006</year><volume>45</volume><issue>8</issue><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1007/s00394-006-0620-0</pub-id><?supplied-pmid 17080260?><pub-id pub-id-type="pmid">17080260</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR98"><text><SENT sid="59109" pm="."><plain><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>IA</given-names></name><name><surname>Persson</surname><given-names>K</given-names></name><name><surname>Hägg</surname><given-names>S</given-names></name><name><surname>Andersson</surname><given-names>RG</given-names></name></person-group><article-title>Effects of green tea, black tea and rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers</article-title><source>Public Health Nutr</source><year>2010</year><volume>13</volume><issue>5</issue><fpage>730</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1017/S1368980010000170</pub-id><?supplied-pmid 20144258?><pub-id pub-id-type="pmid">20144258</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR99"><text><SENT sid="59110" pm="."><plain><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>IA</given-names></name><name><surname>Josefsson</surname><given-names>M</given-names></name><name><surname>Persson</surname><given-names>K</given-names></name><name><surname>Andersson</surname><given-names>RG</given-names></name></person-group><article-title>Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells</article-title><source>J Pharm Pharmacol</source><year>2006</year><volume>58</volume><issue>8</issue><fpage>1139</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1211/jpp.58.8.0016</pub-id><?supplied-pmid 16872562?><pub-id pub-id-type="pmid">16872562</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR100"><text><SENT sid="59111" pm="."><plain><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>IA</given-names></name></person-group><article-title>The pharmacological mechanism of angiotensin-converting enzyme inhibition by green tea, rooibos and enalaprilat-a study on enzyme kinetics</article-title><source>Phytother Res</source><year>2012</year><volume>26</volume><issue>4</issue><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/ptr.3588</pub-id><?supplied-pmid 22095883?><pub-id pub-id-type="pmid">22095883</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR101"><text><SENT sid="59112" pm="."><plain><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantsi</surname><given-names>WG</given-names></name><name><surname>Marnewick</surname><given-names>JL</given-names></name><name><surname>Esterhuyse</surname><given-names>AJ</given-names></name><name><surname>Rautenbach</surname><given-names>F</given-names></name><name><surname>van Rooyen</surname><given-names>J</given-names></name></person-group><article-title>Rooibos (<italic>Aspalathus linearis</italic>) offers cardiac protection against ischaemia/reperfusion in the isolated perfused rat heart</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><issue>14</issue><fpage>1220</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.09.069</pub-id><?supplied-pmid 21982437?><pub-id pub-id-type="pmid">21982437</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR102"><text><SENT sid="59113" pm="."><plain><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Rasmussen</surname><given-names>HE</given-names></name></person-group><article-title>Polyphenols, inflammation, and cardiovascular disease</article-title><source>Curr Atheroscler Rep</source><year>2013</year><volume>15</volume><issue>5</issue><fpage>324</fpage><pub-id pub-id-type="doi">10.1007/s11883-013-0324-x</pub-id><?supplied-pmid 23512608?><pub-id pub-id-type="pmid">23512608</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR103"><text><SENT sid="59114" pm="."><plain><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bors</surname><given-names>W</given-names></name><name><surname>Heller</surname><given-names>W</given-names></name><name><surname>Michel</surname><given-names>C</given-names></name><name><surname>Saran</surname><given-names>M</given-names></name></person-group><article-title>Flavonoids as antioxidants: determination of radical-scavenging efficiencies</article-title><source>Methods Enzymol</source><year>1990</year><volume>186</volume><fpage>343</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(90)86128-I</pub-id><?supplied-pmid 2172711?><pub-id pub-id-type="pmid">2172711</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR104"><text><SENT sid="59115" pm="."><plain><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Kai</surname><given-names>G</given-names></name></person-group><article-title>A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship</article-title><source>Crit Rev Food Sci Nutr</source><year>2012</year><volume>52</volume><issue>1</issue><fpage>85</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1080/10408398.2010.499017</pub-id><?supplied-pmid 21991992?><pub-id pub-id-type="pmid">21991992</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR105"><text><SENT sid="59116" pm="."><plain><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Kai</surname><given-names>G</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect</article-title><source>Crit Rev Food Sci Nutr</source><year>2013</year><volume>53</volume><issue>8</issue><fpage>818</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1080/10408398.2011.561379</pub-id><?supplied-pmid 23768145?><pub-id pub-id-type="pmid">23768145</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR106"><text><SENT sid="59117" pm="."><plain><label>106.</label><mixed-citation publication-type="other">Xiao J. </plain></SENT>
<SENT sid="59118" pm="?"><plain>Dietary flavonoid aglycones and their glycosides: Which show better biological significance? </plain></SENT>
<SENT sid="59119" pm="."><plain>Crit Rev Food Sci Nutr. </plain></SENT>
<SENT sid="59120" pm="."><plain>2015; doi: 10.1080/10408398.2015.1032400.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR107"><text><SENT sid="59121" pm="."><plain><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beelders</surname><given-names>T</given-names></name><name><surname>Sigge</surname><given-names>GO</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>de Beer</surname><given-names>D</given-names></name><name><surname>de Villiers</surname><given-names>A</given-names></name></person-group><article-title>Kinetic optimisation of the reversed phase liquid chromatographic separation of rooibos tea (<italic>Aspalathus linearis</italic>) phenolics on conventional high performance liquid chromatographic instrumentation</article-title><source>J Chromatogr A</source><year>2012</year><volume>1219</volume><fpage>128</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2011.11.012</pub-id><?supplied-pmid 22153205?><pub-id pub-id-type="pmid">22153205</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR108"><text><SENT sid="59122" pm="."><plain><label>108.</label><mixed-citation publication-type="other">Marais C, Steenkamp JA, Ferreira D. </plain></SENT>
<SENT sid="59123" pm="."><plain>Occurrence of phenylpyruvic acid in woody plants: Biosynthetic significance and synthesis of an enolic glucoside derivative. </plain></SENT>
<SENT sid="59124" pm="."><plain>J Chem Soc Perkin Trans. </plain></SENT>
<SENT sid="59125" pm="."><plain>1. </plain></SENT>
<SENT sid="59126" pm="."><plain>1996;(24):2915-2918.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR109"><text><SENT sid="59127" pm="."><plain><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stalmach</surname><given-names>A</given-names></name><name><surname>Mullen</surname><given-names>W</given-names></name><name><surname>Pecorari</surname><given-names>M</given-names></name><name><surname>Serafini</surname><given-names>M</given-names></name><name><surname>Crozier</surname><given-names>A</given-names></name></person-group><article-title>Bioavailability of <italic>C-</italic>linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas</article-title><source>J Agric Food Chem</source><year>2009</year><volume>57</volume><issue>15</issue><fpage>7104</fpage><lpage>7111</lpage><pub-id pub-id-type="doi">10.1021/jf9011642</pub-id><?supplied-pmid 19534535?><pub-id pub-id-type="pmid">19534535</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR110"><text><SENT sid="59128" pm="."><plain><label>110.</label><mixed-citation publication-type="other">Joubert E, De Beer D. </plain></SENT>
<SENT sid="59129" pm="."><plain>Antioxidants of rooibos beverages: role of plant composition and processing. </plain></SENT>
<SENT sid="59130" pm="."><plain>In: Preedy V. </plain></SENT>
<SENT sid="59131" pm="."><plain>Processing and impact on antioxidants in beverages, 1<sup>st</sup> edition. </plain></SENT>
<SENT sid="59132" pm="."><plain>Academic Press; 2014. p. </plain></SENT>
<SENT sid="59133" pm="."><plain>131–143.</mixed-citation> </plain></SENT>
</text></ref><ref id="CR111"><text><SENT sid="59134" pm="."><plain><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courts</surname><given-names>FL</given-names></name><name><surname>Williamson</surname><given-names>G</given-names></name></person-group><article-title>The occurrence, fate and biological activities of <italic>C</italic>-glycosyl flavonoids in the human diet</article-title><source>Crit Rev Food Sci Nutr</source><year>2015</year><volume>55</volume><issue>10</issue><fpage>1352</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1080/10408398.2012.694497</pub-id><?supplied-pmid 24915338?><pub-id pub-id-type="pmid">24915338</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR112"><text><SENT sid="59135" pm="."><plain><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breiter</surname><given-names>T</given-names></name><name><surname>Laue</surname><given-names>C</given-names></name><name><surname>Kressel</surname><given-names>G</given-names></name><name><surname>Gröll</surname><given-names>S</given-names></name><name><surname>Engelhardt</surname><given-names>UH</given-names></name><name><surname>Hahn</surname><given-names>A</given-names></name></person-group><article-title>Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations</article-title><source>Food Chem</source><year>2011</year><volume>128</volume><issue>2</issue><fpage>338</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2011.03.029</pub-id><?supplied-pmid 25212140?><pub-id pub-id-type="pmid">25212140</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR113"><text><SENT sid="59136" pm="."><plain><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuervo</surname><given-names>A</given-names></name><name><surname>Hevia</surname><given-names>A</given-names></name><name><surname>López</surname><given-names>P</given-names></name><name><surname>Suárez</surname><given-names>A</given-names></name><name><surname>Sánchez</surname><given-names>B</given-names></name><name><surname>Margolles</surname><given-names>A</given-names></name><name><surname>González</surname><given-names>S</given-names></name></person-group><article-title>Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients</article-title><source>Nutrients.</source><year>2015</year><volume>7</volume><issue>2</issue><fpage>1301</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.3390/nu7021301</pub-id><?supplied-pmid 25690419?><pub-id pub-id-type="pmid">25690419</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR114"><text><SENT sid="59137" pm="."><plain><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdal</surname><given-names>T</given-names></name><name><surname>Sela</surname><given-names>DA</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Boyacioglu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Capanoglu</surname><given-names>E</given-names></name></person-group><article-title>The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility</article-title><source>Nutrients.</source><year>2016</year><volume>8</volume><issue>2</issue><fpage>78</fpage><pub-id pub-id-type="doi">10.3390/nu8020078</pub-id><?supplied-pmid 26861391?><pub-id pub-id-type="pmid">26861391</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR115"><text><SENT sid="59138" pm="."><plain><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koutsos</surname><given-names>A</given-names></name><name><surname>Tuohy</surname><given-names>KM</given-names></name><name><surname>Lovegrove</surname><given-names>JA</given-names></name></person-group><article-title>Apples and cardiovascular health--is the gut microbiota a core consideration?</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><issue>6</issue><fpage>3959</fpage><lpage>3998</lpage><pub-id pub-id-type="doi">10.3390/nu7063959</pub-id><?supplied-pmid 26016654?><pub-id pub-id-type="pmid">26016654</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR116"><text><SENT sid="59139" pm="."><plain><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowles</surname><given-names>S</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Brunschwig</surname><given-names>C</given-names></name><name><surname>Njoroge</surname><given-names>M</given-names></name><name><surname>Lawrence</surname><given-names>N</given-names></name><name><surname>Wiesner</surname><given-names>L</given-names></name><name><surname>Chibale</surname><given-names>K</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name></person-group><article-title>Intestinal transport characteristics and metabolism of C-glucosyl dihydrochalcone, aspalathin</article-title><source>Molecules</source><year>2017</year><volume>22</volume><issue>4</issue><fpage>554</fpage><pub-id pub-id-type="doi">10.3390/molecules22040554</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR117"><text><SENT sid="59140" pm="."><plain><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snijman</surname><given-names>PW</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Ferreira</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>XC</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Green</surname><given-names>IR</given-names></name><name><surname>Gelderblom</surname><given-names>WC</given-names></name></person-group><article-title>Antioxidant activity of the dihydrochalcones aspalathin and nothofagin and their corresponding flavones in relation to other rooibos (<italic>Aspalathus linearis</italic>) flavonoids, epigallocatechin gallate, and trolox</article-title><source>J Agric Food Chem</source><year>2009</year><volume>57</volume><issue>15</issue><fpage>6678</fpage><lpage>6684</lpage><pub-id pub-id-type="doi">10.1021/jf901417k</pub-id><?supplied-pmid 19722573?><pub-id pub-id-type="pmid">19722573</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR118"><text><SENT sid="59141" pm="."><plain><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Kwak</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Aspalathin and nothofagin from rooibos (<italic>Aspalathus linearis</italic>) inhibits high glucose-induced inflammation <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Inflammation</source><year>2015</year><volume>38</volume><issue>1</issue><fpage>445</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-0049-1</pub-id><?supplied-pmid 25338943?><pub-id pub-id-type="pmid">25338943</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR119"><text><SENT sid="59142" pm="."><plain><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa</article-title><source>Arch Pharm Res</source><year>2015</year><volume>38</volume><issue>6</issue><fpage>1080</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1007/s12272-014-0501-7</pub-id><?supplied-pmid 25325928?><pub-id pub-id-type="pmid">25325928</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR120"><text><SENT sid="59143" pm="."><plain><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najafian</surname><given-names>M</given-names></name><name><surname>Najafian</surname><given-names>B</given-names></name><name><surname>Najafian</surname><given-names>Z</given-names></name></person-group><article-title>The effect of aspalathin on levels of sugar and lipids in streptozotocin-induced diabetic and normal rats</article-title><source>Zahedan J Res Med Sci</source><year>2016</year><volume>18</volume><issue>11</issue><fpage>e4963</fpage></element-citation> </plain></SENT>
</text></ref><ref id="CR121"><text><SENT sid="59144" pm="."><plain><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Hata</surname><given-names>S</given-names></name><name><surname>Minakawa</surname><given-names>M</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Yagasaki</surname><given-names>K</given-names></name></person-group><article-title>Hypoglycemic effect of aspalathin, a rooibos tea component from <italic>Aspalathus linearis</italic>, in type 2 diabetic model <italic>db/db</italic> mice</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><issue>5</issue><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.11.009</pub-id><?supplied-pmid 19188054?><pub-id pub-id-type="pmid">19188054</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR122"><text><SENT sid="59145" pm="."><plain><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>MJ</given-names></name><name><surname>Minakawa</surname><given-names>M</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Yagasaki</surname><given-names>K</given-names></name></person-group><article-title>Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice</article-title><source>Eur J Nutr</source><year>2013</year><volume>52</volume><issue>6</issue><fpage>1607</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1007/s00394-012-0466-6</pub-id><?supplied-pmid 23238530?><pub-id pub-id-type="pmid">23238530</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR123"><text><SENT sid="59146" pm="."><plain><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazibuko</surname><given-names>SE</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Opoku</surname><given-names>AR</given-names></name><name><surname>Muller</surname><given-names>CJ</given-names></name></person-group><article-title>Aspalathin improves glucose and lipid metabolism in 3T3-L1 adipocytes exposed to palmitate</article-title><source>Mol Nutr Food Res</source><year>2015</year><volume>59</volume><issue>11</issue><fpage>2199</fpage><lpage>2208</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500258</pub-id><?supplied-pmid 26310822?><pub-id pub-id-type="pmid">26310822</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR124"><text><SENT sid="59147" pm="."><plain><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Dludla</surname><given-names>PV</given-names></name><name><surname>Muller</surname><given-names>CJ</given-names></name><name><surname>Huisamen</surname><given-names>B</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name></person-group><article-title>The transcription profile unveils the cardioprotective effect of aspalathin against lipid toxicity in an <italic>in vitro</italic> H9c2 model</article-title><source>Molecules</source><year>2017</year><volume>22</volume><issue>2</issue><fpage>219</fpage><pub-id pub-id-type="doi">10.3390/molecules22020219</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR125"><text><SENT sid="59148" pm="."><plain><label>125.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>SE</given-names></name></person-group><source>An investigation into the effects of aspalathin on myocardial glucose transport using cardiomyocytes, and terminally differentiated H9c2 cells</source><year>2016</year><publisher-loc>MSc (Medical Physiology) Thesis</publisher-loc><publisher-name>Stellenbosch University</publisher-name></element-citation> </plain></SENT>
</text></ref><ref id="CR126"><text><SENT sid="59149" pm="."><plain><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dludla</surname><given-names>PV</given-names></name><name><surname>Muller</surname><given-names>CJF</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name><name><surname>Gabuza</surname><given-names>KB</given-names></name><name><surname>Ghoor</surname><given-names>S</given-names></name><name><surname>Huisamen</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name></person-group><article-title>Aspalathin protects the heart against hyperglycemia-induced oxidative damage by up-regulating Nrf2 expression</article-title><source>Molecules</source><year>2017</year><volume>22</volume><issue>1</issue><fpage>129</fpage><pub-id pub-id-type="doi">10.3390/molecules22010129</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR127"><text><SENT sid="59150" pm="."><plain><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Beelders</surname><given-names>T</given-names></name><name><surname>de Beer</surname><given-names>D</given-names></name><name><surname>Malherbe</surname><given-names>CJ</given-names></name><name><surname>de Villiers</surname><given-names>AJ</given-names></name><name><surname>Sigge</surname><given-names>GO</given-names></name></person-group><article-title>Variation in phenolic content and antioxidant activity of fermented rooibos herbal tea infusions: Role of production season and quality grade</article-title><source>J Agric Food Chem</source><year>2012</year><volume>60</volume><issue>36</issue><fpage>9171</fpage><lpage>9179</lpage><pub-id pub-id-type="doi">10.1021/jf302583r</pub-id><?supplied-pmid 22920220?><pub-id pub-id-type="pmid">22920220</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR128"><text><SENT sid="59151" pm="."><plain><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title><italic>In vitro</italic> study of UGTs metabolism and permeability of orientin and isoorientin, two active flavonoid <italic>C-</italic>glycosides</article-title><source>Drug Metab Lett</source><year>2016</year><volume>10</volume><issue>2</issue><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.2174/1872312810666160219121217</pub-id><?supplied-pmid 26891873?><pub-id pub-id-type="pmid">26891873</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR129"><text><SENT sid="59152" pm="."><plain><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name></person-group><article-title>Characterization of the intestinal absorption of seven flavonoids from the flowers of <italic>Trollius chinensis</italic> using the Caco-2 cell monolayer model</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>e0119263</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0119263</pub-id><?supplied-pmid 25789809?><pub-id pub-id-type="pmid">25789809</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR130"><text><SENT sid="59153" pm="."><plain><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yuan</surname><given-names>ZF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>K</given-names></name></person-group><article-title>Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography</article-title><source>J Pharm Biomed Anal</source><year>2008</year><volume>47</volume><issue>2</issue><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2008.01.035</pub-id><?supplied-pmid 18395390?><pub-id pub-id-type="pmid">18395390</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR131"><text><SENT sid="59154" pm="."><plain><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>LP</given-names></name><name><surname>Luo</surname><given-names>SQ</given-names></name><name><surname>Jiang</surname><given-names>HD</given-names></name><name><surname>Zeng</surname><given-names>S</given-names></name></person-group><article-title>Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin</article-title><source>J Agric Food Chem</source><year>2008</year><volume>56</volume><issue>1</issue><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1021/jf072612+</pub-id><?supplied-pmid 18052241?><pub-id pub-id-type="pmid">18052241</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR132"><text><SENT sid="59155" pm="."><plain><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Likhitwitayawuid</surname><given-names>K</given-names></name><name><surname>Klongsiriwet</surname><given-names>C</given-names></name><name><surname>Jongbunprasert</surname><given-names>V</given-names></name><name><surname>Sritularak</surname><given-names>B</given-names></name><name><surname>Wongseripipatana</surname><given-names>S</given-names></name></person-group><article-title>Flavones with free radical scavenging activity from <italic>Goniothalamus tenuifolius</italic></article-title><source>Arch Pharm Res</source><year>2006</year><volume>29</volume><issue>3</issue><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1007/BF02969393</pub-id><?supplied-pmid 16596991?><pub-id pub-id-type="pmid">16596991</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR133"><text><SENT sid="59156" pm="."><plain><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Yim</surname><given-names>N</given-names></name><name><surname>Bae</surname><given-names>K</given-names></name></person-group><article-title>Vitexin, orientin and other flavonoids from <italic>Spirodela polyrhiza</italic> inhibit adipogenesis in 3T3-L1 cells</article-title><source>Phytother Res</source><year>2010</year><volume>24</volume><issue>10</issue><fpage>1543</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1002/ptr.3186</pub-id><?supplied-pmid 20878708?><pub-id pub-id-type="pmid">20878708</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR134"><text><SENT sid="59157" pm="."><plain><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Kwak</surname><given-names>S</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Orientin inhibits high glucose-induced vascular inflammation <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Inflammation</source><year>2014</year><volume>37</volume><issue>6</issue><fpage>2164</fpage><lpage>2173</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-9950-x</pub-id><?supplied-pmid 24950780?><pub-id pub-id-type="pmid">24950780</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR135"><text><SENT sid="59158" pm="."><plain><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrego</surname><given-names>R</given-names></name><name><surname>Leiva</surname><given-names>E</given-names></name><name><surname>Cheel</surname><given-names>J</given-names></name></person-group><article-title>Inhibitory effect of three <italic>C-</italic>glycosylflavonoids from <italic>Cymbopogon citratus</italic> (Lemongrass) on human low density lipoprotein oxidation</article-title><source>Molecules</source><year>2009</year><volume>14</volume><issue>10</issue><fpage>3906</fpage><lpage>3913</lpage><pub-id pub-id-type="doi">10.3390/molecules14103906</pub-id><?supplied-pmid 19924037?><pub-id pub-id-type="pmid">19924037</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR136"><text><SENT sid="59159" pm="."><plain><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LY</given-names></name><name><surname>Ma</surname><given-names>QQ</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>JP</given-names></name><name><surname>Huang</surname><given-names>XL</given-names></name></person-group><article-title>The therapeutic effect of orientin on myocardial infarction rats</article-title><source>Lishizhen Medicine and Materia Medica Research</source><year>2013</year><volume>8</volume><issue>2013</issue><fpage>1807</fpage><lpage>1810</lpage></element-citation> </plain></SENT>
</text></ref><ref id="CR137"><text><SENT sid="59160" pm="."><plain><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>Orientin protects myocardial cells against hypoxia-reoxygenation injury through induction of autophagy</article-title><source>Eur J Pharmacol</source><year>2016</year><volume>776</volume><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2016.02.037</pub-id><?supplied-pmid 26875637?><pub-id pub-id-type="pmid">26875637</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR138"><text><SENT sid="59161" pm="."><plain><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name></person-group><article-title>Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition</article-title><source>Planta Med</source><year>2011</year><volume>77</volume><issue>10</issue><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250718</pub-id><?supplied-pmid 21283956?><pub-id pub-id-type="pmid">21283956</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR139"><text><SENT sid="59162" pm="."><plain><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>KY</given-names></name><name><surname>Ling</surname><given-names>AP</given-names></name><name><surname>Koh</surname><given-names>RY</given-names></name><name><surname>Wong</surname><given-names>YP</given-names></name><name><surname>Say</surname><given-names>YH</given-names></name></person-group><article-title>A review on medicinal properties of orientin</article-title><source>Adv Pharmacol Sci</source><year>2016</year><volume>2016</volume><fpage>4104595</fpage><?supplied-pmid 27298620?><pub-id pub-id-type="pmid">27298620</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR140"><text><SENT sid="59163" pm="."><plain><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>XC</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name><name><surname>Li</surname><given-names>SP</given-names></name><name><surname>Wang</surname><given-names>HL</given-names></name></person-group><article-title>Anti-apoptotic effect and the mechanism of orientin on ischaemic/reperfused myocardium</article-title><source>J Asian Nat Prod Res</source><year>2006</year><volume>8</volume><issue>3</issue><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1080/10286020500207347</pub-id><?supplied-pmid 16864433?><pub-id pub-id-type="pmid">16864433</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR141"><text><SENT sid="59164" pm="."><plain><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>Isoorientin prevents hyperlipidemia and liver injury by regulating lipid metabolism, antioxidant capability, and inflammatory cytokine release in high-fructose-fed mice</article-title><source>J Agric Food Chem</source><year>2016</year><volume>64</volume><issue>13</issue><fpage>2682</fpage><lpage>2689</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.6b00290</pub-id><?supplied-pmid 26961674?><pub-id pub-id-type="pmid">26961674</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR142"><text><SENT sid="59165" pm="."><plain><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>IS</given-names></name><name><surname>Choi</surname><given-names>HJ</given-names></name></person-group><article-title>Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling</article-title><source>Arch Pharm Res</source><year>2007</year><volume>30</volume><issue>12</issue><fpage>1590</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1007/BF02977329</pub-id><?supplied-pmid 18254247?><pub-id pub-id-type="pmid">18254247</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR143"><text><SENT sid="59166" pm="."><plain><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname><given-names>CY</given-names></name><name><surname>Sulong</surname><given-names>NY</given-names></name><name><surname>Man</surname><given-names>F</given-names></name><name><surname>Wong</surname><given-names>TW</given-names></name></person-group><article-title>Vitexin and isovitexin from the leaves of <italic>Ficus deltoidea</italic> with <italic>in-vivo</italic> α-glucosidase inhibition</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>142</volume><issue>3</issue><fpage>776</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.05.062</pub-id><?supplied-pmid 22683902?><pub-id pub-id-type="pmid">22683902</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR144"><text><SENT sid="59167" pm="."><plain><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>G</given-names></name></person-group><article-title>A determination of potential α-glucosidase inhibitors from Azuki Beans (<italic>Vigna angularis</italic>)</article-title><source>Int J Mol Sci</source><year>2011</year><volume>12</volume><issue>10</issue><fpage>6445</fpage><lpage>6451</lpage><pub-id pub-id-type="doi">10.3390/ijms12106445</pub-id><?supplied-pmid 22072898?><pub-id pub-id-type="pmid">22072898</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR145"><text><SENT sid="59168" pm="."><plain><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>KW</given-names></name><name><surname>Shan</surname><given-names>F</given-names></name><name><surname>Ren</surname><given-names>GX</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation end products</article-title><source>Food Chem</source><year>2008</year><volume>106</volume><issue>2</issue><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2007.06.016</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR146"><text><SENT sid="59169" pm="."><plain><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><article-title>Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis</article-title><source>Food Chem Toxicol</source><year>2011</year><volume>49</volume><issue>12</issue><fpage>3211</fpage><lpage>3216</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2011.09.040</pub-id><?supplied-pmid 22001368?><pub-id pub-id-type="pmid">22001368</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR147"><text><SENT sid="59170" pm="."><plain><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name></person-group><article-title>Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice</article-title><source>Phytomedicine</source><year>2015</year><volume>22</volume><issue>3</issue><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2015.01.009</pub-id><?supplied-pmid 25837275?><pub-id pub-id-type="pmid">25837275</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR148"><text><SENT sid="59171" pm="."><plain><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>LY</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhen</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>YN</given-names></name><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>ZG</given-names></name></person-group><article-title>Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway</article-title><source>Am J Chin Med.</source><year>2013</year><volume>41</volume><issue>6</issue><fpage>1251</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1142/S0192415X13500845</pub-id><?supplied-pmid 24228599?><pub-id pub-id-type="pmid">24228599</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR149"><text><SENT sid="59172" pm="."><plain><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XS</given-names></name><name><surname>Hu</surname><given-names>XC</given-names></name><name><surname>Chen</surname><given-names>GL</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>RN</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Kong</surname><given-names>GQ</given-names></name><name><surname>Gao</surname><given-names>SG</given-names></name><name><surname>Feng</surname><given-names>XS</given-names></name></person-group><article-title>Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats</article-title><source>Phytother Res</source><year>2015</year><volume>29</volume><issue>3</issue><fpage>366</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1002/ptr.5260</pub-id><?supplied-pmid 25447838?><pub-id pub-id-type="pmid">25447838</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR150"><text><SENT sid="59173" pm="."><plain><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>LY</given-names></name><name><surname>Li</surname><given-names>XL</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>M</given-names></name></person-group><article-title>Effects of vitexin on hemodynamics and myocardial oxygen consumption in anesthetized dogs</article-title><source>Anhui Med and Pharm J</source><year>2010</year><volume>9</volume><issue>2010</issue><fpage>004</fpage></element-citation> </plain></SENT>
</text></ref><ref id="CR151"><text><SENT sid="59174" pm="."><plain><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>CC</given-names></name><name><surname>Xu</surname><given-names>YQ</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name><name><surname>Hang</surname><given-names>PZ</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>JW</given-names></name><name><surname>Qi</surname><given-names>JC</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>ZM</given-names></name></person-group><article-title>Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways</article-title><source>Naunyn Schmiedeberg's Arch Pharmacol</source><year>2013</year><volume>386</volume><issue>8</issue><fpage>747</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1007/s00210-013-0873-0</pub-id><pub-id pub-id-type="pmid">23624753</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR152"><text><SENT sid="59175" pm="."><plain><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>ZW</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>XP</given-names></name><name><surname>Shao</surname><given-names>X</given-names></name></person-group><article-title>Mechanisms of vitexin preconditioning effects on cultured neonatal rat cardiomyocytes with anoxia and reoxygenation</article-title><source>Am J Chin Med.</source><year>2008</year><volume>36</volume><issue>2</issue><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1142/S0192415X08005849</pub-id><?supplied-pmid 18457368?><pub-id pub-id-type="pmid">18457368</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR153"><text><SENT sid="59176" pm="."><plain><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>EY</given-names></name><name><surname>Jung</surname><given-names>UJ</given-names></name><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Yun</surname><given-names>JW</given-names></name><name><surname>Choi</surname><given-names>MS</given-names></name></person-group><article-title>Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><issue>5</issue><fpage>1658</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.2337/db14-0631</pub-id><?supplied-pmid 25524918?><pub-id pub-id-type="pmid">25524918</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR154"><text><SENT sid="59177" pm="."><plain><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Gou</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Ling</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name></person-group><article-title>Luteolin attenuates diabetes-associated cognitive decline in rats</article-title><source>Brain Res Bull</source><year>2013</year><volume>94</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2013.02.001</pub-id><?supplied-pmid 23415807?><pub-id pub-id-type="pmid">23415807</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR155"><text><SENT sid="59178" pm="."><plain><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>GG</given-names></name><name><surname>Lu</surname><given-names>XH</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name></person-group><article-title>Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats</article-title><source>Evid Based Complement Alternat Med</source><year>2011</year><volume>2011</volume><fpage>323171</fpage><?supplied-pmid 21584231?><pub-id pub-id-type="pmid">21584231</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR156"><text><SENT sid="59179" pm="."><plain><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>S</given-names></name><name><surname>Moldovan</surname><given-names>PL</given-names></name><name><surname>Ben Saad</surname><given-names>A</given-names></name><name><surname>Annabi</surname><given-names>B</given-names></name></person-group><article-title>Biphasic effects of luteolin on interleukin-1β-induced cyclooxygenase-2 expression in glioblastoma cells</article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1853</volume><issue>1</issue><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.10.010</pub-id><?supplied-pmid 25409926?><pub-id pub-id-type="pmid">25409926</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR157"><text><SENT sid="59180" pm="."><plain><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagli</surname><given-names>E</given-names></name><name><surname>Stefaniotou</surname><given-names>M</given-names></name><name><surname>Morbidelli</surname><given-names>L</given-names></name><name><surname>Ziche</surname><given-names>M</given-names></name><name><surname>Psillas</surname><given-names>K</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>Fotsis</surname><given-names>T</given-names></name></person-group><article-title>Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><issue>21</issue><fpage>7936</fpage><lpage>7946</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-3104</pub-id><?supplied-pmid 15520200?><pub-id pub-id-type="pmid">15520200</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR158"><text><SENT sid="59181" pm="."><plain><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>Z</given-names></name><name><surname>Patel</surname><given-names>AB</given-names></name><name><surname>Vasiadi</surname><given-names>M</given-names></name><name><surname>Therianou</surname><given-names>A</given-names></name><name><surname>Theoharides</surname><given-names>TC</given-names></name></person-group><article-title>Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e90739</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0090739</pub-id><?supplied-pmid 24587411?><pub-id pub-id-type="pmid">24587411</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR159"><text><SENT sid="59182" pm="."><plain><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdalla</surname><given-names>S</given-names></name><name><surname>Zarga</surname><given-names>MA</given-names></name><name><surname>Sabri</surname><given-names>S</given-names></name></person-group><article-title>Effects of the flavone luteolin, isolated from <italic>Colchicum richii</italic>, on guinea-pig isolated smooth muscle and heart and on blood pressure and blood flow</article-title><source>Phytother Res</source><year>1994</year><volume>8</volume><issue>5</issue><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650080503</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR160"><text><SENT sid="59183" pm="."><plain><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>HT</given-names></name><name><surname>Yu</surname><given-names>JJ</given-names></name><name><surname>Gao</surname><given-names>JL</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>QS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Pang</surname><given-names>MX</given-names></name><name><surname>Su</surname><given-names>MX</given-names></name><name><surname>Mi</surname><given-names>WJ</given-names></name><name><surname>Chen</surname><given-names>SH</given-names></name><name><surname>Lv</surname><given-names>GY</given-names></name></person-group><article-title>Luteolin ameliorates hypertensive vascular remodeling through inhibiting the proliferation and migration of vascular smooth muscle cells</article-title><source>Evid Based Complement Alternat Med</source><year>2015</year><volume>2015</volume><fpage>364876</fpage><?supplied-pmid 26495010?><pub-id pub-id-type="pmid">26495010</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR161"><text><SENT sid="59184" pm="."><plain><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Bassossy</surname><given-names>HM</given-names></name><name><surname>Abo-Warda</surname><given-names>SM</given-names></name><name><surname>Fahmy</surname><given-names>A</given-names></name></person-group><article-title>Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation</article-title><source>Am J Chin Med.</source><year>2014</year><volume>42</volume><issue>5</issue><fpage>1153</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1142/S0192415X14500724</pub-id><?supplied-pmid 25169908?><pub-id pub-id-type="pmid">25169908</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR162"><text><SENT sid="59185" pm="."><plain><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>D</given-names></name></person-group><article-title>Luteolin inhibits Ischemia/reperfusion-induced myocardial injury in rats via downregulation of microRNA-208b-3p</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>12</issue><fpage>e0144877</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0144877</pub-id><?supplied-pmid 26658785?><pub-id pub-id-type="pmid">26658785</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR163"><text><SENT sid="59186" pm="."><plain><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Bao</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><article-title>Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy</article-title><source>J Diabetes Complicat</source><year>2012</year><volume>26</volume><issue>4</issue><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2012.04.007</pub-id><?supplied-pmid 22626874?><pub-id pub-id-type="pmid">22626874</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR164"><text><SENT sid="59187" pm="."><plain><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>GB</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>JX</given-names></name><name><surname>Si</surname><given-names>JY</given-names></name><name><surname>Xu</surname><given-names>HB</given-names></name><name><surname>Meng</surname><given-names>XB</given-names></name><name><surname>Qin</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>HW</given-names></name><name><surname>Sun</surname><given-names>XB</given-names></name></person-group><article-title>Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression</article-title><source>Toxicol Appl Pharmacol</source><year>2012</year><volume>265</volume><issue>2</issue><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2012.10.002</pub-id><?supplied-pmid 23051850?><pub-id pub-id-type="pmid">23051850</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR165"><text><SENT sid="59188" pm="."><plain><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name></person-group><article-title>ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>12</issue><fpage>e82957</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0082957</pub-id><?supplied-pmid 24386130?><pub-id pub-id-type="pmid">24386130</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR166"><text><SENT sid="59189" pm="."><plain><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odontuya</surname><given-names>G</given-names></name><name><surname>Hoult</surname><given-names>JR</given-names></name><name><surname>Houghton</surname><given-names>PJ</given-names></name></person-group><article-title>Structure-activity relationship for antiinflammatory effect of luteolin and its derived glycosides</article-title><source>Phytother Res</source><year>2005</year><volume>19</volume><issue>9</issue><fpage>782</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1002/ptr.1723</pub-id><?supplied-pmid 16220571?><pub-id pub-id-type="pmid">16220571</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR167"><text><SENT sid="59190" pm="."><plain><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>K</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Tanimura</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name></person-group><article-title>Profiles of potentially antiallergic flavonoids in 27 kinds of health tea and green tea infusions</article-title><source>J Agric Food Chem</source><year>1997</year><volume>45</volume><issue>7</issue><fpage>2561</fpage><lpage>2564</lpage><pub-id pub-id-type="doi">10.1021/jf970024y</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR168"><text><SENT sid="59191" pm="."><plain><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B</given-names></name><name><surname>Priyadarsini</surname><given-names>KI</given-names></name><name><surname>Kumar</surname><given-names>MS</given-names></name><name><surname>Unnikrishnan</surname><given-names>MK</given-names></name><name><surname>Mohan</surname><given-names>H</given-names></name></person-group><article-title>Effect of <italic>O</italic>-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol</article-title><source>Bioorg Med Chem</source><year>2003</year><volume>11</volume><issue>13</issue><fpage>2677</fpage><lpage>2685</lpage><pub-id pub-id-type="doi">10.1016/S0968-0896(03)00232-3</pub-id><?supplied-pmid 12788341?><pub-id pub-id-type="pmid">12788341</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR169"><text><SENT sid="59192" pm="."><plain><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Choi</surname><given-names>EM</given-names></name></person-group><article-title>Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3-E1 cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation</article-title><source>J Appl Toxicol</source><year>2010</year><volume>30</volume><issue>7</issue><fpage>666</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1002/jat.1539</pub-id><?supplied-pmid 20981859?><pub-id pub-id-type="pmid">20981859</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR170"><text><SENT sid="59193" pm="."><plain><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>DY</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>MR</given-names></name><name><surname>Woo</surname><given-names>ER</given-names></name><name><surname>Kim</surname><given-names>YG</given-names></name><name><surname>Kang</surname><given-names>KW</given-names></name></person-group><article-title>Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation</article-title><source>J Biomed Sci</source><year>2005</year><volume>12</volume><issue>6</issue><fpage>949</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1007/s11373-005-9028-8</pub-id><?supplied-pmid 16228289?><pub-id pub-id-type="pmid">16228289</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR171"><text><SENT sid="59194" pm="."><plain><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>G</given-names></name><name><surname>Zamilpa</surname><given-names>A</given-names></name><name><surname>Zavala</surname><given-names>M</given-names></name><name><surname>Perez</surname><given-names>J</given-names></name><name><surname>Morales</surname><given-names>D</given-names></name><name><surname>Tortoriello</surname><given-names>J</given-names></name></person-group><article-title>Chrysoeriol and other polyphenols from <italic>Tecoma stans</italic> with lipase inhibitory activity</article-title><source>J Ethnopharmacol</source><year>2016</year><volume>185</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.03.014</pub-id><?supplied-pmid 26970570?><pub-id pub-id-type="pmid">26970570</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR172"><text><SENT sid="59195" pm="."><plain><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>XD</given-names></name><name><surname>Xin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>YY</given-names></name><name><surname>Liu</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>CN</given-names></name><name><surname>Hui</surname><given-names>RT</given-names></name></person-group><article-title>Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity <italic>in vitro</italic></article-title><source>Chin Med J</source><year>2009</year><volume>122</volume><issue>21</issue><fpage>2652</fpage><lpage>2656</lpage><?supplied-pmid 19951587?><pub-id pub-id-type="pmid">19951587</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR173"><text><SENT sid="59196" pm="."><plain><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollman</surname><given-names>PC</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><article-title>Dietary flavonoids: intake, health effects and bioavailability</article-title><source>Food Chem Toxicol</source><year>1999</year><volume>37</volume><issue>9–10</issue><fpage>937</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1016/S0278-6915(99)00079-4</pub-id><?supplied-pmid 10541448?><pub-id pub-id-type="pmid">10541448</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR174"><text><SENT sid="59197" pm="."><plain><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogiatzoglou</surname><given-names>A</given-names></name><name><surname>Mulligan</surname><given-names>AA</given-names></name><name><surname>Lentjes</surname><given-names>MA</given-names></name><name><surname>Luben</surname><given-names>RN</given-names></name><name><surname>Spencer</surname><given-names>JP</given-names></name><name><surname>Schroeter</surname><given-names>H</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Kuhnle</surname><given-names>GG</given-names></name></person-group><article-title>Flavonoid intake in European adults (18 to 64 years)</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>5</issue><fpage>e0128132</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0128132</pub-id><?supplied-pmid 26010916?><pub-id pub-id-type="pmid">26010916</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR175"><text><SENT sid="59198" pm="."><plain><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scalbert</surname><given-names>A</given-names></name><name><surname>Morand</surname><given-names>C</given-names></name><name><surname>Manach</surname><given-names>C</given-names></name><name><surname>Rémésy</surname><given-names>C</given-names></name></person-group><article-title>Absorption and metabolism of polyphenols in the gut and impact on health</article-title><source>Biomed Pharmacother</source><year>2002</year><volume>56</volume><issue>6</issue><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/S0753-3322(02)00205-6</pub-id><?supplied-pmid 12224598?><pub-id pub-id-type="pmid">12224598</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR176"><text><SENT sid="59199" pm="."><plain><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollman</surname><given-names>PC</given-names></name><name><surname>De Vries</surname><given-names>JH</given-names></name><name><surname>Van Leeuwen</surname><given-names>SD</given-names></name><name><surname>Mengelers</surname><given-names>MJ</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><article-title>Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers</article-title><source>Am J Clin Nutr</source><year>1995</year><volume>62</volume><issue>6</issue><fpage>1276</fpage><lpage>1282</lpage><?supplied-pmid 7491892?><pub-id pub-id-type="pmid">7491892</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR177"><text><SENT sid="59200" pm="."><plain><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Q</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Chow</surname><given-names>MS</given-names></name><name><surname>Ho</surname><given-names>WK</given-names></name></person-group><article-title>Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats</article-title><source>Eur J Pharm Biopharm</source><year>2005</year><volume>59</volume><issue>3</issue><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2004.10.004</pub-id><?supplied-pmid 15760736?><pub-id pub-id-type="pmid">15760736</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR178"><text><SENT sid="59201" pm="."><plain><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertog</surname><given-names>MG</given-names></name><name><surname>Feskens</surname><given-names>EJ</given-names></name><name><surname>Hollman</surname><given-names>PC</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name></person-group><article-title>Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study</article-title><source>Lancet</source><year>1993</year><volume>342</volume><issue>8878</issue><fpage>1007</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(93)92876-U</pub-id><?supplied-pmid 8105262?><pub-id pub-id-type="pmid">8105262</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR179"><text><SENT sid="59202" pm="."><plain><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousef</surname><given-names>MI</given-names></name><name><surname>Omar</surname><given-names>SA</given-names></name><name><surname>El-Guendi</surname><given-names>MI</given-names></name><name><surname>Abdelmegid</surname><given-names>LA</given-names></name></person-group><article-title>Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat</article-title><source>Food Chem Toxicol</source><year>2010</year><volume>48</volume><issue>11</issue><fpage>3246</fpage><lpage>3261</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2010.08.034</pub-id><?supplied-pmid 20804811?><pub-id pub-id-type="pmid">20804811</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR180"><text><SENT sid="59203" pm="."><plain><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Sang</surname><given-names>S</given-names></name><name><surname>Lv</surname><given-names>L</given-names></name></person-group><article-title>Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal</article-title><source>J Agric Food Chem</source><year>2014</year><volume>62</volume><issue>50</issue><fpage>12152</fpage><lpage>12158</lpage><pub-id pub-id-type="doi">10.1021/jf504132x</pub-id><?supplied-pmid 25412188?><pub-id pub-id-type="pmid">25412188</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR181"><text><SENT sid="59204" pm="."><plain><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odbayar</surname><given-names>TO</given-names></name><name><surname>Badamhand</surname><given-names>D</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Takashi</surname><given-names>Y</given-names></name><name><surname>Tsushida</surname><given-names>T</given-names></name><name><surname>Ide</surname><given-names>T</given-names></name></person-group><article-title>Comparative studies of some phenolic compounds (quercetin, rutin, and ferulic acid) affecting hepatic fatty acid synthesis in mice</article-title><source>J Agric Food Chem</source><year>2006</year><volume>54</volume><issue>21</issue><fpage>8261</fpage><lpage>8265</lpage><pub-id pub-id-type="doi">10.1021/jf061135c</pub-id><?supplied-pmid 17032037?><pub-id pub-id-type="pmid">17032037</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR182"><text><SENT sid="59205" pm="."><plain><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanya</surname><given-names>R</given-names></name><name><surname>Arun</surname><given-names>KB</given-names></name><name><surname>Syama</surname><given-names>HP</given-names></name><name><surname>Nisha</surname><given-names>P</given-names></name><name><surname>Sundaresan</surname><given-names>A</given-names></name><name><surname>Santhosh Kumar</surname><given-names>TR</given-names></name><name><surname>Jayamurthy</surname><given-names>P</given-names></name></person-group><article-title>Rutin and quercetin enhance glucose uptake in L6 myotubes under oxidative stress induced by tertiary butyl hydrogen peroxide</article-title><source>Food Chem</source><year>2014</year><volume>158</volume><fpage>546</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.02.151</pub-id><?supplied-pmid 24731381?><pub-id pub-id-type="pmid">24731381</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR183"><text><SENT sid="59206" pm="."><plain><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>QH</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Kong</surname><given-names>LD</given-names></name></person-group><article-title>Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats</article-title><source>Biochem Pharmacol</source><year>2012</year><volume>84</volume><issue>1</issue><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2012.03.005</pub-id><?supplied-pmid 22426011?><pub-id pub-id-type="pmid">22426011</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR184"><text><SENT sid="59207" pm="."><plain><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>KM</given-names></name><name><surname>Annapurna</surname><given-names>A</given-names></name><name><surname>Gopal</surname><given-names>GS</given-names></name><name><surname>Chalam</surname><given-names>CR</given-names></name><name><surname>Madan</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>VK</given-names></name><name><surname>Prakash</surname><given-names>GJ</given-names></name></person-group><article-title>Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats</article-title><source>Can J Physiol Pharmacol</source><year>2005</year><volume>83</volume><issue>4</issue><fpage>343</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1139/y05-009</pub-id><?supplied-pmid 15877109?><pub-id pub-id-type="pmid">15877109</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR185"><text><SENT sid="59208" pm="."><plain><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YB</given-names></name><name><surname>Ge</surname><given-names>ZM</given-names></name><name><surname>Kang</surname><given-names>WQ</given-names></name><name><surname>Lian</surname><given-names>ZX</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>CY</given-names></name></person-group><article-title>Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes</article-title><source>Exp Ther Med.</source><year>2015</year><volume>9</volume><issue>2</issue><fpage>451</fpage><lpage>455</lpage><?supplied-pmid 25574214?><pub-id pub-id-type="pmid">25574214</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR186"><text><SENT sid="59209" pm="."><plain><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimaraes</surname><given-names>JFC</given-names></name><name><surname>Muzio</surname><given-names>BP</given-names></name><name><surname>Rosa</surname><given-names>CM</given-names></name><name><surname>Nascimento</surname><given-names>AF</given-names></name><name><surname>Sugizaki</surname><given-names>MM</given-names></name><name><surname>Fernandes</surname><given-names>AAH</given-names></name><name><surname>Cicogna</surname><given-names>AC</given-names></name><name><surname>Padovani</surname><given-names>CR</given-names></name><name><surname>Okoshi</surname><given-names>MP</given-names></name><name><surname>Okoshi</surname><given-names>K</given-names></name></person-group><article-title>Rutin administration attenuates myocardial dysfunction in diabetic rats</article-title><source>Cardiovasc Diabetol</source><year>2015</year><volume>14</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.1186/s12933-015-0255-7</pub-id><?supplied-pmid 26185015?><pub-id pub-id-type="pmid">26185015</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR187"><text><SENT sid="59210" pm="."><plain><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>MF</given-names></name><name><surname>Hassan</surname><given-names>NA</given-names></name><name><surname>El Bassossy</surname><given-names>HM</given-names></name><name><surname>Fahmy</surname><given-names>A</given-names></name></person-group><article-title>Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>5</issue><fpage>e63784</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0063784</pub-id><?supplied-pmid 23717483?><pub-id pub-id-type="pmid">23717483</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR188"><text><SENT sid="59211" pm="."><plain><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milenković</surname><given-names>M</given-names></name><name><surname>Arsenović-Ranin</surname><given-names>N</given-names></name><name><surname>Stojić-Vukanić</surname><given-names>Z</given-names></name><name><surname>Bufan</surname><given-names>B</given-names></name><name><surname>Vučićević</surname><given-names>D</given-names></name><name><surname>Jančić</surname><given-names>I</given-names></name></person-group><article-title>Quercetin ameliorates experimental autoimmune myocarditis in rats</article-title><source>J Pharm Pharm Sci</source><year>2010</year><volume>13</volume><issue>3</issue><fpage>311</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.18433/J3VS3S</pub-id><?supplied-pmid 21092705?><pub-id pub-id-type="pmid">21092705</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR189"><text><SENT sid="59212" pm="."><plain><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Rahn</surname><given-names>RO</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group><article-title>Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals</article-title><source>Cancer Lett</source><year>1997</year><volume>119</volume><issue>1</issue><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(97)00261-9</pub-id><?supplied-pmid 18372528?><pub-id pub-id-type="pmid">18372528</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR190"><text><SENT sid="59213" pm="."><plain><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psotová</surname><given-names>J</given-names></name><name><surname>Chlopcíková</surname><given-names>S</given-names></name><name><surname>Grambal</surname><given-names>F</given-names></name><name><surname>Simánek</surname><given-names>V</given-names></name><name><surname>Ulrichová</surname><given-names>J</given-names></name></person-group><article-title>Influence of silymarin and its flavonolignans on doxorubicin-iron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin</article-title><source>Phytother Res</source><year>2002</year><volume>16</volume><issue>Suppl 1</issue><fpage>S63</fpage><lpage>S67</lpage><pub-id pub-id-type="doi">10.1002/ptr.811</pub-id><?supplied-pmid 11933142?><pub-id pub-id-type="pmid">11933142</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR191"><text><SENT sid="59214" pm="."><plain><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>AS</given-names></name><name><surname>Heinonen</surname><given-names>M</given-names></name><name><surname>Frankel</surname><given-names>EN</given-names></name></person-group><article-title>Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL oxidation</article-title><source>Food Chem</source><year>1998</year><volume>61</volume><issue>1–2</issue><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(97)00100-3</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR192"><text><SENT sid="59215" pm="."><plain><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>C</given-names></name><name><surname>da Silva</surname><given-names>EL</given-names></name><name><surname>Ohnishi-Kameyama</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>JH</given-names></name><name><surname>Terao</surname><given-names>J</given-names></name></person-group><article-title>Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit</article-title><source>Free Radic Res</source><year>2005</year><volume>39</volume><issue>2</issue><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1080/10715760400019638</pub-id><?supplied-pmid 15763966?><pub-id pub-id-type="pmid">15763966</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR193"><text><SENT sid="59216" pm="."><plain><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahedi</surname><given-names>M</given-names></name><name><surname>Ghiasvand</surname><given-names>R</given-names></name><name><surname>Feizi</surname><given-names>A</given-names></name><name><surname>Asgari</surname><given-names>G</given-names></name><name><surname>Darvish</surname><given-names>L</given-names></name></person-group><article-title>Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial</article-title><source>Int J Prev Med</source><year>2013</year><volume>4</volume><issue>7</issue><fpage>777</fpage><lpage>785</lpage><?supplied-pmid 24049596?><pub-id pub-id-type="pmid">24049596</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR194"><text><SENT sid="59217" pm="."><plain><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>AA</given-names></name><name><surname>Novelli</surname><given-names>EL</given-names></name><name><surname>Okoshi</surname><given-names>K</given-names></name><name><surname>Okoshi</surname><given-names>MP</given-names></name><name><surname>Di Muzio</surname><given-names>BP</given-names></name><name><surname>Guimarães</surname><given-names>JF</given-names></name><name><surname>Fernandes</surname><given-names>JA</given-names></name></person-group><article-title>Influence of rutin treatment on biochemical alterations in experimental diabetes</article-title><source>Biomed Pharmacother</source><year>2010</year><volume>64</volume><issue>3</issue><fpage>214</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2009.08.007</pub-id><?supplied-pmid 19932588?><pub-id pub-id-type="pmid">19932588</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR195"><text><SENT sid="59218" pm="."><plain><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pashikanti</surname><given-names>S</given-names></name><name><surname>de Alba</surname><given-names>DR</given-names></name><name><surname>Boissonneault</surname><given-names>GA</given-names></name><name><surname>Cervantes-Laurean</surname><given-names>D</given-names></name></person-group><article-title>Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products</article-title><source>Free Radic Biol Med</source><year>2010</year><volume>48</volume><issue>5</issue><fpage>656</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.11.019</pub-id><?supplied-pmid 19969069?><pub-id pub-id-type="pmid">19969069</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR196"><text><SENT sid="59219" pm="."><plain><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervantes-Laurean</surname><given-names>D</given-names></name><name><surname>Schramm</surname><given-names>DD</given-names></name><name><surname>Jacobson</surname><given-names>EL</given-names></name><name><surname>Halaweish</surname><given-names>I</given-names></name><name><surname>Bruckner</surname><given-names>GG</given-names></name><name><surname>Boissonneault</surname><given-names>GA</given-names></name></person-group><article-title>Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites</article-title><source>J Nutr Biochem</source><year>2006</year><volume>17</volume><issue>8</issue><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2005.10.002</pub-id><?supplied-pmid 16443355?><pub-id pub-id-type="pmid">16443355</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR197"><text><SENT sid="59220" pm="."><plain><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>P</given-names></name><name><surname>Kamalakkannan</surname><given-names>N</given-names></name></person-group><article-title>Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes</article-title><source>J Biochem Mol Toxicol</source><year>2006</year><volume>20</volume><issue>2</issue><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1002/jbt.20117</pub-id><pub-id pub-id-type="pmid">16615078</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR198"><text><SENT sid="59221" pm="."><plain><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name></person-group><article-title>The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>373</volume><issue>4</issue><fpage>545</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.06.077</pub-id><?supplied-pmid 18586010?><pub-id pub-id-type="pmid">18586010</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR199"><text><SENT sid="59222" pm="."><plain><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umarani</surname><given-names>V</given-names></name><name><surname>Muvvala</surname><given-names>S</given-names></name><name><surname>Ramesh</surname><given-names>A</given-names></name><name><surname>Lakshmi</surname><given-names>BV</given-names></name><name><surname>Sravanthi</surname><given-names>N</given-names></name></person-group><article-title>Rutin potentially attenuates fluoride-induced oxidative stress-mediated cardiotoxicity, blood toxicity and dyslipidemia in rats</article-title><source>Toxicol Mech Methods</source><year>2015</year><volume>25</volume><issue>2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.3109/15376516.2014.1003359</pub-id><?supplied-pmid 25560802?><pub-id pub-id-type="pmid">25560802</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR200"><text><SENT sid="59223" pm="."><plain><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Yue</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name></person-group><article-title>Comparison of the phenolic content and antioxidant activities of <italic>Apocynum venetum L.</italic> (Luo-Bu-Ma) and two of its alternative species</article-title><source>Int J Mol Sci</source><year>2010</year><volume>11</volume><issue>11</issue><fpage>4452</fpage><lpage>4464</lpage><pub-id pub-id-type="doi">10.3390/ijms11114452</pub-id><?supplied-pmid 21151449?><pub-id pub-id-type="pmid">21151449</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR201"><text><SENT sid="59224" pm="."><plain><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dezsi</surname><given-names>S</given-names></name><name><surname>Bădărău</surname><given-names>AS</given-names></name><name><surname>Bischin</surname><given-names>C</given-names></name><name><surname>Vodnar</surname><given-names>DC</given-names></name><name><surname>Silaghi-Dumitrescu</surname><given-names>R</given-names></name><name><surname>Gheldiu</surname><given-names>AM</given-names></name><name><surname>Mocan</surname><given-names>A</given-names></name><name><surname>Vlase</surname><given-names>L</given-names></name></person-group><article-title>Antimicrobial and antioxidant activities and phenolic profile of <italic>Eucalyptus globulus Labill</italic>. and <italic>Corymbia ficifolia</italic> (F. </plain></SENT>
<SENT sid="59225" pm="."><plain>Muell.) K.D. </plain></SENT>
<SENT sid="59226" pm="."><plain>Hill &amp; L.A.S. </plain></SENT>
<SENT sid="59227" pm="."><plain>Johnson leaves</article-title><source>Molecules</source><year>2015</year><volume>20</volume><issue>3</issue><fpage>4720</fpage><lpage>4734</lpage><pub-id pub-id-type="doi">10.3390/molecules20034720</pub-id><?supplied-pmid 25786160?><pub-id pub-id-type="pmid">25786160</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR202"><text><SENT sid="59228" pm="."><plain><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>DM</given-names></name><name><surname>Pu</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>DW</given-names></name></person-group><article-title>Phytochemical profiles, antioxidant and antimicrobial activities of three <italic>Potentilla</italic> species</article-title><source>BMC Complement Altern Med</source><year>2013</year><volume>13</volume><fpage>321</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-13-321</pub-id><?supplied-pmid 24252124?><pub-id pub-id-type="pmid">24252124</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR203"><text><SENT sid="59229" pm="."><plain><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>An</surname><given-names>XF</given-names></name><name><surname>Teng</surname><given-names>SC</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Shang</surname><given-names>WB</given-names></name><name><surname>Zhang</surname><given-names>AH</given-names></name><name><surname>Yuan</surname><given-names>YG</given-names></name><name><surname>Yu</surname><given-names>JY</given-names></name></person-group><article-title>Pretreatment with the total flavone glycosides of <italic>Flos Abelmoschus manihot</italic> and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy</article-title><source>J Med Food</source><year>2012</year><volume>15</volume><issue>5</issue><fpage>461</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1089/jmf.2011.1921</pub-id><?supplied-pmid 22439874?><pub-id pub-id-type="pmid">22439874</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR204"><text><SENT sid="59230" pm="."><plain><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>X</given-names></name></person-group><article-title>Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury</article-title><source>J Nat Med</source><year>2016</year><volume>70</volume><issue>4</issue><fpage>740</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1007/s11418-016-1007-z</pub-id><?supplied-pmid 27255369?><pub-id pub-id-type="pmid">27255369</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR205"><text><SENT sid="59231" pm="."><plain><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Sethiel</surname><given-names>MS</given-names></name><name><surname>Shen</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>S</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name></person-group><article-title>Hyperoside downregulates the receptor for advanced glycation end products (RAGE) and promotes proliferation in ECV304 cells via the c-Jun N-terminal kinases (JNK) pathway following stimulation by advanced glycation end-products <italic>in vitro</italic></article-title><source>Int J Mol Sci</source><year>2013</year><volume>14</volume><issue>11</issue><fpage>22697</fpage><lpage>22707</lpage><pub-id pub-id-type="doi">10.3390/ijms141122697</pub-id><?supplied-pmid 24252909?><pub-id pub-id-type="pmid">24252909</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR206"><text><SENT sid="59232" pm="."><plain><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Um</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name></person-group><article-title>Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages</article-title><source>Am J Chin Med</source><year>2011</year><volume>39</volume><issue>1</issue><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1142/S0192415X11008737</pub-id><?supplied-pmid 21213407?><pub-id pub-id-type="pmid">21213407</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR207"><text><SENT sid="59233" pm="."><plain><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from <italic>Agrimonia Pilosa Ledeb</italic></article-title><source>BMC Complement Altern Med</source><year>2014</year><volume>14</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-14-12</pub-id><?supplied-pmid 24410924?><pub-id pub-id-type="pmid">24410924</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR208"><text><SENT sid="59234" pm="."><plain><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Kwak</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>OJ</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Hyperoside inhibits high-glucose-induced vascular inflammation <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Inflammation</source><year>2014</year><volume>37</volume><issue>5</issue><fpage>1389</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-9863-8</pub-id><?supplied-pmid 24609927?><pub-id pub-id-type="pmid">24609927</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR209"><text><SENT sid="59235" pm="."><plain><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZL</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>XQ</given-names></name><name><surname>Wang</surname><given-names>SW</given-names></name><name><surname>Yi</surname><given-names>DH</given-names></name><name><surname>Zhao</surname><given-names>MG</given-names></name></person-group><article-title>Protective effects of hyperoside against human umbilical vein endothelial cell damage induced by hydrogen peroxide</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>139</volume><issue>2</issue><fpage>388</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.11.020</pub-id><?supplied-pmid 22120016?><pub-id pub-id-type="pmid">22120016</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR210"><text><SENT sid="59236" pm="."><plain><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piao</surname><given-names>MJ</given-names></name><name><surname>Kang</surname><given-names>KA</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Ko</surname><given-names>DO</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>You</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kang</surname><given-names>SS</given-names></name><name><surname>Hyun</surname><given-names>JW</given-names></name></person-group><article-title>Hyperoside prevents oxidative damage induced by hydrogen peroxide in lung fibroblast cells via an antioxidant effect</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1780</volume><issue>12</issue><fpage>1448</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2008.07.012</pub-id><?supplied-pmid 18761393?><pub-id pub-id-type="pmid">18761393</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR211"><text><SENT sid="59237" pm="."><plain><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Xuan</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>HR</given-names></name><name><surname>Chen</surname><given-names>ZW</given-names></name></person-group><article-title>Protective effect against myocardial ischemia reperfusion injuries induced by hyperoside preconditioning and its relationship with PI3K/Akt signaling pathway in rats</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2015</year><volume>40</volume><issue>1</issue><fpage>118</fpage><lpage>123</lpage><?supplied-pmid 25993800?><pub-id pub-id-type="pmid">25993800</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR212"><text><SENT sid="59238" pm="."><plain><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>JY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>XM</given-names></name></person-group><article-title>Protective effect of hyperoside on cardiac ischemia reperfusion injury through inhibition of ER stress and activation of Nrf2 signaling</article-title><source>Asian Pac J Trop Med</source><year>2016</year><volume>9</volume><issue>1</issue><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2015.12.001</pub-id><?supplied-pmid 26851792?><pub-id pub-id-type="pmid">26851792</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR213"><text><SENT sid="59239" pm="."><plain><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZL</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>YL</given-names></name><name><surname>Xue</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>JQ</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yi</surname><given-names>DH</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name><name><surname>Wang</surname><given-names>SW</given-names></name></person-group><article-title>The effect of hyperoside on the functional recovery of the ischemic/reperfused isolated rat heart: potential involvement of the extracellular signal-regulated kinase 1/2 signaling pathway</article-title><source>Free Radic Biol Med</source><year>2013</year><volume>57</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.12.023</pub-id><?supplied-pmid 23291593?><pub-id pub-id-type="pmid">23291593</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR214"><text><SENT sid="59240" pm="."><plain><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Malherbe</surname><given-names>CJ</given-names></name><name><surname>Muller</surname><given-names>N</given-names></name><name><surname>Bonnet</surname><given-names>SL</given-names></name><name><surname>Van Der Westhuizen</surname><given-names>JH</given-names></name><name><surname>Ferreira</surname><given-names>D</given-names></name></person-group><article-title>Occurrence and sensory perception of Z-2-(β-D-glucopyranosyloxy)-3- phenylpropenoic acid in rooibos (<italic>Aspalathus linearis</italic>)</article-title><source>Food Chem</source><year>2013</year><volume>136</volume><issue>2</issue><fpage>1078</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.09.014</pub-id><?supplied-pmid 23122165?><pub-id pub-id-type="pmid">23122165</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR215"><text><SENT sid="59241" pm="."><plain><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Welsh</surname><given-names>M</given-names></name><name><surname>Malaisse-Lagae</surname><given-names>F</given-names></name><name><surname>Hellerstrom</surname><given-names>C</given-names></name><name><surname>Christophe</surname><given-names>J</given-names></name></person-group><article-title>Mechanism of 3-phenylpyruvate-induced insulin release</article-title><source>Metabolic aspects Biochem J</source><year>1983</year><volume>210</volume><issue>3</issue><fpage>921</fpage><lpage>927</lpage><?supplied-pmid 6409083?><pub-id pub-id-type="pmid">6409083</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR216"><text><SENT sid="59242" pm="."><plain><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Abraham</surname><given-names>R</given-names></name><name><surname>Gazit</surname><given-names>V</given-names></name><name><surname>Vofsi</surname><given-names>O</given-names></name><name><surname>Ben-Shlomo</surname><given-names>I</given-names></name><name><surname>Reznick</surname><given-names>AZ</given-names></name><name><surname>Katz</surname><given-names>Y</given-names></name></person-group><article-title>Beta-phenylpyruvate and glucose uptake in isolated mouse soleus muscle and cultured C2C12 muscle cells</article-title><source>J Cell Biochem</source><year>2003</year><volume>90</volume><issue>5</issue><fpage>957</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1002/jcb.10690</pub-id><?supplied-pmid 14624455?><pub-id pub-id-type="pmid">14624455</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR217"><text><SENT sid="59243" pm="."><plain><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>CJF</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Pheiffer</surname><given-names>C</given-names></name><name><surname>Ghoor</surname><given-names>S</given-names></name><name><surname>Sanderson</surname><given-names>M</given-names></name><name><surname>Chellan</surname><given-names>N</given-names></name><name><surname>Fey</surname><given-names>SJ</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name></person-group><article-title>Z-2-(β-d-glucopyranosyloxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (<italic>Aspalathus linearis</italic>) with hypoglycemic activity</article-title><source>Mol Nutr Food Res</source><year>2013</year><volume>57</volume><issue>12</issue><fpage>2216</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300294</pub-id><?supplied-pmid 23943314?><pub-id pub-id-type="pmid">23943314</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR218"><text><SENT sid="59244" pm="."><plain><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathijs</surname><given-names>I</given-names></name><name><surname>da Cunha</surname><given-names>DA</given-names></name><name><surname>Himpe</surname><given-names>E</given-names></name><name><surname>Ladriere</surname><given-names>L</given-names></name><name><surname>Chellan</surname><given-names>N</given-names></name><name><surname>Roux</surname><given-names>CR</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Cnop</surname><given-names>M</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Bouwens</surname><given-names>L</given-names></name></person-group><article-title>Phenylpropenoic acid glucoside augments pancreatic beta cell mass in high-fat diet-fed mice and protects beta cells from ER stress-induced apoptosis</article-title><source>Mol Nutr Food Res</source><year>2014</year><volume>58</volume><issue>10</issue><fpage>1980</fpage><lpage>1990</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201400211</pub-id><?supplied-pmid 25044754?><pub-id pub-id-type="pmid">25044754</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR219"><text><SENT sid="59245" pm="."><plain><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Himpe</surname><given-names>E</given-names></name><name><surname>Cunha</surname><given-names>DA</given-names></name><name><surname>Song</surname><given-names>I</given-names></name><name><surname>Bugliani</surname><given-names>M</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Cnop</surname><given-names>M</given-names></name><name><surname>Bouwens</surname><given-names>L</given-names></name></person-group><article-title>Phenylpropenoic acid glucoside from rooibos protects pancreatic beta cells against cell death induced by acute injury</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>6</issue><fpage>e0157604</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0157604</pub-id><?supplied-pmid 27299564?><pub-id pub-id-type="pmid">27299564</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR220"><text><SENT sid="59246" pm="."><plain><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orzel</surname><given-names>J</given-names></name><name><surname>Daszykowski</surname><given-names>M</given-names></name><name><surname>Kazura</surname><given-names>M</given-names></name><name><surname>De Beer</surname><given-names>D</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Schulze</surname><given-names>AE</given-names></name><name><surname>Beelders</surname><given-names>T</given-names></name><name><surname>De Villiers</surname><given-names>A</given-names></name><name><surname>Malherbe</surname><given-names>CJ</given-names></name><name><surname>Walczak</surname><given-names>B</given-names></name></person-group><article-title>Modeling of the total antioxidant capacity of rooibos (<italic>Aspalathus linearis</italic>) tea infusions from chromatographic fingerprints and identification of potential antioxidant markers</article-title><source>J Chromatogr A</source><year>2014</year><volume>1366</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2014.09.030</pub-id><?supplied-pmid 25283576?><pub-id pub-id-type="pmid">25283576</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR221"><text><SENT sid="59247" pm="."><plain><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dludla</surname><given-names>PV</given-names></name><name><surname>Muller</surname><given-names>CJ</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Gabuza</surname><given-names>KB</given-names></name><name><surname>Huisamen</surname><given-names>B</given-names></name><name><surname>Essop</surname><given-names>MF</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name></person-group><article-title>Phenylpyruvic acid-2-<italic>O</italic>-β-D-glucoside attenuates high glucose-induced apoptosis in H9c2 cardiomyocytes</article-title><source>Planta Med</source><year>2016</year><volume>82</volume><fpage>1468</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1055/s-0042-110856</pub-id><?supplied-pmid 27405104?><pub-id pub-id-type="pmid">27405104</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR222"><text><SENT sid="59248" pm="."><plain><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>O</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Joubert</surname><given-names>E</given-names></name><name><surname>Louw</surname><given-names>J</given-names></name><name><surname>Rosenkranz</surname><given-names>B</given-names></name><name><surname>Awortwe</surname><given-names>C</given-names></name></person-group><article-title>Inhibitory Interactions of <italic>Aspalathus linearis</italic> (rooibos) extracts and compounds, aspalathin and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid, on cytochromes metabolizing hypoglycemic and hypolipidemic drugs</article-title><source>Molecules</source><year>2016</year><volume>21</volume><issue>11</issue><fpage>1515</fpage><pub-id pub-id-type="doi">10.3390/molecules21111515</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR223"><text><SENT sid="59249" pm="."><plain><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Vascular barrier protective effects of orientin and isoorientin in LPS-induced inflammation <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Vasc Pharmacol</source><year>2014</year><volume>62</volume><issue>1</issue><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2014.04.006</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR224"><text><SENT sid="59250" pm="."><plain><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Zhen</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name></person-group><article-title>Vitexin exerts cardioprotective effect on chronic myocardial ischemia/reperfusion injury in rats via inhibiting myocardial apoptosis and lipid peroxidation</article-title><source>Am J Transl Res</source><year>2016</year><volume>8</volume><issue>8</issue><fpage>3319</fpage><lpage>3328</lpage><?supplied-pmid 27648122?><pub-id pub-id-type="pmid">27648122</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR225"><text><SENT sid="59251" pm="."><plain><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Occhiuto</surname><given-names>F</given-names></name><name><surname>Circosta</surname><given-names>C</given-names></name><name><surname>De Pasquale</surname><given-names>A</given-names></name><name><surname>Briguglio</surname><given-names>F</given-names></name></person-group><article-title>Comparative haemodynamic effects of the flavonoids rhoifolin and vitexin in the dog</article-title><source>Phytother Res</source><year>1990</year><volume>4</volume><issue>3</issue><fpage>118</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650040310</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR226"><text><SENT sid="59252" pm="."><plain><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>WY</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Sheng</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name></person-group><article-title>Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a</article-title><source>Exp Ther Med</source><year>2016</year><volume>12</volume><issue>3</issue><fpage>1879</fpage><lpage>1884</lpage><?supplied-pmid 27588105?><pub-id pub-id-type="pmid">27588105</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR227"><text><SENT sid="59253" pm="."><plain><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Bruce</surname><given-names>IC</given-names></name></person-group><article-title>Luteolin induces vasorelaxion in rat thoracic aorta via calcium and potassium channels</article-title><source>Pharmazie</source><year>2005</year><volume>60</volume><issue>6</issue><fpage>444</fpage><lpage>447</lpage><?supplied-pmid 15997834?><pub-id pub-id-type="pmid">15997834</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR228"><text><SENT sid="59254" pm="."><plain><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>PH</given-names></name><name><surname>Hung</surname><given-names>LM</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Kuan</surname><given-names>YH</given-names></name><name><surname>Zhang</surname><given-names>FB</given-names></name><name><surname>Lin</surname><given-names>RH</given-names></name><name><surname>Shih</surname><given-names>HC</given-names></name><name><surname>Tsai</surname><given-names>SK</given-names></name><name><surname>Huang</surname><given-names>SS</given-names></name></person-group><article-title>Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats</article-title><source>Circ J</source><year>2011</year><volume>75</volume><issue>2</issue><fpage>443</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1253/circj.CJ-10-0381</pub-id><?supplied-pmid 21178298?><pub-id pub-id-type="pmid">21178298</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR229"><text><SENT sid="59255" pm="."><plain><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challa</surname><given-names>SR</given-names></name><name><surname>Akula</surname><given-names>A</given-names></name><name><surname>Metla</surname><given-names>S</given-names></name><name><surname>Gopal</surname><given-names>PN</given-names></name></person-group><article-title>Partial role of nitric oxide in infarct size limiting effect of quercetin and rutin against ischemia-reperfusion injury in normal and diabetic rats</article-title><source>Indian J Exp Biol</source><year>2011</year><volume>49</volume><issue>3</issue><fpage>207</fpage><lpage>210</lpage><?supplied-pmid 21452600?><pub-id pub-id-type="pmid">21452600</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR230"><text><SENT sid="59256" pm="."><plain><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>P</given-names></name><name><surname>Rodriguez-Gómez</surname><given-names>I</given-names></name><name><surname>González-Manzano</surname><given-names>S</given-names></name><name><surname>Dueñas</surname><given-names>M</given-names></name><name><surname>Jiménez</surname><given-names>R</given-names></name><name><surname>Menéndez</surname><given-names>C</given-names></name><name><surname>Vargas</surname><given-names>F</given-names></name><name><surname>Tamargo</surname><given-names>J</given-names></name><name><surname>Santos-Buelga</surname><given-names>C</given-names></name><name><surname>Pérez-Vizcaíno</surname><given-names>F</given-names></name><name><surname>Duarte</surname><given-names>J</given-names></name></person-group><article-title>Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>3</issue><fpage>e32673</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0032673</pub-id><?supplied-pmid 22427863?><pub-id pub-id-type="pmid">22427863</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR231"><text><SENT sid="59257" pm="."><plain><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>XD</given-names></name><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Gao</surname><given-names>XJ</given-names></name><name><surname>Parry</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>BL</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation</article-title><source>Mol Nutr Food Res</source><year>2013</year><volume>57</volume><issue>6</issue><fpage>1037</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201200569</pub-id><?supplied-pmid 23504962?><pub-id pub-id-type="pmid">23504962</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR232"><text><SENT sid="59258" pm="."><plain><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annapurna</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>CS</given-names></name><name><surname>Akondi</surname><given-names>RB</given-names></name><name><surname>Rao</surname><given-names>SR</given-names></name></person-group><article-title>Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats</article-title><source>J Pharm Pharmacol</source><year>2009</year><volume>61</volume><issue>10</issue><fpage>1365</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1211/jpp.61.10.0014</pub-id><?supplied-pmid 19814870?><pub-id pub-id-type="pmid">19814870</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR233"><text><SENT sid="59259" pm="."><plain><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Jing</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Miao</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name></person-group><article-title>Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat</article-title><source>Can J Physiol Pharmacol</source><year>2013</year><volume>91</volume><issue>11</issue><fpage>951</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1139/cjpp-2012-0432</pub-id><?supplied-pmid 24117263?><pub-id pub-id-type="pmid">24117263</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR234"><text><SENT sid="59260" pm="."><plain><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchal</surname><given-names>SK</given-names></name><name><surname>Poudyal</surname><given-names>H</given-names></name><name><surname>Arumugam</surname><given-names>TV</given-names></name><name><surname>Brown</surname><given-names>L</given-names></name></person-group><article-title>Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats</article-title><source>J Nutr</source><year>2011</year><volume>141</volume><issue>6</issue><fpage>1062</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.3945/jn.111.137877</pub-id><?supplied-pmid 21508207?><pub-id pub-id-type="pmid">21508207</pub-id></element-citation> </plain></SENT>
</text></ref><ref id="CR235"><text><SENT sid="59261" pm="."><plain><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saklani</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Mohanty</surname><given-names>IR</given-names></name><name><surname>Kumar</surname><given-names>B</given-names></name><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Mathur</surname><given-names>R</given-names></name></person-group><article-title>Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats</article-title><source>Mol Cell Biochem</source><year>2016</year><volume>420</volume><issue>1–2</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s11010-016-2767-1</pub-id><?supplied-pmid 27443845?><pub-id pub-id-type="pmid">27443845</pub-id></element-citation> </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
